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SUMMARY
Human parotid saliva contains many proteins with 
diverse functions. In the course of a number of diseases, 
especially where the normal function of the salivary gland 
is affected, changes may occur in the levels of certain of 
these. Therefore the analysis of some of these proteins may 
be of diagnostic significance. This study has focused on the 
development and refinement of electrophoretic and of protein 
detection techniques in order to allow the fractionation of 
proteins in small volumes of human saliva with the minimum 
of sample preparation. In order to give an example of their 
possible diagnostic significance, the electrophoretic tech­
niques which were developed were applied to the fractiona­
tion and partial characterisation of the anionic salivary 
proteins associated with connective tissue disorders such as 
rheumatoid arthritis and Sjogren's Syndrome.
The saliva of patients with rheumatoid arthritis and 
Sjogren's Syndrome contains additional anionic proteins, 
which are either present in very low levels or below detec­
tion limits in the saliva of normal healthy individuals. 
Research into the identity of these proteins has been 
largely hindered by the relatively high electrolyte and low 
protein content of human parotid saliva, making it necessary 
to desalt and concentrate the saliva samples prior to car­
rier ampholyte-based isoelectric focusing. Desalting re­
quires relatively large volumes (preferably > 2ml) of 
saliva, which may be difficult or even impossible to obtain
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from diseased glands. Also, one-dimensional isoelectric 
focusing cannot separate these anionic proteins from the 
acidic proline-rich proteins of human saliva, as both groups 
of proteins have overlapping isoelectric points.
In this study, a hybrid carrier ampholyte-immobilised 
pH gradient isoelectric focusing technique was developed to 
analyse human salivary proteins. Immobilised pH gradients 
(IPG's) of 3 pH ranges were prepared: broad-range (pH 4-9) 
IPG was used for the general study of human salivary 
proteins; while 2 narrow, acidic range IPG's (pH 2.8-4.5 and 
pH 3.5-5.0) were used to analyse proteins of low 
isoelectric points, such as the anionic salivary proteins 
associated with rheumatoid arthritis and Sjogren's Syndrome. 
This method allowed the difficulties involved when conven­
tional carrier ampholyte-based isoelectric focusing is used 
to be circumvented, thus making it possible to fractionate 
the proteins in small volumes (approximately 50fil) of human 
saliva without prior treatment except for centrifugation.
Parotid salivary proteins were also analysed by one­
dimensional SDS-PAGE. SDS-PAGE gels were subjected to im- 
muno- and lectin affinity-blotting in order to characterise 
or identify some of the protein bands. Proline-rich proteins 
were recognised by their characteristic pink-staining with 
the dye Coommassie Brilliant Blue R250, and some of the 
bands which were revealed have been correlated with
proline-rich proteins which have been isolated and partially 
characterised by other research groups. SDS-PAGE failed to
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reveal any obvious differences between the band patterns of 
normal subjects and those of patients with rheumatoid 
arthritis or Sjogren's Syndrome.
Two-dimensional gel electrophoresis was also carried 
out using hybrid carrier ampholyte-immobilised pH gradient 
polyacrylamide gels in the first dimension and thin-layer 
SDS-polyacrylamide gradient gels in the second. By means of 
a combination of staining and electroblotting of the two- 
dimensional gels onto nitrocellulose followed by probing 
with specific antisera, a two-dimensional map of human 
parotid salivary proteins, in which most of the major com­
ponents have been identified, has been obtained.
These techniques were applied to the investigation of 
the nature of the anionic salivary proteins associated with 
rheumatoid arthritis and Sjogren's Syndrome. Two-dimensional 
electrophoresis with pH 3.5-5.0 IPG's in the first dimension 
followed by silver staining revealed these proteins to be 
heterogeneous (pi's approximately 3.65-4.75) and of a single 
relative molecular weight (approximately 32,000). In normal 
healthy controls these silver stained components were less 
heterogeneous (pi's approximately 3.65-4.25). Incubation 
with neuraminidase showed that their heterogeneity was 
largely due to differing contents of sialic acid in their 
carbohydrate side-chains.
In order to attempt to identify these proteins, the 
o n e - d i m e n s i o n a l  IPG and t w o - d i m e n s i o n a l  gels were 
electroblotted and the blots were probed with a variety of
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antisera. The proteins appeared to be immunoreactive with 
antisera to human tissue kallikrein, a protein the level of 
which has often been reported to be elevated in the saliva 
of patients with Sjogren's Syndrome. The proteins also ap­
peared to correspond in terms of their isoelectric point 
and molecular weight values with salivary kallikrein.
Immunoblotting of IPG's of pH range 3.5-5.0 and 2-D 
PAGE gels^ IPG's of pH range 3.5-5.0 in the first dimension 
showed that the range of isoelectric points of the proteins 
which cross-reacted with antiserum to human tissue kallik­
rein was the same both in normal healthy controls and in the 
patients (approximately 3.65-4.75). The bands produced were 
remarkably similar to those of human urinary kallikrein. 
Elevated levels of kallikrein in rheumatoid arthritis and 
Sjogren's Syndrome patients was observed by immunoblotting 
and by enzyme assay.
However, wheareas silver staining of pH 3.5-5.0 IPG's 
revealed that the anionic proteins being studied appeared to 
be labile to Endo F and PNGase F digestion, immunoblotting 
of these gels using antiserum to kallikrein showed the 
presence of immunoreactive bands whose isoelectric points 
appeared to be unaltered by such treatment. Two possible ex­
planations for this result have been suggested: The first is 
that the anionic proteins associated with rheumatoid 
arthritis and Sjogren's Syndrome and salivary kallikrein may 
be two different proteins with close isoelectric point and 
molecular weight values. The second is that deglycosylation
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by Endo F or PNGase F is incomplete, as often is the case 
when attempting to deglycosylate intact native glycoproteins 
using endoglycosidases; thus there may have been sufficient 
amounts of the undigested glycoproteins to be detected by
immunoblotting.
A partial purification of the anionic salivary proteins
associated with rheumatoid arthritis and Sjogren's Syndrome
was also obtained by Anion-Exchange High Performance Liquid
Chromatography using a Mono-Q column. Separation of these
proteins from the acidic proline-rich proteins was achieved
despite their overlapping isoelectric points. However, the
yield * of anionic proteins was too low either to ascertain 
LV\oir
^purity or for further structural studies. Accordingly,
their identity remains to be ascertained, although there is 
some evidence that indicates that they might be salivary 
kallikrein. If they are, it is likely that in the normal 
subjects, the proteins of pi's approximately 3.65-4.25, 
which were revealed by silver staining of 2-D PAGE gels with 
pH 3.5-5.0 IPG's in the first dimension, are the major 
isozymes of salivary kallikrein, while the minor components 
of higher pi's (approximately 4.25-4.75) were present at 
levels which were too low to be revealed by silver staining. 
However, they were visualised by immunoblotting.
Isoelectric focusing of parotid saliva from these 
patients in IPG's of acidic pH range, such as pH 3.5-5.0, 
could be potentially useful for the diagnosis of these dis­
orders as the presence of elevated levels of the anionic
(xxxi)
proteins has correlated well with diagnoses of Sjogren's 
Syndrome (especially in its secondary form) and rheumatoid
(x x x i i )
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1. INTRODUCTION
1.1. Salivary Glands
1.1.1. The Phylogeny of Salivary Glands
The movement of the early amphibians from their aquatic 
environment to colonise dry land necessitated considerable 
changes in their anatomy and physiology to allow them to 
adapt to their new surroundings. For example, certain 
tissues which could only function when moist had to come 
into direct contact with the atmosphere. These tissues in­
clude the oral cavity which in mammals is bathed by saliva 
(Dickinson et a l ♦, 1987).
The first salivary glands in vertebrates may have 
evolved from secretory granules which appeared in otherwise 
unspecialised buccal epithelial cells. This may have led to 
the development of specialised goblet cells. Salivary glands 
are absent in fishes, with the exception of some Cyclos- 
tomata. These glands are poorly developed in amphibians but 
are well-formed in reptiles, birds and mammals. This shows 
the manner in which an increase in the complexity of 
salivary glands is observed along the evolutionary scale 
(Young and van Lennep, 1978).
1.1.2. Human Salivary Glands
Salivary glands are present in all mammals. In man and 
higher mammals, three pairs of such glands are arranged in a 
bilateral fashion. The mixture of fluids produced and 
secreted by these glands is referred to as "saliva".
Human salivary glands consist of the following minor 
glands: labial, lingual, palatal and buccal; and three pairs 
of major glands; parotid, submandibular and sublingual 
(Mason and Chisholm, 1975 ). The locations of the major 
glands are shown in Fig. 1.1. Their secretions differ in 
composition, and the relative contributions of the secre­
tions from each pair of glands to mixed saliva vary under 
different conditions. Mixed saliva may also contain 
crevicular fluid.
Under "resting" conditions the relative contributions 
of the three pairs of major salivary glands to the total 
volume of saliva are approximately: submaxillary, 60%;
parotid, 35%; and sublingual, 2%. In acid-stimulated saliva, 
their relative contributions are 70%, 25% and 4% 
respectively. The remaining volumes are contributed by the 
minor salivary glands. The minor glands are widely dis­
tributed throughout the mouth but are absent from the an­
terior region of the hard palate. Their average contribution 
to whole saliva is less than 10% of the total volume 
(Jenkins, 1978).
Salivary gland secretion is regulated by the sym­
pathetic and parasympathetic nerves. The main stimulus for 
inducing the flow of saliva comes from the combined actions 
of the parasympathetic system and the Of-adrenergic component 
of the sympathetic system while the ^g-adrenergic component 
of the sympathetic system modulates the composition of 
saliva (Ryberg et a l ., 1989). The neurotransmitters released
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Fig. 1.1. Locations of the major salivary glands 
(Drawing kindly provided by Miss Fiona Peden)
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from these nerve endings act as the first messengers,of 
secretory response in activating the cholinergic and 
adrenergic receptors on the acinar cell surface. The 
parasympathetic nerves release acetylcholine which is 
detected by the muscarinic cholinergic receptors, while the 
sympathetic nerves release norepinephrine which is detected 
by a ~  and ^-adrenergic receptors (Baum, 1987).
Activation of the ^-adrenergic receptors results mainly 
in the exocytosis of secretory granules. The activated 
-adrenergic receptor interacts with a G protein referred to 
as Gs , which in turn interacts with adenylate cyclase, caus­
ing an increase in the level of cyclic adenosine monophos­
phate (cAMP). cAMP then activates cAMP-dependent protein- 
kinase which leads to exocytosis. This system is opposed by 
the activation of the Q^-adrenergic receptor.
Activation of the Q^-adrenergic and muscarinic recep­
tors results primarily in salivary fluid secretion (Baum, 
1987; Putney, 1988). The c^-adrenergic and muscarinic recep­
tors activate a system which utilises inositol 1,4,5- 
triphosphate (iPg), diacylglycerol and ionic calcium. The 
ionic calcium signal mainly regulates the secretion of 
electrolytes and water (Baum, 1987; Izutsu, 1989).
Salivary glands contain two types of secretory cells, 
serous and mucous. Serous secretions are watery and 
protein-rich while mucous secretions are viscous and 
carbohydrate-rich. Serous cells are arranged in clusters 
called acini which are one cell thick and have an extensive
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rough endoplasmic recticulum and prominent secretary 
granules (Tandler, 1987). Mucous cells produce a viscous 
secretion consisting almost entirely of mucins, which are 
glycoproteins of high molecular weight (Tabak et al . , 1982?
De Rossi et a l ., 1987). Macromolecules are stored in zymogen
granules after synthesis, and exocytosis is the major route 
of protein and glycoprotein secretion into saliva. Their 
secretion involves the fusion of the granule membrane with 
the luminal plasma membrane of the acinar cells (Dowd et 
al., 1983).
Salivary fluid production occurs by an osmotic 
mechanism in which sodium, potassium and chloride ions are 
transported across the acinar cell into the acinar lumen by 
a protein molecule located in the basolateral membrane of 
the acinar cell, called the Na+/K+/Cl“ co-transporter. The 
movement of sodium chloride results in the formation of an 
osmotic gradient which draws water from the extracellular 
space, across the acinar cell, and finally into the acinar 
lumen (Martinez, 1987).
The most widely accepted model for saliva production 
is a two-step process (Izutsu, 1987). The first step is the 
production of an isotonic primary secretion by the acini of 
the salivary glands, and in the second step this fluid is 
rendered hypotonic as it flows through the ducts. The latter 
process involves a ductal reabsorption of sodium chloride 
and the secretion of potassium and bicarbonate. The sites of 
secretion and reabsorption of proteins and various ions
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during saliva production are summarised in Figure 1.2.
1.2. Saliva
Arglebe (1981) noted that saliva had been "a stepchild
of research for a long time". Until 1964, only one
laboratory handbook of biochemical data (Kolbe, 1964)
r
provided a list of substances occurring in human saliva. 
Since then, knowledge regarding the composition and function 
of saliva has advanced considerably. This reflects the in­
creasing awareness that the chemical composition of saliva 
may help us to draw conclusions about pathological changes 
in the salivary glands and may also help to indicate the 
presence of disease in other parts of the body.
1.2.1. The Composition of Saliva
1.2.1.(i) Inorganic Constituents
The function of saliva to a large extent depends on its 
composition. The concentrations of the most important con­
stituents of parotid saliva are listed in Table 1.1.
The pH and buffering capacity of saliva are largely 
determined by its inorganic constituents. The major 
monovalent cations are sodium and potassium while the major 
divalent cation is calcium which occurs both as free ions 
and in a protein-bound form in a ratio of approximately 1:1 
(Seifert et a 1 . , 1986). The major anions are chloride,
bicarbonate and phosphate. Salivary phosphate occurs in 
either the free or protein-bound forms. Bicarbonate and
6
Fig. 1.2. Sites of secretion within the gland of some con­
stituents of saliva
(Diagram taken from Waterhouse et a 1., 1990).
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Table 1.1. Concentrations of some constituents of parotid 
saliva (from Mason and Chisholm, 1975)
Unstimulated Stimulated 
Sodium (mmol/l) 2 . 6 + 2 . 0  5 4 . 9 + 1 6 . 9
Potassium (mmol/l) 36.7 + 12.5 16.0 + 2.7
Calcium (mmol/l) 0 . 7 5 + 0 . 2 5  0 . 8 2 + 0 . 5 5
Magnesium (mmol/l) 0.1 + 0.05 0.02 + 0.13
Chloride (mmol/l) 24.8 + 7.6 33.3 + 13.4
Bicarbonate (mmol/l) 1 . 1 + 0 . 1  2 9 . 5 + 9 . 6
Phosphate (mmol/l) (inorganic) 3.4 + 1.4 ~ 3 . 3 + 2 . 6  -
(total) 5.6 + 2.6
Protein (g/1) 2.35 + 3.87 1.64 + 0.51
Q'-Amylase (g/l) 1.03 + 0.11 0.95 + 0.15
slgA (mg/l) 39.5 + 13.7
IgG (mg/l) 0.36 + 0.3
IgM (mg/l) 0.43 + 0.36
Lysozyme (mg/l) 4 2 + 9  2 3 + 1 4
Albumin (mg/l) 2.8
Lactoferrin (mg/l) 5.4 + 2.6
Urea (mmol/l) 3.0 4.64
Uric acid (mmol/l) 0.57 + 0.25 0.17 + 0.05
Glucose (p.mol/1) 42 + 38 8 + 3
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phosphate are the main buffering species in saliva and pLay 
a substantial role in the prevention of dental caries (Argus 
and Schamschula, 1983).
1 . 2 . 1 .  ( i i ) O r g a n i c  C o n s t i t u e n t s
Most of the o r g a n i c  m a t e r i a l  in s a l i v a  is 
proteinaceous. Proteins in whole saliva may arise from the 
salivary glands, gingival fluid and bacteria. Most of the 
salivary proteins are synthesized within the epithelial 
cells (i.e. acini and ducts) of the salivary glands, e.g. 
secretory component (Tomasi and Bienenstock, 1968).
A small proportion of the protein is derived by leakage 
from the serum of the salivary gland capillaries. One ex­
ample is albumin which is probably transudated passively 
from the serum into saliva (Strober et a 1 . , 1970;
Brandtzaeg, 1971).
Non-proteinaceous organic compounds of low relative 
molecular weight (Mr ) in saliva include urea and uric acid, 
the levels of which are related to serum levels. Very low 
amounts of cholesterol, free amino acids, free car­
bohydrates, steroid hormones and lipids are also present 
(Arglebe, 1981). Of these compounds, the most important for 
diagnostic purposes are probably the steroid and polypeptide 
hormones. Corticosteroids in human saliva were first ex­
amined by Shannon et a l . (1959), and all the major steroid
hormones have been found to be present in saliva (Ferguson,
1984). Polypeptide hormones also occur in saliva. An example
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is epidermal growth factor (EGF) which has been identified 
in submandibular saliva (Elder et_al., 1978). EGF stimulates 
cell proliferation and probably has an important role in 
the repair of injury to the gastrointestinal mucosa.
1.2.2. Salivary Proteins
The total protein content of saliva is normally ap­
proximately 1-2 mg/ml/ but this value varies considerably. 
The majority of these proteins belong to one or more of the 
following categories:
1.2.2.(i) Enzymes
(a ) Cl-Amylase
Ct-Amylase (E.C. 3.2.1.1) is the major protein in
saliva, constituting about 10% of the total protein in human 
saliva (Bernfield, 1951). It is an a - (1 ,4)-glucan-4- 
glucanohydrolase which hydrolyses starch, producing maltose, 
glucose and limit dextrans. The enzyme is synthesized in the 
acinar cells and occurs in two forny glycosylated (Mr 
63,000) and non-glycosylated (Mr 59,000). It may be 
separated into a series of isozymes by isoelectric focusing 
(Eckersall and Beeley, 1981), the pattern of which is 
genetically determined. Karn et a l . (1973) postulated that a
single gene is responsible for the production of an 
a-amylase polypeptide and that the multiple molecular forms
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arise by post-translational deglycosylation and deamidation.
Other than starch digestion, CK-amylase may play an an­
tibacterial role as it has been demonstrated that it binds 
to various strains of Streptococci (Douglas, 1983).
(b) Lysozyme
L y s o z y m e  or m u r a m i d a s e  (N - a c e t y 1 m u r a m i d e  
glycanohydrolase, Mr 15,000) was first discovered in saliva 
by Fleming (1922). It hydrolyses the (1, 4 )-gl ucosidic 
l i n k a g e s  b e t w e e n  N - a c e t y 1 m u r a m i n ic a ci d  a n d  
N-acetylglucosamine in the cell wall peptidoglycans of cer­
tain gram-positive bacteria, resulting in an increase in 
membrane permeability or lysis. Autoaggregation of some 
species may also occur (Pollock et a l ., 1985; 1987).
(c ) Lactoperoxidase
Lactoperoxidase (Mr 77,500) is a glycoprotein which is 
synthesized by the parotid and submandibular acinar cells. 
It uses the hydrogen peroxide produced by bacteria to 
oxidise salivary thiocyanate (SCN“ ) to hypothiocyanite 
(OSCN- ) and hypothiocyanous acid (H0SCN“ ) which are oxidis-
Y
ing agents which react with the sulphydrl groups (-SH) in 
key bacterial enzymes, thus inhibiting glycolysis (Tenovuo 
et a l ♦, 1981).
(d) Tissue Kallikrein
Tis s u e  k a l l i k r e i n  (E.C. 3.4.21.35), an acidic
glycoprotein which is secreted by the striated salivary duct 
cells, is a trypsin-like serine protease which cleaves 
kininogen to form kallidin, a vasodilator kinin (Schachter,
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1964; 1980; Skurk et a l ., 1979). The effects of kinin in­
clude vasodilatation and increased vascular permeability 
which alters local blood flow and pressure, and leucotaxis 
(Selwyn et a l ., 1989).
There are two separate kallikrein-kinin systems; one in 
plasma and the other in the exocrine glands. Plasma and 
glandular (or tissue) kallikreins are antigenically and en­
zymatically different ((f)rstavik, 1980). However, both act as 
kininogenases . Plasma kallikrein acts on a high M r 
kininogen, a plasma Qf2_9 l°t>ulin / releasing bradykinin (a 
nonapeptide). Tissue kallikrein acts on both high and low Mr 
kininogens, with a preference for the latter, releasing the 
decapeptide lysyl-bradykinin (kallidin) (MacDonald et a l ., 
1988) .
Salivary kallikrein belongs to the glandular type, and 
rabbit anti-human urinary kallikrein serum cross-reacts with 
both human urinary and salivary kallikreins (Iketika et 
al ., 1983a). Human urinary kallikrein (HUK) has been
purified by Hial et a l . (1974) who established that it had
a Mr of 43,600 and is microheterogeneous with pi values of 
3.80, 3.95 and 4.06. Its carbohydrate moiety has been
studied by Iketika et a l . ( 1983b) who found that the
heterogeneity was largely due to variation not only in the 
charge of the oligosaccharides (arising from differences in 
the degree of sialation) but also to the differing Mr ' s of 
the oligosaccharide moieties. Examples of other tissue kal­
likreins are pancreatic, renal and urinary kallikrein
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(Schachter, 1980).
Tissue kallikreins isolated from different tissues have 
been shown to be closely related or even identical in the 
polypeptide chain to HUK, but to differ in their car­
bohydrate moieties (Kellermann et al . , 1988). Salivary kal­
likrein has been isolated from human saliva by Hare and Ver- 
poorte (1982), who reported that it had a pi of 4.0 and an 
Mr (determined by SDS-PAGE) of 27,000. Although its amino 
acid composition was obtained, it was not sequenced.
Human urinary kallikrein (HUK) has been more exten­
sively studied than salivary kallikrein, and its complete 
amino acid sequence has been determined (Kellermann et a l ., 
1988; Takahashi et a l . , 1988; Lu et al ♦, 1989). HUK occurs
in both inactive and active f o r m s . The inactive form 
(prokallikrein) is a proenzyme with 238 amino acid residues 
and has an additional 7 amino acids at the amino terminus of 
active kallikrein. Prokallikrein is converted to active kal­
likrein by the cleavage of the N-terminal peptide consisting 
of 7 amino acids (Takahashi et al . , 1986). HUK displays
charge heterogeneity which results from differences in 
glycosylation. Kellermann et a l . (1988) has identified 6
carbohydrate side chains on the polypeptide; 3 of them were 
N-glycosidically linked to asparagine and the other 3 were 
O-glycosidi c a 1ly linked to 2 serine and one threonine 
residues.
(e ) Trace Enzymes
Trace enzymes of glandular origin in saliva include
13
glucose-6-pho spha te d e h yd ro ge na se , arginase, lacta-te 
dehydrogenase, alkaline phosphatase, acid phosphatase, 
adenosine triphosphatase and ribonuclease (Arglebe, 1981).
1.2.2.(ii) Proline-Rich Proteins
The major group of proteins in human parotid and sub­
mandibular saliva are the proline-rich proteins (PRP's ). 
About 75% of their amino acids consist of proline, glycine 
and dicarboxylic acids. They were first discovered by Op- 
penheim et a l . (1971).
P R P ' s are a highly complex polymorphic system of 
proteins, and their synthesis is controlled by a set of 
genes located on chromosome 12. Differential mRNA-splicing 
and post-translational modification (Maeda, 1985; Maeda et 
a 1. , 1985) as well as intragenic unequal crossing over
(Lyons et a l ., 1988) may add to their complexity.
PRP' s may be divided into three groups; acidic, basic
and glycosylated which account for 30%, 23% and 17% of the
total proteins in saliva, respectively (Bennick, 1982; 
1987). Four PRP1s (designated "A" - "D") have been purified 
by Bennick and Connell (1971). The amino acid sequence of 
"A" (Mr 9,900) was found to be identical to the N-terminal
106 residues of "C" (Mr 16,300), suggesting that "A" may be
formed by a post-synthetic cleavage of "C" at the arginine- 
glycine bond in positions 106-107 (Wong and Bennick, 1980). 
Although prolonged incubation (72 hrs) with tissue kallik-
14
rein is capable of effecting this cleavage, it is unlikely 
that this process takes place in vivo because the acidic 
PRP' s are synthesized in the acinar cells of the parotid 
gland while kallikrein is present only in the ductal cells. 
After their secretion by the acinar cells, the acidic PRP's 
do not remain in the salivary ducts for a sufficient length 
of time to be subjected to the action of kallikrein (Wong et 
a l . , 1983) .
9 non-glycosylated basic P R P 1s ( " I B 1 " I B 9  " , (Mr 
6,000-12,000) have been isolated by Kauffman et a l . (1986)
and 7 (" P - C " P - I ") of similar Mr 's and structure have been
reported by Saitoh et a l . (1983). The major glycosylated PRP
(Mr 38,900) is basic and contains 30% carbohydrate (Li and 
Levine, 1980; Levine et a l ., 1987).
The function of the basic P R P 1s remains to be 
elucidated. The acidic PRP1s have a strong affinity for cal­
cium, suggesting a possibility that they may play a role in 
the maintainence of calcium concentration in saliva and in 
inhibiting the formation of hydroxylapatite crystals on 
tooth surfaces (Bennick, 1976; Braunlin et a 1 ., 1986).
Another possible role of the PRP's is the binding of dietary 
tannins (Hagerman and Butler, 1981). Tannins may prevent the 
d i g e s t io n of p r o t e in s in t a n n i n - r i c h  f o o d stuff  by 
precipitating them, thereby reducing their nutritional
value. Tannins may also inactivate the digestive enzymes.
r
Tannin-binding by PRP' s may help to reduce the occurrence of 
these events (Mehansho e t a l ., 1985; 1987).
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1.2.2.(iii) Immunoglobulins
The major immunoglobulin in human parotid saliva is 
secretory Immunoglobulin A (slgA, Mr 390,000) (Chodirker and 
Tomasi, 1963). slgA consists of an IgA dimer, joined by a J 
chain and a secretory component (Tomasi et a l ., 1965). About 
95% of the IgA in saliva is synthesized as dimers by the 
plasma cells within the salivary glands. The IgA dimer, held 
in the dimer configuration by a J chain, is produced by 
plasma cells in the insterstitial tissue spaces. Secretory 
component is produced as a transmembrane protein in the 
rough endoplasmic recticulum of secretory epithelial cells. 
B r a d t z a e g  (1985) has p r o p o s e d  that IgA dimers are 
transported through the secretory epithelium by secretory 
component-mediated endocytosis, thus facilitating transport 
of slgA into secretions. Secretory component also protects 
the IgA dimer from proteolysis (Lindh, 1974).
Gingivial exudate is probably the main source of the 
IgG, IgA, IgE and IgM in whole saliva (Grundbacher, 1988).
The IgG content of parotid saliva is approximately 0.4-4 
mg/l (Brandtzaeg et a l ., 1970). 50% of this is transudated
from the serum (Ruhwinkel and Miinzel, 1975). The IgM content 
of parotid saliva is between 0.1-0.8 mg/l (Brandtzaeg et 
al., 1970). IgM is a pentamer of the basic four-chain im­
munoglobulin unit. Its high molecular weight is due to this 
and also the fact that IgM /(-chains have one additional 
domain compared to IgG 7 -chains. The transudation of IgM
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from serum into saliva is largely blocked because of its 
large size (Tomasi, 1972).
1.2.2.(iv) Mucins
Mucins are the main organic constituents of mucus which 
coats all mucosal surfaces. Salivary mucins are secreted by 
the mucous cells of the submandibular/ sublingual and minor 
salivary glands. About 70% of the total mucins in whole 
saliva is produced by the minor glands (Tabak et a l ., 1982). 
Mucins are glycoproteins which contain 70-80% carbohydrate. 
The carbodydrate side-chains are O-glycosidically linked. 
Mucins play an important role in the none-immune protection 
of the oral cavity. Examples are ,,M G 1 , (Mr > 1,000,000)
which is a lubricant, binds to hydroxylapaptite, and is a 
constituent of the pellicle; and "MG2" (Mr 200,000-250,000) 
which is a poorer lubricant but displays strong agglutinat­
ing properties towards oral bacteria (Levine et a l ., 1987;
Cohen et a l ., 1990; Kawagishi et a l ., 1990).
1.2.2.(v) Other Proteins
Examples of other proteins found in human saliva are:
(a ) Lactoferrin
Lactoferrin (Mr 77,000) is an iron-binding metal- 
loglycoprotein which occurs in exocrine secretions. It has 
been shown to be present in parotid saliva by Masson and 
Heremans (1966). In its iron-free (apo-) form, it has a high 
affinity for ferric cations. As iron is a necessary nutrient
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for many bacteria, lactoferrin-mediated iron depletion will 
lead to the inhibition of their growth. Lactoferrin also 
exerts a bacteriocidal effect by binding to bacterial cell 
surfaces (Lassiter et a l ., 1987).
(b) Statherin
Statherin (Mr 5,380) an acidic phosphoprotein, was iso­
lated from saliva by Hay (1973). It prevents the precipita­
tion of calcium phosphate from supersaturated solutions, 
thereby stabilising supersaturated saliva. It is also selec­
tively adsorbed onto apatitic surfaces and may therefore be 
a precursor of the acquired enamel pellicle (Schlesinger and 
Hay, 1977) .
(c ) Histatins
Histatins are histidine-rich polypeptides of low Mr . 
Histatins 1, 3, and 5 which were isolated by Oppenheim €it
a 1 . (1988) contain 38, 32 and 24 amino acid residues,
respectively. Histatins are secreted by the parotid and sub­
mandibular glands. In addition to being anti-microbial and 
anti-fungal, they may also play a role in the maintenance of 
the enamel pellicle (Troxler et a l ., 1990; Vanderspek et
a l . , 1990) .
(d ) Phosphopeptides
Whole saliva contains small phosphopeptides, most of 
which are N-terminal cleavage products from the acidic PRP's 
as a result of rapid degradation by proteolytic enzymes of 
extraglandulary sources, including bacteria and desquamated
18
host cells. The biological roles of these peptides include 
calcium binding and binding to hydroxylapatite (Minaguchi et 
a l ., 1988).
(e ) Blood Group Reactive Substances
The A, B, 0(H) and Lewis antigens, which are oligosac­
charides found on the surface of erythrocytes are also 
present in the mucins of the submandibular saliva of 85% of 
the population, who are termed as "secretors" (Malamud,
1985).
1.2.3. The Functions of Saliva
Saliva fulfils many important roles in the oral cavity 
These include:
1.2.3.(i) Digestion
Saliva acts as a lubricant, softening food and enabling 
the formation of a food bolus prior to swallowing. The only 
important digestive enzyme in saliva is O'-amylase which in­
itiates the digestion of starch. As food retention in the 
mouth is too brief for any significant degree of digestion 
to occur, it is possible that its main action is digesting 
starch from food residues remaining in the mouth (Mandel, 
1987; Cole and Eastoe, 1988).
1.2.3.(ii) Protection
Adherence to tissue surfaces is a crucial event for 
many bacteria. The physical flow of saliva removes a large
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number of potentially harmful bacteria from teeth and 
mucosal surfaces which would otherwise adhere to these sur­
faces (Mandel, 1989).
Mucins provide lubrication, protection against dessica- 
tion and environmental insult. They also have antimicrobial 
properties (Tabak et a l ., 1982; Levine et a l ., 1987).
Salivary glycoproteins, including slgA, contribute to 
the decreased adherence of microorganisms to the teeth and 
oral mucosal surfaces by aggregating bacteria, which are 
eventually removed by swallowing (Ericson and Arwin, 1985). 
Hydroxylapatite-bound acidic PRP1s are selective mediators 
of bacterial adhesion (Gibbons and Hay, 1989).
A number of salivary proteins possess either bacterios­
tatic or bacteriocidal properties. They include lysozyme 
(Pollock et a l ., 1985), lactoperoxidase (Adamson and Pruitt,
1981), histidine-rich polypeptides (MacKay et a l ., 1984a;
1984b), lactoferrin (Lassiter et al . , 1987) and slgA
(Tenovuo et a l ., 1982).
Salivary histatins have been demonstrated to exhibit 
fungistatic and fungicidal activity (Pollock et a l . , 1984).
Histatins are rich in histidine which contains imidazole 
groups which are capable of forming charge-transfer com­
plexes with aromatic residues, giving rise to hydrophobic 
interactions which play a large part in the antibacterial 
and antifungal roles of the peptide (Pollock et al ., 1985).
1.2.3.(iii) Maintenance of pH
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The bicarbonate and phosphate in saliva act as buffers 
which ensure that a relatively neutral pH is maintained in 
the oral cavity under resting conditions (Mandel, 1987).
1.2.3.(iv) Pellicle Formation
The pellicle is a selectively adsorbed coating of 
proteins (including albumin, lysozyme, lactoferrin, 7S IgA, 
acidic PRP's and mucins) and lipids on the tooth surface, 
where it provides a protective barrier and lubricating film 
(Levine et a l ., 1985; Mandel, 1989).
1.2.3.(v) Remineralisation of Early Carious Lesions 
Salivary glycoproteins and proteins rich in calcium and
phosphate form precipitates on the dental enamel which are 
believed to be essential for the effective remineralisation 
of early carious lesions (Gron and Hay, 1978). A group of 
phosphoproteins, including acidic PRP's and statherin, bind 
to calcium, helping to maintain in saliva a state of super­
saturation with respect to calcium phosphate. When the 
plaque pH falls due to acid formation from the fermentation 
of carbohydrates, these proteins release calcium and phos­
phate ions which allow early lesions to be remineralised 
(Hay, 1984).
1.2.3.(vi) Other Functions
Saliva also plays a part in the control of water 
balance, the excretion of endogenous and extragenous
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materials such as iodine, hormones, blood group reactive 
substances and drugs and also in the control of voice and 
speech (Cole and Eastoe, 1988).
1.2.4. Factors Affecting the Composition of Saliva
The composition of saliva is affected by a number of 
factors. In view of this, care should be taken in standard­
izing the conditions under which the salivary samples are 
collected.
Factors which may influence the composition of saliva 
include:
1.2.4.(i) Flow Rate
The concentrations of most of the constituents of 
saliva are dependent on the salivary flow rate of the in­
dividual and the duration of the stimulus applied. The con­
centrations of proteins, sodium, and bicarbonate ions rise 
with increased flow rate, while those of magnesium and phos­
phate fall. The concentration of potassium is little af­
fected by the flow rate (Dawes, 1967; 1969).
At the beginning of stimulation, the protein concentra­
tion in parotid saliva falls below that found in the un­
stimulated secretion, but then increases with the flow rate 
(Dawes, 1981).
1.2.4.(ii) Circadian Rhythms
Almost all salivary components show variations which
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are related to the time of day, and many apparent dif­
ferences in the composition of saliva from different persons 
re often a result of this variation. This is called a cir­
cadian variation because the rhythms are repeated at ap­
proximately 24 hr intervals (Dawes, 1981; Ferguson, 1981).
Daily rhythms in the secretion rate and composition of 
stimulated parotid saliva (Ferguson et a l ., 1973), unstimu­
lated parotid saliva (Dawes and Ong, 1973) and stimulated 
submandibular saliva (Ferguson and Botchway, 1979) have been 
reported. Although considerable differences between in­
dividuals were observed, any one individual showed fairly 
consistent results. For most of the constituents the daily 
rhythm showed typical sine curve patterns with well defined 
maxima and minima.
Unstimulated and stimulated parotid saliva show a cir­
cadian rhythm in protein concentration with the acrophase or
r
peak value occulting in the afternoon (Dawes, 1981).
1.2.4.(iii) Diet
Dawes (1970) reviewed the literature dealing with the 
effects of diet on salivary composition and concluded that 
there is little evidence that difference in diet can exert 
systemic effects on salivary flow rate and composition.
Whether the activity of the salivary glands is to some 
extent determined by the degree of functional stimulation is 
uncertain. Squires (1953) reported that a diet rich in car­
bohydrates leads to elevated a-amylase levels. The results
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of this experiment, however, could not be confirmed by Bates 
(1962).
When a group of men were maintained for 7 days on a 
diet consisting solely of the liquid diet ,lMetrecal,| there 
was a marked reduction in the total protein content of the 
parotid gland secretion, which was attributed to a reduction 
in masticatory and therefore reflex-mediated secretory 
stimulus of the gland (Hall et a l ., 1967).
1.2.4.(iv) Drugs
A wide variety of drugs are capable of affecting 
salivary flow rate, but relatively few have been studied un­
der controlled conditions for their effects on the composi­
tion of saliva. Most of the studies have been conducted on 
animals (Ferguson, 1981).
As the secretion of proteins by the salivary glands is 
under the control of the sympathetic nerves, sympathetic 
stimulation of the human parotid glands by sudden body- 
cooling or by the ingestion of a g-agonist such as 
isoprenaline causes an increase in the concentration 
of a-amylase in parotid saliva, while propranolol, a 
jQ-adrenergic blocker, has an opposite effect (Speirs et a l .,
1974) .
In the rat parotid gland, it has been shown that 
stimulation by a ^-agonist such as isoproterenol or 
epinephrine induced the release of secretory proteins from
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the acinar cells (Kim et a l ., 1989) but had little effect-on 
the oligosaccharide structure of a major N-linked parotid 
glycoprotein (Mr 220,000) (Baum et a l ., 1990).
Bromhexine, which is often used in the treatment of 
Sjogren's Syndrome has been shown by Manthorpe et a l . (1981) 
to reduce the level of salivary IgM, but not secretory IgA, 
IgG or albumin.
Methotrexate is a cytotoxic drug with pronounced im- 
munosupressive and chemotherapeutic effects, and has been 
widely used for the management of leukemia and several 
autoimmune diseases. It has in recent years gained an impor­
tant place in the treatment of rheumatoid art h r i t i s . It 
probably exerts its effect through an anti-inflammatory 
mechanism by inhibiting the activity of Interleukin-1 
without affecting its production or secretion (Segal et a l ., 
1989). Methotrexate has been reported to have no effect on 
the function of rat parotid glands (Wolff et a l ., 1989).
1.2.4.(v) Diseases
A number of diseases may affect the composition of 
saliva. For example, diseases of the salivary glands such as 
chronic inflammation may lead to a reduced secretion of 
salivary-specific substances. If the blood-saliva barrier is 
breached in the event of acute inflammation, serum con­
stituents such as albumin, IgG and IgM may reach the saliva. 
Specific defence mechanisms in the salivary glands may also 
be activated, resulting in an increase in the levels, for
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example, of slgA and lysozyme.
Metabolic diseases such as cystic fibrosis and diabetes 
mellitus may also affect the salivary glands (Seifert et 
al., 1986).
1.2.5. Salivary Analysis (Sialochemistry) as a Diagnostic 
Tool
Alterations in the composition of saliva are known to 
occur not only in diseases which affect the salivary glands, 
but also in diseases where other bodily tissues are in­
volved .
Examples of non-tumorous diseases of the salivary 
glands are sialadenitis, parotitis and Sjogren's Syndrome. 
Sialadenitis is characterised by increased levels of slgA, 
lysozyme and protein (Eichner et a l . , 1977), and parotitis
by decreased protein levels (Skurk et a l ., 1979).
Cystic fibrosis is a disease of the exocrine glands. 
The changes in the composition of saliva in cystic fibrosis 
patients include alterations in the levels of calcium and 
sodium (Marmar et a l ., 1966), protein (Allars et a l ., 1976) 
and Ctf-amylase (Chernick et a l ., 1964).
HIV-1 antibody-positive patients exhibit elevated 
levels of salivary albumin, lysozyme, lactoferrin, slgA and 
histatins, which may reflect alterations in the salivary 
gland function following HIV-1 infection (Atkinson et a l ., 
1989b).
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The saliva of patients with juvenile chronic arthritis 
has been reported to have decreased levels of calcium, phos­
phate, potassium, lysozyme and slgA (Siamopoulou et a l ., 
1989) .
During pregnancy there is a decrease in the levels of 
salivary proteins and sialic acid, which is probably related 
to hormonal changes (D 1 Alessandro et a l ., 1989).
Membrane damage as a result of salivary gland tumours, 
may facilitate the leakage of serum proteins into saliva 
(Eichner, 1976).
With increasing knowledge of the properties of saliva 
and how its composition may be altered under different con­
ditions, it has in recent years become more widely used for 
diagnostic purposes (Mandel, 1980; Ferguson, 1987; Baum,
1989). Sialochemistry has been applied to studying diseases 
of the salivary glands per se with no evidence of systemic 
involvement; for example, in acute viral or bacterial 
sialadenitis. It has also been applied to assist in the 
study of systemic diseases in which the salivary glands are 
involved; for example, Sjogren's Syndrome and cystic 
fibrosis; and in clinical situations in which salivary flow 
rate and chemistry are helpful in diagnosis or monitoring 
patient progress.
Other than the endogenous substances such as the 
proteins produced by the acinar cells of the salivary 
glands, saliva may also contain exogenous substances such as 
drugs and pharmaceutical agents which may be utilised for
27
diagnostic purposes. Examples of exogenous substances that 
may reach the saliva are steroid hormones (Ferguson, 1984), 
pharmaceutical agents such as phenytoin and phenobarbital 
(Seifert et a l ♦, 1986) and ethanol (McColl et a l ., 1979).
Although it is not yet possible to diagnose any disease 
on the basis of biochemical data obtained from saliva alone, 
nevertheless the information derived from salivary analysis 
may be useful in furthering the knowledge of disease 
pathogenesis, and may also serve as an indicator of how 
patients are responding to treatment.
1.3. Sjogren*s Syndrome and Rheumatoid Arthritis
Sjogren * Syndrome (SS) is an autoimmune exocrinopathy 
which predominantly affects females, who constitute ap­
proximately 90% of all patients (Talal, 1985). The three 
main components of SS are keratoconjunctivitis sicca (dry 
eyes), xerostomia (dry mouth) and one of a number of well- 
defined chronic inflammatory connective tissue disorders. 
Primary SS occurs when keratoconjunctivitis sicca and 
xerostomia are present, and secondary SS occurs when another 
connective tissue disease is present together with either 
keratoconjunctivitis sicca or xerostomia, or both (Manthorpe 
et a 1 . , 1986). Secondary SS with RA accounts for ap­
proximately 50% of all patients with SS . Other connective 
tissue diseases commonly associated with SS are systemic 
lupus erythematosus (SLE), osteoarthritis (OA), progressive 
systemic sclerosis (PSS) and mixed connective tissue disease
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(MCTD) (Manthorpe et a l . , 1981b).
The classic lesion of SS is lymphocytic and plasma cell 
infiltration of salivary, lachrymal and often other exocrine 
glands resulting in symptoms such as xerostomia and 
keratoconjunctivitis sicca.
The immunological features of SS include hypergam- 
maglobulinaemia, which is a diffuse elevation of all im­
munoglobulin classes; the presence of multiple serum autoan­
tibodies including antinuclear antibodies, anti-salivary 
duct antibodies and precipitating antibodies to tissue ex­
tracts (Alspaugh et a l ., 1976).
The serum of RA patients contains all of the classes 
of anti-gammaglobulin antibodies, called rheumatoid factors 
(Heimer and Levin, 1966).
Parekh et a l . (1985; 1988) showed that the oligosac­
charide structure of serum IgG from patients with RA differs 
from that of serum IgG from normal individuals in the degree 
of galactosylation of the outer arms. This results in a 
shift in the population of IgG molecules towards those in 
which one or more arms of the carbohydrate moieties ter­
minate with N-acetylglucosamine.
In studying the circulating B cells of RA patients, Ax- 
ford e t a l .  (1987) found a reduction in the activity of 
galactosyltransferase, the enzyme which catalyses the addi­
tion of galactose to the oligosaccharide side-chains of
r
glycoproteins. This finding helped to explain the occurrence 
of reduced galactosylation of IgG in RA patients, and indi­
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cated that the glycosylation defect that leads to reduced 
galactosylation of IgG is synthetic in nature, rather than 
due to a post-secretory cleavage.
Tomana et a l . (1988) has hypothesized that this defect
in glycosylation may be responsible for the induction of 
rheumatoid factor, possibly by exposing new antigenic deter­
minants in the IgG molecule, or by creating lectin-like ac­
tivity which results in autoaggregation.
1.3.1. Salivary Gland Dysfunction in Sjogren's Syndrome and
Rheumatoid Arthritis
1.3.1.(i) Salivary Gland Morphology
SS is characterised by lymphocytic infiltration of 
salivary and lachrymal glands which leads to symptomatic dry 
eyes and mouth (Block et al ., 1965 ). The majority of
patients have benign infiltrates with minimal glandular en­
largement, but a small number develop massive swelling of 
the salivary glands (Fox et a l ., 1983a; 1983b). The affected 
parotid glands show diffuse infiltrations of lymphocytes, 
histiocytes and plasma cells (Kitamura et a l ., 1970). Most
acinar cells are collapsed and the content of their 
secretory granules is decreased.
The spectrum of lymphoproliferation in SS ranges from 
prelymphoma to malignant lymphomas (Schmid et a l ., 1989).The
majority of lymphocytes infiltrating the salivary glands are 
T cells which account for more than 70%, while B cells ac­
count for 5-15% of the infiltrating cells (Fox et a l . ,
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1982). Monoclonal antibodies to cell surface determinants, 
such as antibody 0KT4 , which is reactive with T 
helper/inducer cells, and antibody 0KT8, which is reactive 
with T cytotoxic/supressor cells, allows recognition of T 
lymphocyte subsets. This revealed the predominance of 0KT4- 
positive (T helper/inducer cells) in salivary gland and lip 
biopsies (Takaya et a^ L. , 1985; Fox et a_l., 1982). As local
rheumatoid factor production occurs in the salivary glands 
of SS patients (Anderson et a_l., 1972) and rheumatoid fac­
tors have been detected in their salivary secretions (Dunne 
et a l ., 1979; Mairs and Beeley, 1985), it seems likely that
the synthesis of rheumatoid factor is dependent on 0KT4- 
positive T cells, and the infiltration of the salivary 
glands by T helper and B cells may lead to local autoan­
tibody production and subsequent tissue damage by complement 
or antibody-dependent cytotoxicity. Large amounts of IgG and 
IgM are synthesized by lymphoid cells infiltrating the 
labial salivary glands (Talal et a l . , 1970; Matthews et^
al., 1986). The majority of IgA-producing cells were 
restricted to histologically normal areas of the infiltrated 
glands and there was no significant difference in the number 
of these cells in patients and controls.
Class II major histocompatability antigens, which are 
encoded for by the HLA region of chromosome 6 in man, have 
been associated with autoimmune diseases including SS 
(Moutsopoulos et al., 1979). The HLA-DR region of 
chromosome 6 encodes 2 non—identical polypeptides ( OL and (3 )
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that were initially recognised on macrophages and B-cel-ls 
(Unanue, 1984). Salivary gland epithelial cells of patients 
with SS express high levels of HLA-DR antigens (Fox et al., 
1986a; Lindahl et a l . , 1985). HLA-DR—positive cells were
seen in close proximity to the periphery of dense lym­
phocytic infiltrates. The HLA-DR molecules on the epithelial 
cells may allow them to present antigens to immune T cells, 
thus initiating or perpetuating the immune responses.
Freimark et a 1 . (1989) studied the immunoglobulin and T
cell antigen receptor (TCAR) gene rearrangements in DNA ob­
tained from salivary gland lymphocytes from SS patients and 
reported that there were oligoclonal rearrangements of the 
K and TCAR |g-chain genes. This suggested that the B or T 
cells may clonally expand in the salivary gland tissues of 
SS patients with pseudolymphoma.
Salivary gland abnormalities may also occur in patients 
with RA alone. Waterhouse and Doniach (1966) demonstrated 
that there was an increased prevalence of focal lymphocytic 
submandibular adenitis in patients with RA, and suggested
that this focal lesion represented a subclinical form of
r
SS. Janin-Mercier et a l . (1982) reported the occurence of
impaired salivary scintigraphy and mild lymphocytic in­
filtrates in RA patients and proposed that RA produced a
frequent, although limited, salivary gland dysfunction. An-
r
donopoulos et a l . (1989) reported the occurence of parotid
gland enlargement without severe extraglandular manifesta­
tions in 20% of RA patients studied. Abnormal scintiscans
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have also been reported in patients with the autoimmune dis­
ease systemic lupus erythematosus (SLE) (Katz et a l ., 1980).
1.3.1. (ii) Alterations in the Composition of Saliva
By quantifying the constituents of saliva, valuable in­
formation regarding salivary gland function which may be 
useful in the diagnosis and study of the pathogenesis of SS 
may be obtained (Mandel, 1980; Stuchell et a l ., 1984; Baum,
1989; Thorn et a l ., 1989).
The levels of sodium and potassium in unstimulated 
saliva of SS patients were significantly elevated (Nahir et 
a l ♦, 1987). Upon stimulation there was a marked decrease of
40% in sodium concentration and a significant decrease in 
potassium concentration. By contrast,the normal response of 
healthy salivary glands to stimulation includes a sig­
nificant increase in sodium concentration and little change 
in that of potassium (Shannon et al, 1974).
The levels of a number of proteins are elevated, in­
cluding albumin and IgA (Stuchell et a l ., 1984), lactoferrin
(Jezequel et al . , 1989), IgG (Bluestone et a l , 1972 ),
j32-microglobulin (Swaak et a l ., 1988) and kallikrein (Friberg
et a l ., 1988).
Michalski et a l ., (1975) found a correlation between
the concentration of salivary $2~^i^roglobulin and the de­
gree of local lymphoid infiltration.
The salivary IgA of SS patients consists of 11S IgA 
(slgA) and a small quantity of 7S IgA (Ben-Aryeh et a l .,
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1983). This shows that the elevation in IgA levels is due.to 
an increase in local production of the immunoglobulin rather 
than transudation from serum, as serum IgA is composed 
predominantly of the 7S type.
In SS patients, the total salivary protein levels are 
increased (Anderson et a 1 . , 1972; Benedek-Spat et a 1 . ,
1975). A possible explanation for this has been proposed by 
F n b e r g  et a l . (1988): during an acute stage of inflammation
there might be disintegration of glandular tissue which also 
includes damage to striated duct cells. This leads to the 
release of salivary kallikrein, the level of which is 
elevated, not only into the normal secretion, but also into 
the interstitial tissues of the gland. In these tissues, 
kallikrein could exert its activity on its natural sub­
strate, kininogen, with resulting liberation of the vasoac­
tive kinin, kallidin. Kallidin then acts upon the vessels 
causing increased vasodilation and increased vascular per­
meability, leading to the transudation of plasma proteins 
and inflammatory cells.
Rheumatoid factor of IgA, IgG and IgM classes is also 
present in the saliva of patients with RA and SS (Dunne et 
a l . , 1979; Mairs and Beeley, 1985).
Increased amounts of anionic proteins have been ob­
served in the saliva of RA and SS patients. Fischer et a l . 
(1968) used paper electrophoresis to study the saliva of SS 
patients, and reported that whole and parotid saliva from 
patients with SS contained a greater quantity of proteins
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which migrated to the anode. This finding was later con­
f i r m e d  by H e r z b e r g  et a 1 . (1973) using disc
electrophoresis. Chisholm et a l . (1973) fractionated
salivary proteins from RA and SS patients by isoelectric 
focusing in carrier ampholyte-containing polyacrylamide rod 
gels and noted the presence of proteins with low isoelectric 
points. Benedak-Spat et a l . (1980) performed electrophoresis 
in polyacrylamide gels to study the band patterns of saliva 
from SS patients and found that the concentration of protein 
fractions with a low Rf (Relative Mobility) showed a con­
siderable increase, while one or two additional protein 
bands with high Rf values could be detected.
Mairs and Beeley (1985) subjected parotid saliva from 
RA patients to isoelectric focusing in carrier ampholyte- 
containing polyacrylamide slab gels and found multiple 
protein bands of pi's 3.95-4.25, which did not cross-react 
with antisera to IgG, IgA or albumin.
Most recently, utilising isoelectric focusing followed 
by immunoblotting, Greaves et a l . (1989) reported that some
of these anionic salivary proteins correspond to multiple 
forms of tissue kallikreins and their low pi values are due 
to their high sialic acid content, the latter being inferred 
from the shift in the pi's of the proteins after incubation 
with neuraminidase. However, this study had the following 
limitations:
(1) Only the most anodal proteins (in the pH range 3.0 to 
4.0) were investigated, possibly because one-dimensional
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IEF gels are unable to resolve the kallikreins from the 
acidic PRP1s which dominate the IEF pattern above pH 4.0. 
Thus most of the bands identified as tissue kallikreins have 
lower pi's than those earlier described by Mairs and Beeley 
(1985), which have pi's of 3.95-4.25. Urinary tissue kallik­
rein has been resolved by isoelectric focusing into at least 
8 different pi (isoelectric point) forms (pi's approximately 
3.75-4.25) by Lu et a l . (1989).
(2) The study failed to show conclusively whether the sia- 
lated forms of kallikrein occur in healthy subjects who do 
not have high concentrations of the anionic proteins. Thus, 
whether the increase in the levels of tissue kallikreins is 
accompanied by unusual glycosylation remains questionable.
(3) The saliva samples were concentrated by lyophilisation 
and reconstituted with water, but they were not desalted 
prior to isoelectric focusing. The high levels of salts 
present in saliva resulted in the loss of resolution of the 
protein bands and distortion of the pH gradient of carrier 
ampholyte-based isoelectric focusing gels.
(4) No attempts were made to improve the resolution of the 
protein bands, nor were any further studies on their nature 
carried out (e.g. determination of their molecular weights).
1.3.2. Methods of Monitoring the Oral Component of 
Sjogren's Syndrome 
Salivary gland function in SS may be monitored by 
several methods which vary in sensitivity and specificity.
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Opinions differ concerning the value of these methods. The 
most commonly used criteria for evaluating salivary gland 
function in SS are:
1.3.2.(i) Biopsy
The presence of focal lymphocytic infiltration in the 
labial salivary glands of SS patients is well documented 
(Chisholm and Mason, 1973; Daniels et a l ., 1975). The quan­
titation of the infiltrate has been largely made by the 
method of Chisholm and Mason (1968) or the "Focus-Score" 
method (Daniels et a l ., 1975; Daniels, 1984).
The clinical usefulness of biopsy techniques is limited 
by their lack of specificity. For example, Hedfors and Lin­
dahl (1989) demonstrated the presence of lymphocytic in­
filtration in the labial salivary glands of patients who had 
undergone bone marrow transplantation, patients with myaes- 
thenia gravis (an organ-specific autoimmune disease) and 
also patients with various connective tissue disorders.
A further weakness of this method is that labial 
salivary gland biopsy is carried out on the assumption that 
it also reflects changes in the major salivary glands 
(Schi^dt and Thorn, 1989). A study by Marx et a l . (1988) in­
dicated that parotid gland biopsy has a higher sensitivity 
for SS than labial gland biopsy. Biopsy of the parotid 
glands is considered to carry more risk than labial gland 
biopsy (Wise et a l ., 1988).
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1.3.2.(ii) Parotid Sialography
In this method, a water-soluble contrast medium is in­
jected into the ducts of the parotid gland after the 
catheterisation of the Stensen's duct (Vitali et a l ., 1988).
Following this, radiographs are taken. The disadvantage of 
this technique include the difficulty involved in cannulat- 
ing the Stensen's duct. The procedure is painful and there 
is also a possibility that the contrast medium may be 
retained in the salivary glands for long periods afterwards 
(Shi^dt and Thorn, 1989). Sialography gives a static picture 
of the status of the salivary gland ductal system as it em­
phasizes the morphological abnormalities of the gland, but 
not its functional state (Arrago et a l ., 1987).
1.3.2.(iii) Scintigraphy
In contrast to sialography, scintigraphy shows the 
functional abnormalities of the salivary glands because it 
is based on the ability of the major salivary glands to trap 
the radioisotope technetium-sodium pertechnetate ( ^ T c m ) 
(Sugihara and Yoshimura, 1988). After intravenous injection, 
the radioisotope becomes rapidly concentrated in the 
salivary glands. Scanning by a gamma scintillation camera 
provides functional information about the glands. In SS, the 
production of saliva is impaired due to the destruction of 
glandular parenchyma. This loss of active acinar cells is 
indicated by a reduced uptake of the radioisotope.
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1.3.2.(iv) Ultrasonography
Ultrasonography is the most recent technique for 
monitoring salivary gland function in SS (Kawamura et al.,
1990). It has the distinct advantage of being non-invasive. 
Using this method, de Clerck et a l . (1988) detected a
decreased parotid gland echogenicity in SS patients which 
could be due to the lymphocytic infiltrates in the gland.
1.3.2.(v) Sialometry
Sialometry, or the measurement of the flow-rate of 
saliva, although not specific for SS, is a simple, non- 
invasive assessment for the evaluation of xerostomia in SS . 
There has been difficulty in establishing a range of normal 
values. Fox et a l . (1986b) measured parotid flow and estab­
lished a lower normal limit of 0.5 ml/min, but Skopouli et 
a l . (1986) established a lower limit of 0.2 ml/min.
1.3.2.(vi) Sialochemistry
Sialochemistry, or the chemical analysis of salivary 
composition, has at present a limited role in monitoring 
the oral component of SS because it is often non-specific 
(Scully, 1989). There have been few attempts to correlate 
salivary changes with data obtained from histopathology. As 
such, the available data is as yet not sufficiently proven 
to be of diagnostic use (Schi^dt and Thorn, 1989).
In view of its non-invasive nature, the analysis of 
sialochemical changes could be of potential value in
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monitoring the disease process. Sialochemistry also has the 
advantage of being considerably less costly and less time- 
consuming than the other methods of monitoring salivary 
gland involvement in RA and S S . Saliva samples may be easily 
collected from the patients, causing them little or no dis­
comfort. Indeed, in recent years there has been an increas­
ing interest in sialochemistry as a diagnostic aid which may 
be of use in the evaluation of pathogenic events and prog­
nosis (Thorn et a l ., 1989).
1.4. Electrophoretic Techniques and their Application to 
Sialochemistry
1.4.1. Isoelectric Focusing
1.4.1.(i) Historical Background
Isoelectric focusing (IEF) is presently one of the 
most successful techniques in separating ampholytes such as 
proteins. It has wide applications in research. Its begin­
nings may be traced back to Ikeda and Suzuki (1912) who
described a method for producing sodium glutamate in an 
electrolysis apparatus consisting of compartments separated 
by membranes permeable to ions. This method was later
adapated to separate amino acids and other ampholytes
(Williams and Waterman, 1929). An important contribution to
the understanding of the phenomenon of isoelectric frac­
tionations was made by Tiselius (1941), who noted that if an 
ampholyte is added to a multimembrane electrolyser, it will 
migrate until it reaches a compartment with a pH equal to
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its isoelectric point. Thus, in the stationary state all 
anions are found in the compartment adjoining the anode 
while all cations in that adjoining the cathode with the am­
pholytes in intermediate compartments.
Kolin (1954; 1955a; 1955b) made a significant contribu­
tion to IEF methodology by developing an artificial pH 
gradient in a column by placing the substance to be 
separated at the interface between an acidic and basic buf­
fer. After an appropriate diffusion time, an electric field 
was applied. However, Kolin's pH gradients are "artificial 
gradients" as their slope was continuously changed by 
migration and diffusion of the buffer ions. This made the 
recovery of separated proteins difficult.
Svensson (1961; 1962a; 1962b) developed the concept of 
a "natural" pH gradient in which the buffers used in the 
system had two fundamental properties: firstly, in order to
reach a steady state position along the separation column, 
they were amphoteric. Secondly, they were carriers, or good 
conductors of electricity. Stable pH gradients could be ob­
tained by the isoelectric stacking of a large series of car­
rier ampholytes which when subjected to an electric current 
become arranged in order of increasing isoelectric points 
from the anode to the cathode. In effect, the pH in every 
part of the gradient is defined by the buffering capacity 
and conductivity of the isoelectric carrier ampholyte lo­
cated in that region.
A list of good ampholytes was compiled by Svensson
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(1961; 1962a; 1962b), but it became clear that between pH 5
and pH 7 there were no species which satisfied this require­
ment .
This problem was solved by Vesterberg (1969a; 1969b)
who successfully synthesized carrier ampholytes over the pH 
range 3-10. These ampholytes were polyprotic aminocar- 
boxylic acids synthesized by coupling a fjg-unsaturated acids 
to oligoamines. They were made commercially available by LKB 
Produkter AB, Bromma, Sweden, as "Ampholine".
Initially, isoelectric focusing was carried out in liq­
uid columns. For analytical purposes, these were superceded 
firstly by polyacrylamide rod gels and subsequently by 
flat-bed gels.
1.4.1.(ii) Limitations of Isoelectric Focusing in Carrier 
Ampholyte-Based Systems
(a ) Cathode Drift
Although the pH gradient generated by carrier am­
pholytes was sufficiently stable in most cases for the op­
timum resolution of proteins, it soon became evident that 
the pH gradient had a tendency to migrate slowly towards the 
cathode (Bates and Degoe, 1972). This phenomenon, called
"cathode drift" or the "plateau phenomenon", progresses with 
time and voltage.
Various hypotheses for the cause of cathode drift have 
been put forward. Miles et a l . ( 1972) proposed that am­
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pholytes at their isoelectric points can reach a state *of
"transient charge" which causes a temporary migration. 
Before such a transient ion has been discharged it will meet 
another molecule of different isoelectric point with which 
it forms a complex. The formation of such complexes will im­
poverish the neutral zone as molecules gradually migrate 
away and complex with other ampholytes towards the ends of 
the gradient.
Another explanation (Haglund, 1975), is that the pH 
drift may be the result of hydrolytic or chemical changes at 
the basic and acidic ends of the pH gradient. Thus the 
isoelectric points of the carrier ampholyte molecules would 
gradually change during IEF, decreasing the pH of the acidic 
end of the gradient and increasing the pH of the basic end.
It seems more likely, however, that the reason for the 
pH drift is electroosmosis. The water production within a pH 
gradient has a maximum near pH 7.1, inducing lateral water 
flow which may wash out the mobile ampholytes present in 
this region (Hagedorn and Fuhr, 1990a; 1990b).
Although cathode drift is not normally detrimental to 
the resolution achieved, difficulties may arise when basic 
proteins are fractionated, especially those with pi's > 9. 
Thus in practice, use of this procedure above pH 8 is 
limited.
(b) Sensitivity of the pH Gradient to Electrolytes
If a sample containing electrolytes is fractionated by 
carrier ampholyte-based IEF, the application of an electric
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field will dissociate the electrolytes into their component 
cations and anions. This results in the formation of acidic 
and alkaline boundaries which migrate towards the cathode 
and anode respectively. These boundaries will distort the pH 
gradient and impair the resolution of protein bands 
(Jonsson, 1980). Therefore prior to focusing all samples 
must be desalted to ensure that their ionic strengths are 
extremely low.
(c ) Chemical Interactions with Proteins
There are few reports of carrier ampholytes causing
chemical changes in proteins although there are known cases
where IEF has caused proteins to be denatured or lose ac­
tivity. Possible explanations of this phenomenon have in­
cluded protein insolubility at their isoelectric points 
leading to denaturation (Haglund, 1975).
Changes in proteins resulting from the splitting of 
protein complexes during IEF have been known to occur. An
example is albumin-fatty acid complexes which are gradually
dissociated after prolonged focusing (Valmet, 1970).
Oxidation of proteins in the course of IEF has been
noted. Wadstrom and Vesterberg (1971) demonstrated that the
activity of an enzyme was higher when an antioxidant such as 
dithiothreitol (DTT) was present in the IEF gel. Changes in 
the amino acid composition of the enzyme bovine ribonuclease 
(a basic protein) during IEF include the partial oxidation 
of the sulphur-containing amino acids, cysteine and 
methionine (Jacobs, 1973).
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Reactions occurring in the electrode compartments are 
the most common cause of oxidation. In particular, if the 
samples are applied at the extreme ends of the gel, chemical 
changes may occur due to exposure of the sample to extremes 
of pH. Thus Haglund (1975) recommended that in the case of 
flat-bed IEF the samples should be applied to several dif­
ferent parts on the gel.
Carrier ampholytes may chelate metals. The chelation 
maxima occur in the pH region 8.5-10.5 where most of the 
nitrogen functions are deprotonated (Davies, 1970; Galante 
et a l ., 1975). Carrier ampholytes are powerful chelators of
copper, thus copper-containing proteins may be rapidly in­
activated (Christensen et a l ., 1971). The chelating power of
carrier ampholytes towards other metals is generally weak. 
The loss of activity by metal chelation is seldom irrevers­
ible and full activity may usually be restored by incubation 
in appropriate amounts of the sequestered cofactor.
1.4.1.(iii) Immobilised pH Gradients
In 1982, a new and innovative method of IEF, called im­
mobilised pH gradients (IPG's) was introduced by Bjellqvist 
et al. These were subsequently made commercially available 
by LKB Produkter AB, Bromma, Sweden, as "Immobiline".
In this method, the pH gradient is grafted, or immobi­
lised, to the matrix of the polyacrylamide gel. This repre­
sented a departure from amphoteric buffers in favour of 
non—amphoteric ones. Immobilines are derivatives of
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acrylamide with the general structure: 
c h 2=c h
C-N-R
II I
O H
where the R is either a carboxylic acid or a tertiary amino 
group. The molecular formulae of Immobilines, which are not 
disclosed by LKB, have been established by Chiari et a l . 
(1989a; 1989b), and are listed in Table 1.2.
The Immobilines are copolymerised into the gel matrix 
with acrylamide and bisacrylamide, where they effectively 
determine the ionic strength, buffering capacity and the pH 
range of the IEF gel. Recipes for the preparation of gels 
spanning the pH range 4 to 10 are supplied by LKB. In addi­
tion, Altland (1990) and Altland & Altland (1990) have for­
mulated computer programs for creating recipes for IPG's.
IPG's offer the following advantages over IEF in car­
rier ampholyte-based systems:
(1) Since the pH gradients are covalently bound to the gel 
matrix, "cathode drift" is abolished. There is therefore no 
risk of losing basic proteins by this phenomenon. This means 
that long running times may be used, which gives proteins 
with low mobilities close to their isoelectric points time 
to reach their equilibrium positions.
(2) There is no longer any need to use samples of extremely 
low ionic strengths as electrolytes will not distort the pH 
gradient.
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Table 1.2. Chemical formulae of Immobilines
(from Chiari et a l ., 1989a; 1989b)
pK Formula
3.6 CH2=CH-CO-NH-CH2-COOH
4.6 CH2=CH-CO-NH-(CH2 )3-COOH
m
6.2 CHo=CH-C0-NH-(CH9 )9-N 0 
2 2 2 \_/
r~\
7.0 CH,=CH-CO-NH-(CH,),-N O
VJ
8.5 CH2=CH-CO-NH-(CH2 )2-N(CH3 )2
9.3 CH2=CH-CO-NH-(CH2 )3-N(CH3 )2
Name
N-acryloyl glycine
4-acrylamido butyric 
acid
2-morpholino 
ethylacrylamide
3-morpholino 
propylacrylamide
N #N-dimethyl 
aminoethyl acrylamide
N,N-dimethyl 
aminopropyl acrylamide
129
157
184
198
142
156
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(3) IPG's offer the possibility of performing pH gradient 
engineering, i.e. tailoring the limits and widths of the
gradient to suit the needs of any possible separation
problem. It is usual to make use of narrow gradients of 1 pH 
unit, or even 0.1 pH unit. Broader gradients of 2-6 units 
have been described by Gianazza et a l . (1985a; 1985b).
\S
(4) The pH gradient of IPG's more reproducible
than that of carrier ampholyte gels, as the desired pH in­
terval is mathematically formulated and fixed before the run 
(Righetti, 1984).
(5) IPG's are well suited for preparative work as Immobi­
lines, unlike carrier ampholytes, are bound to the gel and 
will not contaminate extracted materials (Ek et a l ., 1983).
(6) Greater loads of samples may be applied to IPG's than
carrier ampholyte-based gels. This may be useful in detect­
ing minor components (Bjellqvist et a l ., 1982).
1.4.1.(iv) Problems Generated by the IPG Technique and Their 
Solutions
The IPG technique, however, was soon discovered to give 
rise to new problems, most of which are a result of the in­
herent low conductivity of the gels or the instability of 
the alkaline Immobilines. The problems include:
(a) The low conductivity of IPG’s, which is a hundredth of 
that of carrier ampholyte gels, results in difficulties such 
as partial failure of samples to enter the gel, lateral zone 
spreading and the formation of "salt fronts" which halt
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protein migration (Righetti, 1984; Fawcett and Chrambach, 
1986a) .
(b) The amide bonds of Immobilines, especially the alkaline 
ones, are susceptible to hydrolysis which results in the 
formation of acrylic acid and a primary amine (Pietta et 
a l ., 1985). The reaction proceeds as follows:
c h 2= c h -c =o + h 2o  » c h 2=c h -c o o h  + r - n h 2
N-R
l
H
In a subsequent step, the primary amine released un­
dergoes nucleophilic addition to the double bond of acrylic 
acid:
r-nh2 + ch 2=ch- c o o h  > r-nh-ch2-ch2-cooh + H+
(c) The alkaline I mmobilines are susceptible to 
autopolymerisation (Righetti et a l ., 1987). This phenomenon
is autocatalytic and is accelerated by deprotonated amino 
groups. This process results in the formation of oligomers 
which may be incorporated into the gel. These oligomers may 
cause proteins to precipitate out of solution because they 
are able to bridge them by two unlike binding surfaces 
(ionic on one side and hydrophobic on the other) (Rabilloud 
et a l ., 1987).
(d) The amino groups of the alkaline Immobilines may be 
oxidised by ammonium persulphate during the polymerisation 
process, leading to the formation of tertiary amine oxide
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(R3N+0 - ), which in turn may oxidise cysteine residues -of 
proteins, leading to the formation of disulphide bridges. In 
exceptional cases, the disulphide bridges may even be fur­
ther oxidised into cysteic acid (Righetti et a l ., 1989).
Solutions to these problems have been proposed. The 
difficulties brought about by the low conductivity of the 
IPG's may be remedied by "hybrid isoelectric focusing" or 
"mixed-bed carrier ampholyte-immobilised pH gradient gels" 
(Fawcett and Chrambach, 1986a; Altland et a l ., 1987). In
these gels a primary insolubilised pH gradient coexists with 
a secondary, soluble, carrier ampholyte-driven pH gradient. 
This procedure overcomes most of the problems related to 
conductivity. Also, hydrophobic interactions between 
proteins and the autopolymerisation products of the alkaline 
Immobilines are minimised because the carrier ampholytes may 
act as shielding agents between the proteins and the 
oligomers produced by autopolymerisation (Rabilloud et a l ., 
1987).
The first generation of Immobilines was supplied in
liquid or powder form. Each bottle had to be reconstituted
with 25ml of distilled water to make 0. 2M solutions.
However, when the alkaline Immobilines are stored as aqueous
solutions, they are prone to undergo hydrolysis of the amide
bond. This occurs even when they are stored frozen (Astrua-
Testori et a l . , 1986). Following the discovery by Gaveby et
al. (1988) that reconstituting the alkaline Immobilines in
r
n-propanol abolishes the occurrence of deamidation and
50
autopolymerisation, "Immobiline II" was launched late -in 
1988. These were supplied directly as 0. 2M solutions. The 
acidic species (pK 3.6 and 4.6) were supplied in inhibitor- 
containing water, and the basic species (pK 6.2, 7.0, 8.5
and 9.3) in n-propanol.
The problem of the formation of tertiary amine oxide 
(R3N+0“ ) during polymerisation is solved in the following 
manner: as the tertiary amine oxide is unreactive in the
protonated state, it was recommended by Righetti et a 1 . 
(1989) that following polymerisation, the gels should be 
subjected to a short washing step in 0. 1M ascorbic acid 
solution.
1.4.1.(v) Measurement of the pH Gradient
The pH gradient of carrier ampholyte-containing gels 
may be measured by an antimony microelectrode with a calomel 
reference electrode (Beeley et a l ., 1972), but it is not
possible to measure the pH gradient of IPG's by such a 
method because the buffering ions and titrants are grafted 
to the gel matrix (Righetti et a l ., 1986).
The pH gradient of IPG's may be measured by focusing 
mixed-type gels containing Immobilines and 1% (w/v) carrier 
ampholytes, after which gel slices were cut from the anode 
to the cathode and the carrier ampholytes contained in each 
slice were eluted with a solution of potassium chloride. The 
pH of each eluate was measured (Righetti et al ., 1986). This
method, however, is laborious, and may suffer from errors
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due to the absorption of atmospheric carbon dioxide by the 
gel slices and by dilution of the eluted carrier ampholytes 
in potassium chloride solution. Furthermore/ in order to en­
sure that there are sufficient amounts of carrier ampholytes 
to be eluted from the gel slices for pH measurement/ it was 
recommended that 1mm thick mixed-type gels be prepared, 
rather than the standard 0.5mm thick gels, a procedure that 
would entail increased cost.
Another means of determining the pH gradient is by 
using a calibrated mixture of pH markers covering the range 
of interest. Ideally these markers should be coloured 
proteins or dyes of known pi's which allow the progress of 
focusing to be mOnitored visually (Righetti and Caravaggio,
1976).
1.4.1.(vi) Urea as a Gel Additive
Urea is frequently used as a solubilising agent in 
electrophoresis (Andrews, 1986). At high concentrations, it 
destabilises the native configuration of a protein suffi­
ciently to produce its unfolded state. This is possibly 
brought about by increasing the aqueous solubility of the 
hydrophobic portions of the protein while maintaining the 
hydrogen-bonding capability of the aqueous solvent (Nozaki 
and Tanford, 1963; Roseman and Jencks, 1975).
Creighton (1979) studied the behaviour of proteins 
which were separated by electrophoresis in polyacrylamide 
gels containing urea concentration gradients perpendicular
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to the direction of protein migration and found that the un­
folding of proteins was accompanied by a reduction of 
mobility because the expanded polypeptide chains experiences 
greater molecular sieving by the gel matrix.
Urea concentration gradients perpendicular to the pH 
axis in IEF gels (Hobart (1975) , Altland et a l . (1981),
Altland et a l . (1984) and Gorg et a l . (1985)) may yield im­
portant clues to the structure of proteins. For example, 
proteins which consist of non-covalently associated subunits 
are often dissociated by high urea concentrations, and in 
the process a single protein band may give rise to a number
of subunit bands as the urea concentration is increased
(Hobart, 1975). Alterations to the net charge of proteins 
will occur if their unfolding results in the exposure of
charged groups (Creighton, 1979).
1.4.1.(vii) Isoelectric Focusing of Human Salivary Proteins
The first attempt at isoelectric focusing of human 
salivary proteins was made by Beeley (1969) using carrier 
ampholyte-containing polyacrylamide rod gels, and by Ar- 
neberg (1969; 1972) using sucrose density gradient columns.
Unlike many biological fluids ( e.g. serum) saliva contains 
relatively few proteins (20-30 bands were visualised upon
staining of the IEF gels), and is therefore well suited to 
this technique. Parotid, mixed and submandibular salivary 
proteins have been fractionated in thin-layer polyacrylamide 
gels (Beeley, 1975). Using pH 3-10 IEF gels, Eckersall et
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a l . (1981) compared the band patterns of several individuals
and concluded that they were essentially similar with minor 
individual variations.
Parotid saliva from patients with RA and SS were 
studied by focusing in rod gels (Chisholm et a l ., 1973) and
the anionic proteins associated with these disorders were 
easily visualised and detected by densitometry as they 
precipitated out at or near their pi's. Mairs and Beeley 
(1985) analysed parotid saliva from RA patients in thin- 
layer gels and found multiple protein bands of pi's 3.95- 
4.25.
Carrier ampholyte-based IEF depends on the presence of 
samples of extremely low ionic strengths. As saliva has a 
low protein content of approximately 0.5-1.5 mg/ml but a 
high content of electrolytes, concentration and desalting 
prior to IEF is necessary. These procedures could be ac­
complished simultaneously by ultrafiltration (Beeley, 1975). 
Alternatively, the saliva samples could be dialysed, and 
then concentrated by means of Aquacide (Eckersall et a l . , 
1981). Such procedures, apart from being time-consuming, re­
quire relatively large volumes of saliva (preferably > 2ml). 
While such volumes are easily obtainable from healthy glands 
with normal flow rates, it is often difficult, or even im­
possible, to obtain similar volumes from diseased glands 
such as those of patients with xerostomia. Continued 
research into the nature of the additional anionic proteins 
associated with RA and SS has been largely hindered by this
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factor.
Desalting may also result in the loss of some minor 
components of saliva (Beeley, 1975), especially those of low 
Mr (< 1 0 ,0 0 0 ) due to passage through the dialysis membrane.
The IPG technique has not hitherto been applied to the 
analysis of human salivary proteins. The advantages that 
IPG's offer, such as higher tolerance to the electrolyte 
levels of samples, thus allowing the desalting step to be 
bypassed, high resolution and the possibility of designing 
the pH gradient around the pi's of the proteins of interest, 
make their application to the study of salivary proteins 
highly desirable. In addition, because the basic salivary 
PRP ' s have pi's > 8 , they are especially well-suited to
analysis by this technique as they are probably lost from 
conventional carrier ampholyte gels through cathode drift.
1.4.2. SDS-Polyacrylamide Gel Electrophoresis
1.4.2.(i) Introduction
Polyacrylamide gel electrophoresis (PAGE) is one of the 
most widely-used procedures for the estimation of the rela­
tive molecular weights (Mr 's) of polypeptides, which is of 
great importance in their characterisation.
At any pH other than their pi's, proteins will carry a 
net charge and will migrate when placed in an electric 
field. The rate of migration is proportional to the charge 
density (ratio of charge to mass) of the protein. In zone 
electrophoresis, proteins of different mobilities travel as
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discrete zones which gradually separate from one another 
(Hames, 1981). Zone electrophoresis of proteins in 
polyacrylamide gels is most commonly carried out in a buffer 
system which dissociates proteins into their individual 
polypeptide units. The most commonly used reagents for this 
purpose are the anionic detergent sodium dodecyl sulphate 
(S D S ) and the thiol reagent dithiothreitol (D T T ) which 
cleaves disulphide bonds. These reagents are usually used 
together, and protein mixtures are denatured by heating in 
an excess of SDS and DTT. Large amounts of SDS may be bound 
to the proteins, which is sufficient to overwhelm the 
intrinsic charge of the polypeptides, thus making the net 
charge per unit mass approximately constant. Viscosity 
analysis suggests that the reduced polypeptide-SDS complexes 
form rod-like particles with lengths proportional to their 
M r 's (See and Jackowski, 1989).
1.4.2.(ii) Gradient Gels
Polyacrylamide gels with a gradient of increasing 
acrylamide concentration produce greater sharpening of the 
protein bands as the migrating proteins are continually en­
tering areas of decreasing pore size, the advancing edge of 
the migrating zone is retarded more than the trailing zone. 
On approaching the "pore-limit" when further progress is im­
peded by the pore-size, the protein banding pattern does not 
change appreciably with time. This results in a sharpening 
of the protein bands and therefore increases their resolu­
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tion. In addition, the polyacrylamide gradient increases the 
range of Mr ' s of proteins which may be fractionated on a 
single gel (Hames, 1981).
1.4.2.(iii) SDS-PAGE of Human Salivary Proteins
SDS-PAGE has been used to study human salivary proteins 
(Smith et a l ., 1974; Oberg et a l ., 1982; Shiba et a l ♦, 1986;
Lindsay and Beeley, 1986; Marshall and Williams, 1987; Mar­
shall et a l ., 1989). Oberg et a l . (1982) reported that the
protein patterns of different individuals varied markedly, 
while the pattern for each individual was constant and free 
from circadian and feeding effects.
Human salivary proteins contain a group of phos- 
phoproteins referred to as "lumicarmines" which exhibit un-
m
usual stair^g properties with the dye Comassie Brilliant Blue 
R250. These are stained pink-violet instead of the usual 
blue (Shatzman and Henkin, 1983). This phenomenon, known as 
metachromasia, was first noted in collagen (Duhamel, 1983) 
and the salivary proteins of rats (Shatzman and Henkin, 
1983) before it was reported in human salivary proteins 
(Humphreys-Beher and Wells, 1984) . It is most clearly ob­
served when the gels are destained in a solution of 10% 
(v/v) acetic acid in the absence of alcohol (Lindsay and 
Beeley, 1986). Metachromasia has been hypothetically at­
tributed to the presence of closely-spaced proline and 
hydroxyproline residues in sequences from triple-helical 
domains (Duhamel, 1983).
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1.4.3. Two-Dimensional Electrophoresis
1.4.3.(i) Introduction
The underlying concept of two-dimensional (2-D)
electrophoresis is the coupling of a charge fractionation 
method with a size fractionation method. O'Farrell (1975) 
successfully combined IEF with SDS-PAGE, thereby fractionat­
ing proteins according to their pi's in the first dimension 
and according to their Mr 's in the second. Using this tech­
nique, over a thousand proteins from lysed Eschericia coli 
could be visualised on a single 2-D map.
1.4.3.(ii) 2-D PAGE with IPG's in the First Dimension
IPG's (Dunn and Patel, 1986; Gorg et a l ., 1987) and
hybrid carrier ampholyte-immobilised pH gradient gels (Gorg 
et a l ., 1985) have^used in the first dimension of 2-D PAGE.
The most significant advantage of using IPG's rather than
carrier ampholytes is the abolition of cathode drift which 
has been the cause of much inter-experiment pattern- 
variability (Fawcett and Chrambach, 1986b). By combining 
hybrid carrier ampholyte-IPG polyacrylamide gels with 
polyacrylamide gradient electrophoresis, highly reproducible 
2-D patterns could be obtained. In each case, the steady 
state is defined as a gel pattern which remains constant 
with time. IEF in IPG's is truly an equilibrium method while 
pore limit, or gradient-pore electrophoresis, is a quasi­
equilibrium method as the protein zones are embedded in a
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maximally restrictive pore and do not migrate appreciably 
with time (Fawcett and Chrambach, 1986b).
1.4.3.(iii) Thin-layer Polyacrylamide Gradient Gels as the 
Second Dimension of 2-D PAGE
The use of thin-layer (0.5mm thick) polyacrylamide 
gradient gels (Gorg et a l ., 1986) for second-dimension 
separation in 2-D PAGE has the following advantages:
(a) Thin-layer gels are more efficiently cooled than conven­
tional thick gels, so the vertical thermal gradient is 
abolished, thus the zones migrate perpendicular to the ap­
plied voltage.
(b) The improved heat dissipation also allows the applica­
tion of higher field strengths, which improves the resolu­
tion of protein zones and shortens the separation time.
(c) Staining and destaining are achieved in much shorter 
times than for thicker gels.
(d) The gels may be cast on a plastic backing, and thus do 
not alter in size during staining and destaining. This 
facilitates more accurate comparisons of the protein spots 
between different gels.
1.4.3.(iv) 2-D PAGE of Human Salivary Proteins
There are few reports of 2-D PAGE of human salivary 
proteins in the literature. Giometti and Anderson (1980) 
and Marshall (1984) analysed the proteins of whole human 
s a l i v a  u s i n g  c o n v e n t i o n a l  O' F a r r e l l  (1975) 2 — D
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electrophoresis. Bustos and Fung (1981) obtained 2-D maps 
of the abnormal salivary proteins associated with cystic 
fibrosis. Mogi et a l . (1986) fractionated protein mixtures
of sublingual and submandibular saliva by microscale 2-D 
electrophoresis. All these studies have utilised carrier 
ampholyte-based IEF for first dimensional separation. The 
prolonged focusing time (usually overnight) necessary for 
IEF rod gels make cathode drift unavoidable, thereby result­
ing in some loss of basic proteins through cathode drift. 
Thus previous 2-D maps of human salivary proteins displayed 
very few protein spots of pi's > 8 .
The most recent methods of 2-D PAGE, including the use 
of hybrid carrier ampholyte-IPG polyacrylamide gels in the 
first dimension and thin-layer SDS-polyacrylamide gradient 
gels in the second, have hitherto not been applied to the 
fractionation of salivary proteins. The abolition of cathode 
drift by using IPG's would enable basic proteins to be lo­
cated on 2-D maps.
2-D PAGE would provide invaluable information regarding 
the anionic salivary proteins associated with RA and SS. Al­
though the pi's of these proteins are known, their Mr 's have 
not yet been established.
1.5. Protein Detection Methods
1.5.1. Staining Procedures
Following gel electrophoresis, proteins were detected 
by one or more of the following methods:
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Three general protein-staining methods, i.e. Coomassie 
Brilliant Blue R250 (CBB R250), Coomassie Brilliant Blue
G250 (CBB G250 ) and silver stain; as well as a 
glycoprotein-specific stain (PAS) were used. Coomassie Bril­
liant Blue G250 is a dimethyl substitute of Coomassie Bril­
liant Blue R250. They differ markedly in their staining 
properties towards salivary proline-rich proteins (PRP's ). 
The phenomenon of metachromasia which results in P R P ' s 
staining with a pink-violet colour (Lindsay and Beeley, 
1986) is observed when CBB R250, but not CBB G250, is used. 
Other salivary proteins, such as cx-amylase, are stained a 
blue colour by CBB R250. This provides a means of distin­
guishing P R P 1s from other salivary proteins in SDS-PAGE 
gels .
A colloidal suspension of CBB G250 in trichloroacetic 
acid (Dietzel et a l . , 1975; Neuhoff, 1988; Neuhoff et a l . ,
1990) is a convenient means of staining proteins because 
very little destaining is necessary. The bands, therefore, 
may be visualised within an hour.
Silver stain has proven to be one of the most sensitive 
staining developments. It was first reported by Switzler et 
al. (1979), and has since undergone a number of modifica­
tions with varying degrees of sensitivity. Examples of 
various modifications of the silver stain technique are 
those of Oakley et a l . (1980), Sammons et a l . (1981), Mor-
risey (1981) and Heukeshoven and Dernick (1985).
Friedman (1982) reported the lack of silver-staining
61
sensitivity in salivary PRP's , this being especially so with 
the acidic PRPs which have a high content of glycine, 
proline and dicarboxylic acids but are lacking in sulphur- 
containing amino-acids such as tryptophan, tyrosine and 
threonine. Basic and sulphur-containing amino-acids are 
believed to be responsible for the binding of silver ions 
(Heukeshoven and Dernick, 1985; Hochstrasser et a l . , 1988)
and the low levels, or absence, of these amino acids in most 
salivary PRP's is the most likely explanation for their poor 
staining properties with silver stain.
1.5.2. Protein Blotting
1.5.2.(i) Principles of Protein Blotting and Detection
A method of electrophoretically transferring frac­
tionated DNA to nitrocellulose was described by Southern 
(1975). Subsequently, Towbin et a l . (1979) devised a method
for the transfer of proteins from polyacrylamide gels to 
nitrocellulose membranes. The mechanism of protein binding 
to nitrocellulose is not well understood but hydrophobic in­
teractions are believed to be largely responsible (Tovey and 
Baldo, 1989).
Most of the advantages of protein blotting are due to 
the greater accessibility of macromolecules bound to the 
surface of a thin sheet compared to those buried within the 
matrix of a gel. This makes the processing times for the 
staining, destaining, and incubation of the membranes very 
much shorter than for gels (Gershoni and Palade, 1983).
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The immobilised proteins may be detected by various 
staining, immunochemical and lectin-binding procedures. The 
use of secondary antibodies is common. In this method, the 
additional binding sites on the nitrocellulose membrane are 
blocked by excess protein or a non-ionic detergent such as 
Tween 20. A specific antibody to the protein of interest is 
then added to it, and finally a secondary antibody, usually 
an anti-immunoglobulin directed against the first antibody, 
is added as the detecting antibody. This antibody may be 
coupled to fluorophores, radioisotopes or enzymes.
Following gel electrophoresis, proteins may also be 
e l e c t r o b l o t t e d  to p o l y v i n y 1 idene difluoride (P V D F ) 
membranes. PVDF, being inert to most solvents, is ideally 
suited for use in automated gas-phase sequencers. In this 
procedure, the proteins electroblotted to PVDF may be 
detected by staining with Coomassie Blue, after which the 
protein bands of interest are cut out to be analysed by 
protein micro-sequencing (Matsudaira, 1987; Findlay and 
Geisow, 1989).
1.5.2.(ii) Detection by Antibodies
Most proteins retain their antige n i c i t y  after 
electrophoresis and electroblotting, and therefore may be 
detected by immunological methods using specific antibodies. 
Proteins which have been immobilised on blots may be 
detected using the following systems:
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(a ) Detection of antigens by alkaline phophatase-conjugated
anti-antibody
Following electroblotting, the remaining sites of at­
tachment on the membrane are blocked by washing with a solu­
tion of non-ionic detergent such as Tween 20 dissolved in 
Phosphate-Buffered Saline (PBS). The blot is incubated in a 
specific antiserum-containing solution, washed, and then in­
cubated with an alkaline phosphatase-conjugated anti­
antibody-containing solution. The blot is finally incubated 
in a solution containing 5-bromo-4-chloro-3-indoxyl phos­
phate (BCIP), a substrate for alkaline phosphatase. This is 
cleaved by the enzyme to form to form an intense blue 
precipitate of diformazan (Blake et al ., 1984). Fig. 1.3 il­
lustrates the detection of antigens by this method.
(b) Detection of antigens using immune complexes of alkaline
phosphatase and monoclonal anti-alkaline phosphatase
(APAAP complexes)
The previously mentioned method occasionally results in 
weak staining reactions, particularly if the antigen is 
present in small amounts (< 1 Hg) . In order to intensify
staining, an immune complex of alkaline phosphatase and 
monoclonal anti-alkaline phosphatase (APAAP complex) may be 
used (Cordell et a l ., 1984). The APAAP complex consists of 4
molecules of alkaline phosphatase enzyme complexed to an 
equal number of mouse monoclonal antibodies (Fig. 1.4). The 
rabbit antibody against mouse IgG is used as a "bridge" be­
tween two APAAP complexes. Two repetitions of stages 3 and 4
64
Fig. 1.3. D e t e c t i o n  of a n t i g e n s  by the alkaline 
phosphatase-conjugated second anti-antibody method
alkaline phosphatase •k
antigen
ant i- 1mmunog1obu1i n- 
“ alkaline phosphatase conjugate
anti-Ag Immunoglobulin
Ag
Membrane
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Fig. 1.4. Detection of antigens using the APAAP method
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in Fig. 1.4 results in amplification of the signal.
1.6. Aims of the Study
The aim of this study is the development and refinement 
of electrophoretic techniques with the view of enabling the 
analysis of proteins in small volumes (e.g. < 100 Hi) of
human saliva. Such sensitive and high-resolution techniques 
could prove invaluable when the volumes of saliva samples 
available are relatively small, as is often the case in RA 
and SS as many of these patients suffer from xerostomia. 
These techniques were then applied towards the characterisa­
tion of the anionic parotid salivary proteins associated 
with RA and SS. The analysis of these anionic proteins may 
form the basis of a non-invasive diagnostic procedure and 
also further the understanding of salivary gland involvement 
in connective tissue disorders.
Research into the nature of the anionic proteins has 
hitherto been hindered by the relatively high electrolyte 
and low protein contents of human parotid saliva, which 
necessitates desalting and concentrating saliva samples 
prior to analysis by isoelectric focusing. However, this re­
quires relatively large (preferably > 2ml) volumes of 
parotid saliva, which may be difficult or even impossible to 
obtain from the patients, many of whom suffer from xeros­
tomia. The IPG technique is ideal for the analysis of human 
salivary proteins as its pH gradient is unaffected by 
electrolytes present in the samples, thus allowing applica—
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tion of samples without prior desalting. Another significant 
advantage of IPG's is that they allow pH gradient- 
engineering. Therefore, an acidic range (e.g. pH 3.5-5.0) pH 
gradient could be tailored in order to fractionate the 
anionic salivary proteins.
Further information regarding the anionic salivary 
proteins could be obtained from 2-D PAGE using IPG's in the 
first dimension and SDS-PAGE in the second. By electroblot- 
ting the 2-D gels onto nitrocellulose membranes and incubat­
ing the blots with specific antisera, a 2-D map of human 
salivary proteins could be constructed.
The identity of the anionic proteins could be estab­
lished by protein blotting followed by probing the blots 
with antisera to specific proteins, especially proteins the 
levels of which in either serum or saliva are known to be 
elevated during the course of inflammation. Further charac­
terisation of the anionic proteins could be achieved by in­
cubation with exo- and endoglycosidases in order to 
elucidate the nature of their pi heterogeneity.
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2. MATERIALS AND METHODS
2.1. Materials
2.1.1. Sources
Materials were obtained from the following sources: 
Amersham Laboratories, Amersham, Bucks, U . K .: "Hybond-C"
nitrocellulose membrane and "Rainbow" protein molecular 
weight markers.
BDH, Poole, Dorset/ U.K.: Arginine, acetic acid, acrylamide, 
ammonium persulphate (APS), bromophenol blue, sulphuric 
acid, h y d r o c h l o r i c  acid, p h o s p h o r i c  acid, coloured 
isoelectric point markers (pH 2.4-5.65 and pH 4.7-10.6), 
ethanol, formaldehyde, glutamic acid, glycine, glutaral- 
dehyde, glycerol, HPLC-grade water, hydrogen peroxide, 
methanol, 2-mercaptoethanol, N , N '-methylenebisacrylamide 
(bisacrylamide), potassium hexacyanoferrate III, potassium 
hydroxide pellets, perchloric acid (PCA), periodic acid, 
sodium dodecyl sulphate (SDS), sodium azide, sodium car­
bonate, sodium thiosulphate, sodium hydroxide pellets, 
s o d i um c h l o r i d e ,  s o d i  um a c e t a t e ,  s o d i u m
ethylenediaminetetraacetate (EDTA), sodium sulphate, sodium 
thiosulphate, toluene and trichloroacetic acid (TCA) were of 
"Analar" or " Electran" grades.
Activated charcoal, dimethyldichlorosilane and Triton 
X-100 were of "Laboratory Reagent" grade. Polyethyelene 
glycol 10,000 was of "Organics" grade and urea of "Aristar"
grade.
The Binding Site Ltd., Edgbaston, Birmingham, U.K: Sheep an­
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tiserum to human aj-acid glycoprotein.
Bio-Rad Laboratories Ltd., Hemel Hempstead, Herts, U.K. : 
Bio-Rad Protein Assay Reagent.
bioMerieux, Marcy l'Etoile, France: "Arthri-Slidex" latex
slide test kit for the detection of rheumatoid factors. 
Boehringer Mannheim, Lewes, East Sussex, U.K: Dithiothreitol 
(DTT), Endo-^-N-acetylglucosaminidase F (Endo F), Peptide:
N - G l y c o s i d a s e  F (PNGase F), Trasylol (lyophilised 
aprotinin), and tris(hydroxymethyl)aminomethane (Tris). 
Calbiochem, La Jolla, CA, U.S.A.: "Aquacide", Concanavalin
A (ConA), goat antiserum to human serum albumin, rabbit an­
tiserum to human plasma kallikrein and protease- free 
neuraminidase purified from Vibrio Cholerae.
Cymbus Bioscience Ltd., Southhampton, Hampshire, U.K: Mouse 
monoclonal antibody to human J-chain, rabbit antiserum to 
mouse IgG and the immune complex of alkaline phosphatase and 
mouse monoclonal anti-alkaline phosphatase (APAAP complex). 
Dako Ltd., High Wycombe, Bucks, U.K.: Rabbit antiserum to
human secretory component, rabbit antiserum to human 
C-reactive protein and rabbit antiserum to human lysozyme. 
Davis Gelatin Ltd., Leamington Spa, U.K.: Agar.
Difco Laboratories, Surrey, U.K.: Freund's Complete Adjuvant 
and Freund's Incomplete Adjuvant.
Formachem Ltd., Strathaven, Scotland, U . K .: Disodium
hydrogen phosphate and potassium dihydrogen phosphate. 
Gibco-BRL, Paisley, Scotland, U.K.: Microdialysis membrane
with cut-off of Mr 6 ,000-8 ,0 0 0 .
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ICN Biochemicals, Bucks, U .K .;GelBond PAG film.
Johnson Matthey Chemicals Ltd., Herts, U.K.: Silver nitrate. 
KabiVitrum, Uxbridge, Middlesex, U.K.:
H-D-Val-Leu-Arg-NH-pNA (S-2266, a chromogenic substrate for 
glandular kaliikreins).
Millipore, London, U.K.: Polyvinylidene difluoride (PVDF)
membrane and filtration membranes of pore-size 20jnm.
Nordic Immunological Laboratories, Berkshire, U.K.: Sheep
antiserum to human salivary a-amylase and rabbit antiserum 
to human lactoferrin.
Pelikan, Hanover, West Germany: India ink.
Pharmacia-LKB Biotechnology, Milton Keynes, U . K .: Immobi-
lines (pK's 3.6, 4.6, 6.2, 7.0, 8.5 and 9.3), Ampholines (pH 
3.5-10.0, pH 5-7 and pH 3.5-5.0) and Electrophoresis 
Calibration Kit (Mr 's 14,400 to 94,000).
Pierce and Warriner (U.K.) Ltd., Chester,C h eshire,U .K .: 
Bicinchoninic acid (BCA) protein assay reagent.
Protogen AG, Laufelfingen, Switzerland: Human urinary kal-
likrein and goat antiserum to human urinary kallikrein. 
Scottish Antibody Production Unit, Law Hospital, Carluke, 
Scotland, U . K .: Mouse monoclonal antibody against human
HLA-DR Class II antigen, sheep antiserum to human IgG 
( 7 -chain specific) and sheep antiserum to human IgM ( fl- 
chain specific).
Sigma Chemical Co., Poole, Dorset, U . K .: Anti-mouse
immunoglobulin—alkaline phosphatase conjugate, anti-rabbit 
immunoglobulin—alka1ine phosphatase conjugate, anti—sheep
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immunoglobulin-alkaline phosphatase conjugate, anti-goat 
immunoglobulin-alkaline phosphatase conjugate, bovine serum 
a l b u m i n ,  b o v i n e  (X- c h y m o t r y p s i n o g e n ,  1 , 3 - 
b i s [ t r i s (  hy dr oxyme thy 1 ) - me thy 1 amino ] propane (bis-tris 
propane), 5-bromo-4-chloro-3-indolyl phosphate (BCIP),
3-( cy cl o h e x y  lamino )-1-propane sulphonic acid (CAPS), 
Coomassie Brilliant Blue R250 (CBB R250), Comassie Brilliant 
Blue G250 (CBB G250), 4-chloro-l-naphthol, Folin-Ciocalteau 
reagent, gelatin, goat antiserum to human IgA (Oi-chain 
specific), human colostral slgA, human serum IgG, horse 
radish peroxidase, iodoacetamide, CK-D-methylmannoside, 
mouse monoclonal antibody to goat IgG, mouse monoclonal an­
tibody to human ^ “Hiicroglobulin, Nitro Blue Tetrazolium 
(N B T ), N ,N ,N ' ,N '-t e t r a m e t h y 1 ethy 1 enediamine (TEMED), 
pararosaniline hydrochloride, p o l y o x y e t h y  1 e n e s o r b i t a n  
monolaureate (Tween 20), rabbit antiserum to human K-light 
chain and rabbit antiserum to human X-light chain.
Whatman Biosystems Ltd., Maidstone, Kent, U.K.: DE32 anion
exchanger and No. 1 filter paper.
Gifts
These items were kindly donated:
(a) The acidic acrylamido derivative (pK 0.8) was a gift 
from Prof. P.G. Righetti, University of Milano, Italy.
(b) Acidic proline-rich human salivary proteins "A" and "C"  
were a gift from Prof. A. Bennick, University of Toronto, 
Canada.
(c) Basic proline-rich human salivary proteins "IB1", "IB3",
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"IB4 " , "IB5 " , "IB6 ", "IB7 " , "IB8 ", "I B 9 " " and "Basic
proline-rich glycoprotein" (BPR glycoprotein) were a gift 
from Dr. D. Kauffman, University of Washington, Seattle, 
U.S.A..
2.1.2. Buffers
Phosphate-Buffered Saline (PBS), pH 7.2, contained 
170mM sodium chloride, 3.4mM potassium chloride, lOmM dis­
odium hydrogen phosphate and 1.8mM potassium dihydrogen 
phosphate. Phosphate-Buffered Saline containing sodium azide 
(PBS-azide) consisted of 0.01% (w/v) sodium azide in PBS.
All other buffers, unless otherwise indicated, were 
prepared as recommended by Dawson et al . (1986).
2.2. Collection and Subsequent Treatment of Human Parotid 
Saliva
2 . 2 . (i ) Subjects
Parotid saliva was collected from normal healthy in­
dividuals, from patients with primary and secondary SS, and 
from RA patients. The RA patients were seropositive for 
rheumatoid factor. The samples were collected from patients 
at either the Department of Oral Medicine and Pathology in 
the Glasgow Dental Hospital or the Rheumatology Clinic in 
the Glasgow Royal Infirmary.
2.2.(ii) Collection and Treatment of Samples
Lemon juice was used as the stimulant and the saliva
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samples were collected using a modified Carlsson-Crittenden
cup (Stephen and Spiers, 1976) (Fig. 2.1).
When it was necessary to concentrate the samples, this 
was accomplished by one of the following methods:
(a) the samples were l y o p h i l i s e d  and s u b s e q u e n t l y  
reconstituted to a fifth of their original volume with dis­
tilled water.
(b) the samples were dialysed overnight against 30% (w/v) 
polyethylene glycol 10,000 using a BRL 1200MA Microdialysis 
Unit fitted with a membrane with a cut-off of Mr 6,000- 
8,000. This procedure reduced the samples to 20-30% of their 
original volumes.
The samples were stored at -20°C before use. After 
thawing, they were centrifuged at 10,000g for 20 minutes
at 4°C to remove insoluble material. All subsequent opera­
tions were performed at 4°C.
2.3. Protein Assay
The protein content of saliva was determined by the BCA 
micro-protocol (Smith et a1 ., 1985). Bovine
Q!-chymotrypsinogen, standardised by its extinction coeffi­
cient, was used as the protein standard (Wilcox et al . , 
1947). This procedure allows the determination of protein 
concentrations in saliva volumes as small as 5 fll • After in­
cubation with the BCA working reagent for 30 minutes at 
60°C, the absorbance was read at 562nm using a Pye Unicam 
SP8-100 uv/visible Spectrophotometer.
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Figure 2,1, Modified Carlsson-Crittenden Cup for Collection of Human Parotid Saliva.
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In order to compare the sensitivities of different as­
say methods when used on saliva and to obtain absorbance 
curves using different protein standards, the Lowry assay 
(Lowry et a l ., 1951) and the Bio-Rad assay (Bradford, 1976) 
were also studied, although these two methods were not used 
in the routine analysis of saliva samples. Standard curves 
were also obtained for the BCA standard procedure, in which 
the samples were incubated at 37^C for 30 minutes. Bovine 
serum albumin (BSA) was also standardised by its extinction 
coefficient was used in order to compare the sensitivities 
of the methods.
2.4. SDS-PAGE
2.4.1. Stock Solutions
Stock solutions were prepared as follows:
(A) Acrylamide ("30:08") solution containing 30% (w/v) 
acrylamide and 0.8*/o(w/v) N, N ' -methylenebisacrylamide .
(B) 10% (w/v) ammonium persulphate in water.
(C) 20% (w/v) SDS in water.
(D) Resolving gel buffer for 12.5 %T (%T=Total acrylamide,
or the polyacrylamide gel concentration defined as percent­
age total monomers, i.e. acrylamide + bisacrylamide g/100ml) 
gels was 750mM Tris-HCl, pH 8 .8 .
(E) Resolving gel buffer for 20 %T acrylamide gels was 3M
Tris-HCl, pH 8 .8 .
(F) Stacking gel buffer was 170mM Tris-HCl buffer solution, 
pH 6 .8 .
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(G) The reservoir buffer contained 25mM T r i s , 192mM
glycine, 0.1% (w/v) SDS and 0.01% (w/v) sodium azide, pH
8.3.
(H) The solution used to denature the saliva samples con­
tained 20% (w/v) SDS. 250mM DTT and 0.01% (w/v) bromophenol 
blue in aqueuous solution.
2.4.2. Gel Preparation
A Bio-Rad Protean II apparatus was used for casting and 
running the gels. The gels were prepared as follows:
2.4.2.(i) Homogeneous Gels
SDS-polyacrylamide gels were prepared using a modifica­
tion of the method of Laemmli (1970). Gels with a stacking 
portion of 5 %T and resolving portion of 12.5 % or 20 %T 
were prepared using the following volumes of solutions:
Solutions 5 %T gel 12.5 %T gel 20 %T gel
(A) 2.0ml 12.5ml 20.0ml
(B) 40/il 100/U 100/11
(C) 60/11 150/11 150/11
(D) --- 15.0ml ---
(E )     3.75ml
(F) 8 .8ml --- ---
distilled water 1.16ml 2.25ml 6.0ml
TEMED 5/11 10/ll 10/11
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2.4.2.(ii) Gradient Gels
A gradient former (Bio-Rad Model 385) was used to
prepare 5-20 %T linear gradient acrylamide gels (Hames,
1981). The apparatus for forming gradient gels is shown in
Fig. 2.2. Thirty ml each of light and dense solutions, suf­
ficient for making 2 gels, were prepared as follows:
Light solution (5 %T)
5.0ml stock acrylamide solution (A)
3.75ml 3M Tris-HCl, pH 8.8 (E)
0.3ml 10% (w/v) SDS solution
0.7ml 1.5% (w/v) ammonium persulphate solution 
20.25ml distilled water
Dense solution (20 %T)
20.0ml stock acrylamide solution (A)
3.75ml 3 M Tris-HCl, pH 8.8 (E)
0.3ml 10% (w/v) SDS solution
0 .7ml 1 .5% (w/v) ammonium persulphate solution 
4.5g sucrose (equivalent volume to 2.5ml)
2.75ml distilled water
Fifteen ml each of the light and dense solutions were 
pipetted into the reservoir and mixing chambers, respec­
tively, of the gradient former. Ten /zl of TEMED was pipetted 
into each chamber before the gel was poured.
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Fieure 2.2 Diagram of a Gradient Former.
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2.4.3. Running Conditions
All gels were run overnight at 4°C and continued the 
following day until the dye front reached the bottom of the 
gel, a total running time of approximately 17 hours. A con­
stant voltage of 60V was applied using a Shandon Vokam 2621 
power supply system.
2.4.4. Treatment of Saliva Samples
Ten fX1 of solution H and 10 jLtl of 95% (w/w) glycerol
were added to 100/11 of parotid saliva and the mixture was 
placed in a boiling water bath for 2 minutes before loading 
to the gel.
In order to determine the optimum protein load for dif­
ferent stains such as Coomassie Brilliant Blue R250 (Lindsay 
and Beeley, 1986), Coomassie Brilliant Blue G250 (Mairs and 
Beeley, 1985) and silver stain (Damerval et a l ., 1987),
various protein loads were applied to the gel.
2.4.5. Determination of Molecular Weights
Gels which were to be stained after electrophoresis 
were loaded with Pharmacia Electrophoresis Calibration Kit 
standard Mr markers. Gels which were to be electroblotted 
onto immobilising membranes such as nitrocellulose were 
loaded with Amersham "Rainbow" protein molecular weight 
markers which being coloured are easily visualised on the 
membrane.
The Pharmacia low Mr markers consisted of the following 
proteins:
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Protein Subunit Mr
Phosphorylase B 94,000
Bovine Serum Albumin 67,000
Ovalbumin 43,000
Carbonic Anhydrase 30,000
Soybean Trypsin Inhibitor 20,100
C^-Lactalbumin 14,400
Five /xl of these markers were loaded onto each gel
The Amersham coloured Mr markers consisted of the fol­
lowing proteins:
Proteins Subunit Mr
Myosin 200,000
Phosphorylase B 97,400
Bovine Serum Albumin 69,000
Ovalbumin 46,000
Carbonic Anhydrase 30,000
Trypsin Inhibitor 21,500
Lysozyme 14,300
Ten /xl of these markers were loaded onto each gel.
2.4.5.(i) Homogeneous Gels
Standard protein markers were treated and loaded ac­
cording to the manufacturers' instructions. Relative 
mobility (Rf ) values were calculated and the Mr ' s deter­
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mined by using a plot of log10 Mr versus Rf, which gives a
straight line relationship (Hames, 1981).
2.4.5.(ii) Gradient Gels
The molecular weights of protein spots were estimated 
as recommended by Lambin (1980). In the presence of SDS, 
there is a linear relationship between the log^of the 
molecular weight and the log-^Q of the acrylamide concentra­
tion reached by the protein after electrophoresis.
Using protein standards, a linear relationship of Mr to 
%T as defined by the following equation is obtained:
log10 Mr= a log10(%T) + b
where a and b are constants, %T the total acrylamide and Mr 
the relative molecular weight of the polypeptide.
2.4.6. Running Conditions
Electrophoresis was carried out overnight at a contant 
voltage of 60V and a cooling temperature of 4°C. This was 
continued until the dye front reached the bottom of the gel. 
A Shandon SAE 2621 power supply unit was used.
2.5. Isoelectric Focusing in Immobilised pH Gradients 
(IPG 1s )
2.5.1. Preparation of the Gel Mould
Glass plates with U-frames of dimensions 0.5 X 1Z0 X
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250mm and 1.0 X 110 X 250mm, supplied by Pharmacia-LKB, were 
used to prepare gels of 0.5mm and 1.0mm thicknesses, respec­
tively. In order to prevent gels from sticking to the glass 
plates, the plates were coated with dimethyldichlorosilane 
solution which makes the glass surface hydrophobic.
Prior to use, the GelBond PAG film upon which the gels 
were cast were washed for 3 X 20 minutes in distilled water 
in order to minimise the occurrence of spot streaking when 
the IPG's were used for 2-D PAGE (Gorg et al ., 1985).
After applying a few drops of ethanol to the surface of 
a plain glass plate of dimensions 3.0 X 110 X 250mm (thus 
ensuring good contact) a sheet of GelBond PAG film was 
placed on the surface of the plate with its hydrophilic side 
facing up. This glass plate and the glass plate bearing a 
U-frame were then clamped together with the GelBond PAG film 
sandwiched in between. This set-up is illustrated in Fig.
2.3. Finally, the assembled mould was cooled to 4°C prior to 
use in order to decrease the rate of polymerisation when the 
gel was being poured.
2.5.2. Preparation of IPG's
The following stock solutions were prepared:
(A) Immobiline solutions were prepared by the addition of 25 
ml of distilled water to the contents of each bottle of Im­
mobiline. This produced 0.2M solutions which were then ali- 
quoted as 1ml portions and stored at -20°C for up to 6 
months. After thawing, they were stored at 4°C for periods
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Figure 2.3. Preparation o f a Gel Mould for Gels Cast on GelBond PAG Film.
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of up to 6 weeks. The acidic acyrylamido derivative (pK 0.8, 
Mr 207) was also dissolved in distilled water to make a 
0.2M solution. It was then stored in the same way as the Im­
mobilines. Storage of these solutions for longer periods was 
avoided because Immobilines, particularly the alkaline ones 
(pK's 6.2, 7.0, 8.2 and 9.3) are susceptible to hydrolysis
and autopolymerisation (Pietta et al . , 1985; Astrua-Testori
et a l ., 1986).
Following the report by Gaveby e t a 1 . (1988) that
reconstituting Immobilines in n-propanol rather than water
r
prevents the hydrolysis of the amide bond and the occurence 
of autopolymerisation; in the latter part of 1988, 
"Immobiline II" was introduced. This new generation of Im­
mobilines was supplied as 10ml aliquots of 0. 2M solutions. 
The alkaline Immobilines were supplied in solution in 
n-propanol and the acidic Immobilines in an inhibitor- 
containing water.
(B) Acrylamide/bisacrylamide solution ("30:08") consisted 
of 30% (w/v) acrylamide and 0.8% (w/v) bisacrylamide.
(C) 10% (w/v) ammonium persulphate.
(D) 10% (v/v) TEMED.
(E) 95% (w/w) glycerol solution.
Linear pH gradients were generated by mixing two solu­
tions, an acidic and dense solution, and a basic and light 
one, in a Bio-Rad Model 385 gradient former (Fig. 2.2).
2.5.2.(i) 0.5mm Thick gels
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IPG's which were subsequently to be stained were cast 
on GelBond film. These gels were 0.5mm thick.
IPG's of three pH ranges, i.e. pH 4-9, pH 2.8-4.5 and 
pH 3.5-5.0, were prepared using a modification of the proce­
dure recommended by LKB Application Note No. 324 and the LKB 
Laboratory Manual for the Multiphor II Electrophoresis Sys­
tem .
Sixteen ml each of acidic and basic solutions, suffi­
cient for two gels, were prepared. Although the LKB Applica­
tion Note recommended preparing 15ml of each of these solu­
tions, enough for two gels, and subsequently pipetting 7.5ml 
of each into the chambers of the gradient former for making 
one gel, in practice it was found that small volumes of the 
solutions were retained in the beakers in which they were 
made up and also in the chambers of the gradient former. 
Therefore 16ml, rather than 15ml, of each solution was 
prepared so that 7.8ml of each could be pipetted into the 
chambers of the gradient former.
The solutions for pH 4-9 IPG's were prepared according 
to Table 2.1. The solutions for pH 3.5-5.0 IPG's were 
prepared according to Table 2.2.
The solutions for pH 2.8-4.5 IPG's were prepared as 
recommended by Gianazza et a l ♦ (1987), and are described in
Table 2.3.
Basic, light solution (7.8ml) was pipetted into the 
reservoir chamber of the gradient former and an equal volume 
of the acid, dense solution into the mixing chamber. Twenty
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Table 2.1. Solutions for pH 4-9 IPG's of 0.5mm thickness
Acidic/dense solution (pH 4) Basic/light solution (pH 9)
Volume Volume
Immobiline pK 3.6 884/11 157/11
Immobiline pK 4.6 251/11 452/11
Immobiline pK 6.2 247/11 384/11
Immobiline pK 7.0 23/11 316/11
Immobiline pK 8.2 267/11 76/11
Immobiline pK 9.3 236/11 707/11
Stock solution A 2.67ml 2 .67ml
Stock solution E 4.48ml ---
Distilled water 6.94ml 11.24ml
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Table 2.2. Solutions for pH 3.5-5.0 IPG's of 0.5mm thickness
Acidic/dense solution (pH 3.5) Basic/light solution
(pH 5.0)'
Volume Volume
Immobiline pK 3.6 319(11 226(11
Immobiline pK 4.6 238/11 331(11
Immobiline pK 6.2 167(11 496/tL
Stock solution A 2.67ml 2.67ml
Stock solution E 4.48ml ---
Distilled water 8.13ml 12.28ml
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Table 2.3. Solutions for pH 2.8-4.5 IPG's of 0.5mm thickness
Acidic/dense solution (pH 2.8)
Volume
Acrylamido-
derivative pK 0.8 550/11
Immobiline pK 3.6 813/11
Immobiline pK 4.6 292/11
Immobiline pK 6.2 365/11
0.2M NaOH 1058/11
Stock solution A 2.67ml
Stock solution E 4.48ml
Distilled water 5.78ml
Basic/light solution 
(pH 4.5)
Volume
613/11
977/11
1025/11
2 . 67ml
10. 72ml
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fll each of the TEMED and ammonium persulphate stock solu­
tions were added to the solutions in both chambers before 
they were poured into the pre-cooled mould.
After the gel had been poured, it was allowed to stand 
for 10 minutes to enable the gradient to stabilise before 
being polymerised at 50°C for 1 hour.
pH 4-9 and pH 3.5-5.0 IPG's were removed from the 
mould and washed for 2 X 20 minutes with distilled water to 
remove the remaining catalysts and unreacted Immobilines, 
followed by a 20 minutes wash with 1% (w/v) glycerol. The
gels were then dried overnight at room temperature in a 
dust-free atmosphere, wrapped in plastic bags and stored at 
-20°C.
pH 2.8-4.5 IPG's were treated differently after 
polymerisation. They were not washed so that the glycerol 
density gradient, which is beneficial to IPG's of extremely 
low pH ranges, was not lost. Instead, they were wrapped in 
plastic bags and stored at 4°C for up to a week.
Immobilines for focusing below pH 3.5 are not commer-
to
cially available. In order^ focus below this pH, an 
"Immobiline-type" acrylamido derivative (pK 0.8) was used.
Strongly acidic IPG's have a tendency to burn because 
of problems arising from the substantial difference between 
the conductivities of the Immobiline matrix and the bulk li­
quid, and also from electroosmosis due to the net negative 
charge around pH 3 which leads to the drying of anodic end 
of the gel (Righetti et a l ., 1988). Accordingly, the treat­
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ment and focusing of pH 2.8-4.5 IPG's differed from that-of 
pH 4-9 and pH 3.5-5.0 IPG's in the following ways:
(a) The gels were focused without prior washing so that they 
contained a glycerol gradient with the dense gradient lo­
cated at the anodic end. The g radient acts as a 
"conductivity-quencher" which smoothes the voltage across 
the gel and prevents the anodic end of the gel from drying 
as a result of electroendosmosis.
(b) The gels were focused at a lower voltage than the other 
IPG's .
Before focusing, the dried pH 4-9 and pH 3.5-5.0 IPG's 
were placed in an LKB reswelling cassette and rehydrated 
for at least 4 hours as follows:
(1) pH 4-9 IPG's were rehydrated with 0.5% (w/v) pH 3.5-10.0 
Ampholine in 20% (w/v) glycerol.
(2) pH 3.5-5.0 IPG's were rehydrated with a solution of 8M 
urea containing 0.5% (w/v) pH 3.5-5.0 Ampholine and 20%
(w/v) glycerol.
Glycerol inhibits liquid exudation from the surface of 
the gels. This exudation of liquid, or "sweating", may ad­
versely affect the final band pattern (Altland et a 1 . ,
1986).
A limitation of IPG's is their inherently low conduc­
tivity which causes difficulties such as slow sample entry, 
lateral zone spreading and the formation of salt fronts 
which halt protein migration. Incorporation of carrier am- 
pholvte IPG's, known as hybrid or mixed carrier
A
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ampholyte immobilised pH gradient gels, helps to overcome 
the problems which result from the low conductivity of IPG's 
(Fawcett and Chrambach, 1986a; Altland et a l ., 1987).
Spaces (0.5cm) were cut between 1.0cm wide tracks in 
order to prevent lateral dispersion of samples.
2.5.2.(ii) 1mm Thick gels
Prior to electroblotting, IPG's must be removed from 
their backings so that they may be transferred to the blot­
ting membranes. The presence of charged groups in the Immo- 
biline gels make them adhere tenaciously to any surface, 
especially to the hydrophilic surface of the GelBond film. 
Even by using an LKB FilmRemover apparatus, it is often im­
possible to remove the IPG's from their GelBond backing 
without damaging them.
In view of this difficulty, the IPG's which were to be 
electroblotted were cast on a glass, rather than GelBond, 
surface. They were cast on plain glass plates of dimensions
1.0 X 120 X 250mm. In addition, in order to minimise the 
possibility of damaging the gel during transfer from the 
electrophoresis apparatus to the electroblotting apparatus, 
gels of 1mm thickness were prepared.
Electroblotting was performed only on pH 3.5-5.0 IPG's, 
which were incorporated with 0.5% (w/v) pH 3.5—5 Ampholine. 
In addition, the IPG's also contained 4.46M urea to optimise 
the resolution of the protein bands.
Acidic and basic solutions (15ml of each) sufficient
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were
for preparing one gel, Aprepared. The solutions for ,1mm 
thick pH 3.5-5.0 IPG's were prepared according to Table 2.4.
Basic, light solution (14.1ml) was pipetted into the
reservoir chamber of the gradient former; and an equal
volume of the acidic, dense solution into the mixing cham­
ber . Forty jul each of TEMED and ammonium persulphate stock 
solutions were added to the solutions in both chambers 
before these were poured into the pre-cooled mould.
After the gel had been poured, it was allowed to stand 
for 10 minutes to enable the gradient to stabilise before 
being polymerised at 50°C for 1 hour, after which it was 
removed from the mould, wrapped in a plastic bag, and stored 
for up to 1 week at 4^C before use. One mm thick gels were
run without the washing and rehydration steps to which the
0.5mm thick gels were subjected.
2.5.3. Preparation of Samples and Their Application to the
Gels
Parotid saliva samples, collected and stored as 
described in Section 2.2 could be applied to IPG's without 
prior desalting. For protein loads of 50jtig and above, it was 
necessary to concentrate the samples by lyophilisation and 
reconstitution with distilled water to a fifth of their 
original volumes, followed by centrifugation at 10,000g for 
20 minutes .
Sample volumes of up to 5 0 /il were applied to the sur­
face of the IPG's. The optimum protein load was determined
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Table 2.4. Solutions for pH 3.5-5.0 IPGs of 1mm thickness
Acidic/dense solution (pH 3.5) Basic/light solution
(pH 5.0)
Volume Volume
Immobiline pK 3.6 299/11 212/11
Immobiline pK 4.6 223/11 310/11
Immobiline pK 6.2 157/11 465/11
pH 3.5-5 Ampholine 188/11 188/11
9M urea solution 7.43ml 7.43ml
Stock solution A 2.50ml 2.50ml
Stock solution E 4.20ml ---
Distilled water --- 3.89ml
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by the application of various protein loads (from 10-250 jttg) 
on a pH 4-9 IPG which was subsequently stained with 
Coomassie Brilliant Blue G250 followed by a silver stain 
technique.
The effect of the application position of the sample on 
the focused pattern was investigated by applying 20 jitg of 
proteins (for pH 4-9 IPG's) and lOOjLtg (for pH 3.5-5.0 IPG's) 
at various positions on the gel. After focusing and stain­
ing, the application point which caused the least distortion 
was determined.
2.5.3. Running Conditions
IPG's were placed on the cooling plate of an LKB 2217 
electrofocusing unit. The anolyte was lOmM glutamic acid and 
the catholyte was lOmM sodium hydroxide.
If salts are present in the samples, application of a 
voltage across the gel results in the formation of strongly 
alkaline and acidic boundaries. This may induce protein 
modification or denaturation. This effect was reduced by 
initially focusing the gel at low voltage to allow the ionic 
boundaries to migrate slowly out of the sample application 
points. pH 4-9 and pH 3.5-5.0 IPG's were initially focused 
at 500V (constant voltage) for 1 hour thereafter the focus­
ing was performed at maximum voltage 5000V, maximum current 
5mA and 5W (constant wattage) at a cooling temperature of 
10°C overnight (Righetti et al . , 1988). An LKB 2297 Macro­
drive 5 constant power unit system was used.
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For pH 2.8-4.5 IPG's, a different set of conditions was 
applied, i.e. 200V (constant voltage) for 5 hours, followed 
by 1000V (constant voltage) overnight (Gianazza et a 1 .,
1987) .
2.5.4. Measurement of the pH Gradient
Coloured protein markers were used to determine the pH 
gradient in IPG's. Wide range standards, pH 4.7-10.6, were 
loaded onto pH 4-9 IPG's, and narrow range standards, pH 
2.4-5.65, onto pH 3.5-5.0 and pH 2.8-4.5 IPG's. Each vial 
of markers was reconstituted with 100/xl of distilled water 
and lOjxl was loaded onto each gel.
The wide-range pi markers (pH 4.7-10.6) consisted of 
the following proteins:
Protein pi M r
C-Phycocyanin (Asperigillus nidulans)
4.75, 4.85 232,000
Azurin (Pseudomonas aeruginosa)
5.65 14,000
Trifluoroacetylated Myoglobin 
Met (Porcine)
Myoglobin Met (Porcine) 
Myoglobin Met (Equine) 
Myoglobin Met (Sperm Whale) 
Cytochrome C (Horse Heart) 10.60
8. 30
6.45
5.90
7.30
17,000
12,360
17,567
17,569
17,815
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The narrow-range pi markers (pH 2.4-5.65) consisted-of 
the following components, which, with the exception of the 
dye Patent Blue, are proteins:
Protein/dye pi m .^
Patent Blue (VF), sodium salt 2.40 567
Amyloglucosidase (Aspergillus) 3.65 99,000
Acetylated Cytochrome C
(Horse Heart) 3.95 13,000
Glucose Oxidase (Fungal) 4.25 153,000
C-Phycocyanin (A. nidulans) 4.75, 4.85 232,000
/3-Lactoglobulin (A) (Cow's Milk) 5.25 18,363
j^-Lactoglobulin (B) (Cow's Milk) 5.35 18,277
Azurin (P. aeruginosa) 5.65 14,000
2.5.5. Effects of Salt Content on the Focused Pattern
Salts contained in samples fractionated in IPG's have 
been reported to cause protein modification even at low 
levels (Righetti et al . , 1988; Strahler et a 1 ., 1988).
Oxidation of the iron moiety of haemoglobin occurred at 
sodium chloride concentrations of above 5mM, and protein 
precipitation occurred above 50mM sodium chloride (Righetti 
et al . , 1988) .
The following experiment was therefore designed to 
determine the salt concentration at which denaturation of 
parotid salivary proteins would occur:
Twelve ml of parotid saliva from one individual was
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desalted by overnight dialysis against 1 litre of distilled 
water in a microdialysis unit and concentrated by further 
overnight dialysis against 30% (w/v) polyethylene glycol.
The protein concentration was then determined, and volumes 
containing 25 fig of protein were mixed with increasing con­
centrations of sodium chloride (0-600mM). This was ac­
complished by adding measured volumes of 50mM, 0.1M, 0.5M
and 1. 0M sodium chloride solutions to fixed volumes of the 
concentrated saliva. These were then loaded onto a pH 4-9 
IPG.
An experiment was also performed to compare the pat­
terns of undialysed and dialysed lyophilised concentrates: 
Seven 1ml aliquots of parotid saliva from one individual 
were lyophilised and reconstituted with distilled water in 
order to prepare solutions of the following concentrations: 
XI (i.e. unconcentrated), X2 , X3, X4, X 5 , X6 and XI. Half of 
each sample was desalted by overnight dialysis, in a 
microdialysis unit, against distilled water. The IEF pat­
terns of undialysed and dialysed samples were compared on 
adjacent tracks on a pH 4-9 IPG in order of increasing con­
centration. Twenty five fig of protein was applied to each 
track.
The sodium, potassium and calcium concentrations of the 
unconcentrated and undialysed parotid saliva were determined 
using a Corning flame photometer and were found to be 18mM, 
16mM and 0.2mM respectively.
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2.5.6. Preparation of IPG's Containing Urea Concentration.
Gradients Perpendicular to the pH Axis
In order to investigate the effects of increasing urea 
concentrations on the isoelectric points of salivary 
proteins, dried pH 4-9 and pH 3.5-5.0 IPG's were placed in 
an LKB re-swelling cassette and rehydrated, using a gradient 
maker, with a urea concentration gradient of 0-8 M perpen­
dicular to the pH gradient. The reservoir chamber of the 
gradient former was filled with 8.3ml of distilled water and 
the mixing chamber was filled with an equal volume of 8M 
urea solution. After the solutions had been poured, the gel 
was allowed to rehydrate for 4 hours.
A continuous zone of human parotid saliva was applied 2 
cm from the cathode (Fig. 2.4) throughout the length of the 
gel using a piece of Whatman No.l filter paper of dimensions
22.0 X 0.5cm as the sample application strip. A volume of 
unconcentrated parotid saliva (approximately 1ml) containing 
lmg protein was applied to the pH 4-9 IPG and a volume of X5 
concentrated parotid saliva (approximately 0.2ml, previously 
concentrated by lyophilisation and reconstitution with dis­
tilled water) containing 10.5mg protein was applied to the 
pH 3.5-5.0 IPG.
2.6. 2-D PAGE using Isoelectric Focusing in Carrier
Qmpholyte-Containinq Gels in the lirst Dimension
The method described is based on an adaptation of 
0 1 Farrell's (1975) 2-D procedure (Bio-Rad Bulletin 1244).
99
Figure 2.4. Diagram of an IPG with a 0 - 8M Urea Gradient 
Superimposed Perpendicular to the pH Gradient.
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2.6.1. Stock Solutions
Stock solutions were prepared as follows:
(A) Acrylamide ("30:08") solution containing 30% (w/v) 
acrylamide and 0.8/£(w/v) N, N 1 -methylenebisacrylamide .
(B) 10%(v/v) Triton X-100.
(C) 10%(w / v ) SDS.
(D) 10%(w / v ) APS.
(E) The IEF gel solution consisted of 48.6g urea. 28.8ml
distilled water, 11.8ml of solution (A), 20.3ml solution of
(B) 4.5ml pH 5-7 Ampholine, and 0.5ml pH 3.5-10.0 Am-
pholine. This was stored as 5.5ml aliquots at -20°C.
of
(F) The overlay buffer, consisted^3g urea, 2ml of solution
(B) 0.45ml Ampholine, pH 5-7, and 0.05ml Ampholine, pH 3.5-
10.0 made up to 10 ml with distilled water.
(G) The IEF sample concentrate consisted of 0.1ml
of solution (C), 0.02ml pH 3.5-10.0 Ampholine, 0.18ml pH 5-7 
Ampholine, 0.1ml of 2-mercaptoethanol and 0.2ml of undiluted 
Triton X-100.
(H) 0 . 1M sodium hydroxide solution was used as the 
catholyte.
(I) 0.06% (w/v) phosphoric acid solution was used as the
anolyte.
(J) The IEF gel equilibration buffer consisted of 12.5ml of 
0.5M Tris-HCl, pH 8.8, 5.5 ml of 2-mercaptoethanol solution, 
10ml of solution (C) and O.Olg of bromophenol blue made up 
to 100ml with distilled water.
1 0 1
Solutions (H) and (I) were degassed prior to use.
2.6.2. Preparation of First Dimension Gels
,5-5nl,
Solution (E)^was thawed and degassed for 1 minute, fol­
lowed by the addition of 5 /tL of TEMED and 10 [XI of APS solu­
tion (D) . This solution was then used to fill a 10ml syringe 
fitted with 25cm of fine tubing. The tubing was inserted to 
the bottom of 18cm long glass tubes (1.5mm internal 
diameter), the bases of the tubes had been previously sealed 
with 2 layers of parafilm. The tubes were slowly filled to a 
height of 10cm, with care being taken to dislodge any 
bubbles trapped at the base. Another syringe was used to 
overlay the tubes with 20/11 of solution (F). Polymerisation 
was usually complete within 1 hour.
2.6.3. Preparation and Loading of the Samples
Ten ml aliquots of parotid saliva were desalted by 
overnight dialysis against 1 litre of distilled water, con­
centrated by using Aquacide and centrifuged at 10,000g for 
20 minutes at 4^C. The protein concentrations of the samples 
were then determined, and a volume of saliva containing 
100/ig of protein was added to an equal volume of glycerol. 
Urea (0.5mg) was added and mixed, followed by 1 fil of solu­
tion (G) per 5/il of sample.
The parafilm and overlay solution were removed from the 
rod gels and the saliva samples were applied to the top of 
the gels using a Hamilton microlitre syringe. After sample
1 0 2
application, 10 fil of solution (F) was overlayed onto each 
tube. These were then filled to the top with 0.1M sodium 
hydroxide solution. This system is illustrated in Fig. 2.5.
2.6.4. Running Conditions
Phosphoric acid solution (2.5 litres, 0.06%(w/v)) was 
added to the lower reservoir and 0.5 litres of 0.1M sodium 
hydroxide solution to the upper reservoir. A Bio-Rad Protean 
II electrophoresis apparatus was used in conjunction with an
LKB 2103 constant power unit. IEF was carried out at 400V
for 12-15 hours, followed by 800V for 2 hours.
2.6.5. Removal and Equilibration of the IEF Rod Gels
The rod gels were removed by first loosening them with 
a solution of 10% (w/v) glycerol. This was applied using a
syringe with a short length of fine tubing. Each tube was 
then connected to a low pressure air line and the gels care­
fully extruded. Each gel was shaken for 10 minutes with 3 
ml of IEF equilibration buffer (J), after which the
solution was removed and the gel was either applied directly 
to the SDS gel or stored at -20°C.
2.6.6. SDS-PAGE
SDS-PAGE was performed on either 12.5 %T polyacrylamide 
gels or 5-20 %T linear gradient polyacrylamide gels. 
Electrophoresis was carried out at a constant voltage of 
60V and a cooling temperature of 4°C overnight, and con-
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tinued until the dye front reached the bottom of the gel.,A 
Shandon Vokam SAE 2761 power supply unit was used.
2.7. 2-D PAGE with IPG's in the First Dimension
2.7.1. First Dimension
2.7.1(i) Preparation of the Gels
0.5mm thick pH 4-9 and pH 3.5 —5.0 IPG's were prepared/ 
washed and dried as described in Section 2.5.2. The dried 
IPG's were cut into 5mm wide strips, using a Rotatrim preci­
sion paper cutter (Gorg et a l .,1985). 20 strips were 
prepared for each run. The IPG strips were rehydrated in an 
LKB rehydrating cassette for at least 4 hours before use. 
The rehydration solutions for the IPG strips consisted of 8M 
urea and 0.5 % (w/v) Ampholines dissolved in 20% (w/v)
glycerol solution. pH 3.5-10.0 Ampholines were used for the 
pH 4-9 IPG's and pH 3.5-5 Ampholines for the pH 3.5-5.0 
IPG's .
After the IPG strips had been rehydrated, they were 
lightly pressed between 2 sheets of moistened Whatman No.l 
filter paper in order to remove excess urea solution. They 
were then placed 2mm apart on the cooling plate of an LKB 
2217 Ultrophor electrofocusing unit. Pharmacia-LKB silicon 
rubber sample applicators, which can contain sample volumes 
of up to 40/11, were placed on the IPG strips at a distance 
of 2cm from the cathode (Fig. 2.6). The saliva samples were 
applied in the wells of the sample applicators using 
micropipettes.
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2.7.1.(ii) Running Conditions
An LKB 2297 Macrodrive 5 constant power supply unit 
was connected to the electrofocusing unit. For improved 
sample entry, a low constant voltage (300V) was applied for 
the first hour of IEF, after which the conditions were 
changed to 3000V (maximum voltage), 2mA (maximum current) 
and 5W (constant power) overnight at a cooling temperature 
of 10°C (Gorg et a l ., 1988). Glutamic acid solution (lOmM) 
was used as the anolyte and lOmM sodium hydroxide as the 
catholyte.
2.7.1(iii) Equilibration of the IPG Strips
After focusing, each IPG strip was placed in a test
tube and equilibrated, using a mechanical shaker, for 15 min 
in 10ml of an equilibration buffer of 0.05M Tris-HCl, pH 6.8 
containing 2% (w/v) SDS, 65mM DTT, 6M urea and 30% (w/v)
glycerol containing a few grains of bromophenol blue (Gorg
et a l ., 1987). This was followed by shaking for a further 15
minutes in 10ml of fresh equilibration buffer containing
260mM iodoacetamide.
Thiol-reducing agents such as DTT are capable of par­
tially solubilising particulates which eventually cause the 
point-streaking observed in silver stained 2-D gels. In or­
der to overcome this problem, iodoacetamide was added to the 
equilibration solution. Iodoacetamide carboxymethylates ex­
cess DTT in the equilibration solution, and thus reduces the
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occurrence of point-streaking.
After the IPG strips had been equilibrated, they were 
placed on edge on a dry filter paper and allowed to drain 
thoroughly• If not used immediately, they were frozen and 
stored at -20°C.
2.7.2. Second Dimension
2.7.2(i) Linear Polyacrylamide Gradient SDS-PAGE
For the second dimension of protein fractionation, the 
equilibrated IPG strip was placed on the surface of a 
horizontal linear polyacrylamide gradient SDS-PAGE gel.
2.7.2(ii) Stock Solutions
The following stock solutions were prepared:
(A) Acrylamide ("30:08") solution containing 30% (w/v) 
acrylamide and 0.8 (w/v) N, N '-methylenebisacrylamide.
(B) 3M Tris-HCl buffer, pH 8.8
(C) 10% (w/v) SDS solution.
(D) 95% (w/w) glycerol solution.
(E) 20% (w/v) ammonium persulphate solution.
(F) 10% (v/v) TEMED.
2.7.2.(iii) Preparation of the Gradient Gels
The gel mould was prepared as described in Section 
2.5.1.. All gels were cast on GelBond PAG film.
A gradient former was used to pour the 3-15 -eT linear 
gradient polyacrylamide gels. Sixteen ml of each solution, 
sufficient for two gels, was prepared according to Table
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2.5.
Light solution (7.8ml) was pipetted into the reservoir 
chamber of the gradient former and an equal volume of the 
dense solution into the mixing chamber, followed by 20 jLtl 
each of TEMED and ammonium persulphate solutions into each.
After the gel had been poured, it was allowed to stand 
for 10 minutes before it was polymerised at 50°C for 1 hour. 
Upon the removal of the gel from the mould, unless im­
mediately used, it was sealed in a plastic bag and stored at 
4°C for up to a week.
2.7.2.(iv) Transfer of IPG Strips to SDS gels
Two IPG strips were placed on an SDS gel. Each strip 
was placed on the SDS gel with its gel-side facing downwards 
and its anodic end on the left hand side (Fig. 2.7).
2.7.2.(v) Running Conditions
An LKB 2217 Multiphor electrophoresis unit was used in 
conjunction with an LKB 2103 power supply system. The reser­
voir buffer was 0.1% (w/v) SDS, 0.025M Tris, 0.192M glycine 
and 0.01% (w/v) sodium azide, pH 8.3. The electrode wicks
were placed so that they covered 2cm of each end of the gel 
(Fig 2.8). The cooling temperature was 10°C.
For the first 90 minutes, a maximum voltage of 200V was 
applied to facilitate the slow entry of proteins from the 
IPG strips into the matrix of the gel. After this, the IPG 
strips were removed and the cathode wick was repositioned so
1 1 0
Table 2.5. Solutions for linear gradient SDS-PAGE gels -for 
the second dimension of 2-D PAGE
Light solution (3 %T ) 
Solution
Stock solution A 
Stock solution B 
Stock solution C 
Distilled water
Dense solution (15 %T )
Solution
Stock solution A 
Stock solution B 
Stock solution C 
Distilled water 
Stock solution D
Volume (ml)
1. 60 
2.00 
0.16 
12 .24
Volume (ml)
8.00
2.00
1.60
1.36
4.48
1 1 1
F igure 2.1. P o s i t io n in g  o f  the IPG Strips on an S D S  Polvacrvlnmirie  
G e l for  T w o - D im e n s io n a l  P A G E .
25cm
Plastic Bacldng
©
12cm
0
KEY
m IPG Strips
Filter paper (3 x 5mm)
-.V loaded with M r standards
1 1 2
Figure 2.8. Cross-Section . Parallel to the Direction of Protein
M igration, of an Electrophoresis Tank for the Second Dimension 
of Two-Dimensional-PAGE.
Direction of Protein 
Migration
Cathodic Wick Anodic Wick
Cooling Plate
Reservoir
Buffer
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that it covered the application sites of the IPG strips -on 
the gel. The running conditions were then changed to 600V 
(maximum voltage), 30mA (constant current) and 30W (maximum 
wattage), until the dye front reached the anodic of the gel. 
This took approximately 90 minutes.
2.8. Staining Procedures
2.8.1. Coomassie Brilliant Blue G250 Stain
A colloidal suspension of CBB G250 in trichloroacetic 
acid (T C A ) and perchloric acid (P C A ) was prepared as 
described by Mairs (1981; p.65):
Two g of CBB G250 was dissolved in 100ml of distilled 
water. One hundred ml of 1M sulphuric acid solution was 
added and the mixture was stirred for 1 hour. The 
precipitate formed was allowed to settle overnight, and the 
solution was passed through a Whatman No. 1 filter paper. 
The pH of the filtrate was raised to 5.5 by the addition of 
10M potassium hydroxide solution. Finally, PCA, TCA and dis­
tilled water were added to give a total volume of 400ml and 
final concentrations of 0.5% (w/v) CBB G250, 3.5% (w/v) PCA
and 10% (w/v) TCA.
Gels were fixed and stained in this solution for 1 hour 
before being destained in 10% (v/v) acetic acid.
2.8.2. Comassie Brilliant Blue R250 Stain
Half mm thick gels were fixed for 30 minutes in 10% 
(w/v) TCA containing 3.5% (w/v) PCA prior to staining, while
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1 . 5mm thick gels were Coomassie — stained without prior 
fixing.
The staining and destaining procedures were performed 
as described by Lindsay and Beeley (1986):
The gel was fixed and stained in a solution of 0.1%
(w/v) CBB R250 in 40% (v/v) ethanol containing 10% (v/v)
acetic acid for 3 hours, after which it was destained with 
several changes of 10% (v/v) acetic acid over a period of
2-3 days.
2.8.3. Silver Stain
The procedure for silver stain is a modification of the 
procedure of Damerval et a l . (1987) and is outlined in Table
2.6 .
2.8.4. PAS Stain for Glycoproteins
2.8.4 (i) Preparation of Schiff's Reagent
The Schiff's reagent was prepared according to the 
method of Kapitany and Zebrowski (1973).
One g of pararosaniline hydrochloride was dissolved in 
200ml of boiled, distilled water, removing the flask from 
the heat just before addition of the dye. The solution was 
cooled to 50°C in cold water and 2g of potassium metabisul­
phite was added. After cooling to room temperature, 2ml of 
concentrated hydrocholoric acid was added and the solution 
mixed and allowed to stand overnight in the dark. Powdered, 
activated charcoal (0.2g) was added and the flask shaken for
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Table 2.6. Procedure for silver staining.
Step
1. Fix.
2. Fix.
3. Wash.
4. Sensitise.
5. Wash.
6. Silver.
7. Rinse.
8. Rinse.
9.Develop.
10. Stop.
11. Rinse.
12. Store.
Solution Duration
10% (w/v) trichloroacetic acid 
containing 10*/(w/v) perchloric a 
2.5% (w/v) glutaraldehyde in
1M sodium acetate solution.
distilled water.
Farmer's Reducer consisting of
0.15% (w/v) potassium 
hexacyanoferrate III, 0.3% (w/v) 
sodium thiosulphate and 0.05% 
(w/v) sodium carbonate, 
distilled water.
0.1% (w/v) silver nitrate, 
distilled water, 
developer (0.5% (w/v) 
sodium carbonate in 0.2%
(w/v) formaldehyde), 
developer (as above).
30min. 
cid.
30min.
4 X 30min. 
lmin.
5% (v/v) acetic
distilled water.
5% (w/v) glycerol.
acid.
2 X 15min 
30min.
2 X lOsec 
2 X lOsec
as re­
quired, 
normally
3-8mins.
lOmin 
2 X lOmin.
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10 minutes. The mixture was filtered through a Whatman No- 1 
filter paper. The charcoal treatment was repeated if neces­
sary until the solution was pale yellow to clear in colour. 
The reagent was stored in a dark bottle at 4°C.
2.8.4(ii) Schiff Staining Procedure
The method of Glossmann and Neville (1971), which in­
volves elution of SDS from the gel, was used. Other proce­
dures such as that of Kapitany and Zebrowski (1973) do not 
work well with SDS-containing gels because SDS causes
high background staining. The procedure, to which the gels 
are subjected immediately after electrophoresis, is outlined 
in Table 2.7.
2.9. Protein Blotting
2.9.1. Electroblotting Procedure
An LKB 2117-005 Multiphor II Novablot System, which is 
a unit for semi-dry horizontal electrophoretic transfer, was 
used. A semi-dry transfer technique is one which uses filter 
paper soaked in electrode solution as the only reservoir 
buffer.
2.9.2. (i) Electroblotting of Proteins onto Nitrocellullose 
Membranes
The stock solutions consisted of the following, as 
recommended by the LKB Multiphor II Novablot Instructions 
Manual:
(1) For the transfer of proteins from SDS gels, a continuous
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Table 2.7. Procedure for Schiff stain.
Step
1. Wash.
2. Wash.
3. Oxidise.
in
4. Incubate.
5. Wash.
6. Store.
Solution Duration
and conditions
40% (v/v) methanol in overnight.
7% (v/v) acetic acid.
40% (v/v) methanol in 8hrs.
7% (v/v) acetic acid.
1% (v/v) periodic acid lhr. at 4°C in
7% (v/v) acetic acid. the dark.
Schiff's Reagent. lhr. at 4°C in
the dark.
1% (w/v) sodium thiosulphate 4 X lOmin. 
in 0.1M hydrochloric acid.
Schiff's Reagent.
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buffer consisting of 39mM glycine, 48mM Tris and 0.035% 
(w/v) SDS in 20% methanol was used.
(2) For the transfer of proteins from IEF gels, a discon­
tinuous buffer system, consisting of these solutions, was 
used:
Anode solution N o .1 (pH 10.4) was 0.3M Tris,
Anode solution No.2 (pH 10.4) was 0.1M Tris, and
Cathode solution (pH 10.5) was 0.1M arginine in 0.01%(w/v)
SDS.
As gels cast on GelBond PAG film tend to adhere tena­
ciously to their backings they had to be removed using an 
LKB FilmRemover Unit which separates the gel from its back­
ing by drawing a thin wire between the gel and the backing.
The transfer unit assembly is illustrated in Fig. 2.9. 
A current of 0.8mA per cm of the membrane was applied for 2 
hours.
2.9.2. (ii) Electroblotting of Proteins onto Polyvinylidene 
difluoride Membranes
The procedure of Matsudaira (1987) was used. The trans­
fer buffer consisted of lOmM 3-(cyclohexylamino)-1-propane 
sulphonic acid (CAPS), pH 11.0 (titrated to this pH value 
with 2M sodium hydroxide solution) in 10% (v/v) methanol. A
piece of PVDF membrane was rinsed briefly in pure methanol 
and washed for 5 minutes in the transfer buffer.
Following SDS-PAGE, the gel was soaked for 5 minutes in 
the transfer buffer in order to reduce its content of Tris
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Figure 2.9. Assembly of Electroblotting Transfer Unit
A. For blotting of SDS Gels
B. For blotting of IEF Gels.
SDS-gel
Nitrocellulose or 
PVDF M embrane
Cathode
(-)
IEF gel
Membrane
B
Anode 
(+)
KEY.
-v.-J 9 layers of filter paper
soaked in blotting buffer
9 layers of filter paper
soaked in Cathode Solution
\ \  3 layers of filter paper
^  soaked in Anode Solution No. 2
6 layers of filter paper
soaked in Anode Solution No. 1.
1 2 0
and glycine, after wlnicln it wss sandwiched between a sbeet 
of PVDF membrane and 9 sheets of Whatman No. 1 filter paper 
on each side. A current of 0.8mA per cm2 of the membrane 
was applied for 2 hours.
2.9.3. Methods for the Detection of Proteins on Blots
2.9.3.(i) General Staining of Proteins by India Ink
In order to check the efficiency of the electroblot and 
for the precise location of the protein bands or spots, it 
is necessary to stain all the proteins which have been 
electroblotted onto the nitrocellulose membrane. For this, 
the India ink staining method of Sutherland and Skerritt 
(1986) was used. The procedure for the treatment of 
nitrocellulose membranes to be stained after electroblotting 
is outlined in Table 2.8.
2.9.3.(ii) Coomassie Brilliant Blue Staining of Proteins
Electroblotted onto PVDF
The procedure recommended by Matsudaira (1987) was 
used: after electroblotting had been carried out, the PVDF
membrane was washed for 5 minutes in distilled water, 
stained with 0.1% (w/v) CBB R250 in 50% (v/v) methanol for 5 
minutes and subsequently destained in several changes of 50% 
(v/v) methanol and 10% (v/v) acetic acid for 10 min. The
membrane was washed for 3 X 5  minutes with HPLC-grade water 
and air-dried in a dust-free atmosphere. The stained protein 
bands of interest were cut out using a clean scalpel and
1 2 1
Table 2.8.Procedure for India Ink staining of proteins -fol
lowing e l e c t r o b l o t t i n g  onto 
membranes
Step Solution
1. Sensitise
2. Wash.
3. Stain.
4. Wash.
1% (w/v) potassium 
hydroxide.
10% (v/v) methanol 
in PBS for SDS-PAGE 
gels, PBS for non-SDS 
PAGE gels.
0.5% (v/v) India ink 
and 1% (w/v) Tween 20 
in PBS.
PBS.
nitrocellulose
Duration 
5min.
2 X lOmin. 
lhr.
2 X lOmin.
1 2 2
stored in Eppendorf tubes at -20°C.
2.9.3.(iii) Detection of Antigens by Alkaline Phophatase- 
Conjugated Anti-Antibody
A modification of the method of Eap and Baumann (1988), 
based on the procedure of Blake et a l . (1984) was used.
Stock 5 mg/ml nitroblue tetrazolium (NBT) and 3 mg/ml 
5-bromo-4-chloro-3-indolyl phosphate (BCIP) solutions were 
prepared, stored frozen at -20°C, and thawed just prior to 
use. The alkaline phosphatase substrate solution, which was 
prepared just before use, consisted of the following 
reagents: 2ml of NBT stock solution, 1.6ml of BCIP stock 
solution, 1.2ml of 0.1 M magnesium chloride, 1.2 ml of 0.1M 
zinc chloride and 94ml of 0.05 M sodium carbonate-sodium 
hydrogen carbonate buffer, pH 9.6.
The alkaline phosphatase-conjugated anti-antibody 
method for the detection of proteins electroblotted onto the 
nitrocellulose membranes is outlined in Table 2.9.
2.9.3.(iv) Detection of Antigens Using Immune Complexes of 
Alkaline Phosphatase and Monoclonal Anti-Alkaline Phos­
phatase (APAAP Complexes)
Western blotting followed by the detection of proteins 
by the alkaline phosphatase-conjugated anti-antibodies oc­
casionally results in weak staining reactions, particularly 
if the antigen is present in small amounts {< 1/ig) • In or­
der to intensify staining, an immune complex of alkaline 
phosphatase and monoclonal anti—alkaline phosphatase (APAAP
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Table 2.9. Procedure for the detection of antigens - by 
alkaline phophatase-conjugated anti-antibody
s t e P Solution Duration
1. "Quenching" of 
the remaining 
sites of attachment.
2. Incubation in a 
specific antiserum 
to antigen
3. Wash.
4. Incubation in 
alkaline
phosphatase-conjugated 
anti-antibody.
5. Wash.
6. Wash.
Develop
8. Wash.
1% (w/v) Tween 20 
in PBS (Tween-PBS 
solution)
1:1000 dilution of 
the antiserum in 
Tween-PBS. 
Tween-PBS.
1:1000 dilution 
of the
conjugate in 
Tween-PBS. 
Tween-PBS.
0.05M sodium 
carbonate-sodium 
hydrogen carbonate 
buffer, pH 9.6. 
Alkaline phosphatase 
substrate solution, 
distilled water.
2 X 30min
3hrs .
3 X lOmin 
2hrs.
3 X lOmin 
2 X 5min.
Up to 2hrs.at 
37°C.
2 X lOmin.
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complex) may be used (Cordell et_al. , 1984). The APAAP com­
plex consists of 4 molecules of alkaline phosphatase enzyme 
complexed to an equal number of mouse monoclonal antibodies. 
The rabbit antibody against mouse IgG is used as a "bridge" 
between two APAAP complexes. One stage of incubation in the 
APAAP complex would theoretically attach 4 molecules of 
alkaline phosphatase to each molecule of the first antibody, 
while an additional one and two stages would add 16 and 54 
molecules, respectively, of alkaline phosphatase molecules.
The APAAP method for the detection of proteins which 
have been electroblotted onto nitrocellulose membranes is 
outlined in Table 2.10.
2.9.3.(v) Detection of Concanavalin A-Binding Glycoproteins 
Concanavalin A (ConA) is a lectin which preferen­
tially binds to a-D-mannopyranosyl and Or -D-glucopyranosyl 
residues. Hawkes (1982) described a method in which ConA was 
used as a p robe for g l y c o p r o t e i n s  which had been 
electroblotted onto nitrocellulose. In the second stage, 
horse-radish peroxidase (HRP), a ConA-binding glycoprotein 
was added. Finally, the membrane was incubated in a sub­
strate solution for HRP. A modification of this method was 
used.
As ConA is capable of binding small hydrophobic 
molecules at a different site from that which binds car­
bohydrates (Edelman and Wang, 1978), a control experiment 
was performed in which QJ—D—methyl mannoside, a sugar which
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Table 2.10. Detection of antigens using immune complexes* of 
alkaline p h o s p h a t a s e  and monoclonal anti-alkaline phos­
phatase (APAAP complexesT "
Step
1. "Quenching" of 
the remaining 
sites of attachment
2. Incubation in 
goat antiserum 
to antigen
3. Wash.
4. Incubation in 
mouse monoclonal 
antibody against 
goat IgG.
5. Wash.
6. Incubation in 
rabbit antiserum 
against mouse 
IgG.
7. Wash.
8. Incubation in 
APAAP complex.
Solution
1% (w/v) Tween 20 
in PBS (Tween-PBS 
solution).
1:1000 dilution of 
the antiserum in 
Tween-PBS.
Tween-PBS.
1:1000 dilution of 
the antibody in 
Tween-PBS.
Tween-PBS.
1:1000 dilution of 
the antibody in 
Tween-PBS.
Tween-PBS.
1:1000 dilution of 
the complex in 
Tween-PBS.
Duration
2 X 30min
3hrs .
3 X lOmin 
2 hrs.
3 X lOmin 
2hrs .
3 X lOmin. 
2hrs .
9. Wash. Tween-PBS. 3 X lOmin.
10. Repeat Step 6.
11. Wash. Tween-PBS. 3 X lOmin.
12 . Repeat Step 8.
13 . Wash. Tween-PBS. 3 X lOmin.
14. Repeat Step 6.
15. Wash. Tween-PBS. 3 X lOmin.
16. Repeat Step 8.
X lOmin.17 . Wash. Tween-PBS. 3
18. Wash. 0.05M sodium 
carbonate-sodium 
hydrogencarbonate 
buffer, pH 9.6.
2 X 5min.
21. Develop. Alkaline phosphatase Up to 2hrs 
at 37°C.substrate solution.
22 . Wa s h . distilled water. 2 X lOmin.
N.B. As a result of the number of steps involved/ it 
was necessary to carry out the whole procedure over a period 
of 2-3 days. Thus when it was necessary, the incubation in 
an antibody- or APAAP complex-containing solution was per­
formed overnight at 4^C, and the procedure was continued the 
following day.
1 2 6
has a strong inhibitory effect on ConA-binding, was added to 
the ConA incubating solution.
The following stock solutions were prepared:
(a) 0.2M sodium chloride in 50mM Tris-buffered saline (TBS), 
pH 7.4.
(b) 0.1M sodium acetate-acetic acid buffer solution, pH 5.6.
(c) 0.3% (w/v) 4-chloro-l-napthol solution in methanol. This 
was stored in the dark at 4^C.
(d) Horse-radish peroxidase substrate (HRP) solution con­
sisting of 0.06% (w/v) 4-chloro-l-naphthol and 0.01% (v/v) 
hydrogen peroxide in 0.1M sodium acetate-acetic acid buffer 
solution, pH 5.6.
The procedure for the detection of glycoproteins which had 
been electroblotted onto nitrocelluose membranes is outlined 
in Table 2.11.
2.10. Immunochemical Techniques
2.10.1. Double Immunodiffusion
A modification of the procedure recommended by 
Johnstone and Thorpe (1987; pp. 133-135), which is a varia­
tion of the original method of Ouchterlony (1948), was used.
GelBond PAG film was cut into 26 X 76mm-sized pieces.
A 1% (w/v) agar solution was prepared by heating lg of agar
in PBS-azide until completely dissolved. When the agar solu-
|!
tion ha^ cooled to 45^C, 3.5ml was pipetted onto the ,j
hydrophilic side of each piece of GelBond film which had ,
\been placed on a levelling table. A template was placed over «
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Tab 1e 2.11. Procedure for the detection of ConA-bindinq 
glycoproteins following electroblotting onto nitrocel- 
lulose membranes
Step Solution Duration
1. "Quenching" of the 
remaining binding 
sites.
2. Incubation in 
ConA-containing 
solution.
3. Wash.
4. Incubation in 
horse-radish 
peroxidase (HRP) 
containing 
solution.
5. Wash.
6. Wash.
7. Develop
8. Wash.
1% (w/v) gelatin 
in Tris-buffered 
saline (Gelatin- 
TBS) .
50jU,g/ml ConA in 
Gelatin-TBS.
In the control, 
this solution also 
contained 0.1M 
CK-D-methyl mannoside. 
Gelatin-TBS.
50/ig/ml HRP in 
Gelatin-TBS.
Gelatin-TBS.
0.1M sodium acetate- 
acetic acid buffer, 
pH 5.6.
HRP substrate
2 X 30min
lhr.
3 X lOmin 
lhr.
3 X lOmin. 
lOmin.
solution, 
distilled water.
up to 30min
2 X lOmin.
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the solidified agar, and holes were punched into the agar 
using a gel punch. Each well had a capacity of 20 fil. The 
centre well was filled with the undiluted antigen, and the 
six surrounding wells were filled with varying dilutions of 
the antiserum; i.e. undiluted, 1/2, 1/4, 1/8, 1/16 and 1/32;
and incubated overnight in a humid box at room temperature, 
after which the gel was checked for immunoprecipitin lines. 
If staining was necessary to visualise the immunoprecipitin 
lines, the gel was washed five times over 2 days with 100ml 
of PBS-azide, stained for 2 hours with 0.1% (w/v) CBB R250
in 40% (v/v) ethanol containing 10% (v/v) acetic acid, and
destained with several changes of 10% (v/v) acetic acid over 
2-3 days.
2.10.2 . Latex Slide Test for Rheumatoid Factors
The Latex RF (rheumatoid factor reagent) contains latex 
particles coated with human Y-globulins which agglutinate in 
the presence of rheumatoid factors.
P a r o t i d  s a l i v a  s a m p l e s  w e r e  l y o p h i l i s e d  and 
reconstituted with distilled water to a fifth of their 
original volumes and centrifuged as described in Section
2.2. 20/11 of each concentrated sample was mixed with an
equal volume of the Latex RF reagent. A positive reaction 
was indicated by agglutination while a negative reaction was 
indicated by a homogeneous suspension.
2.10.3. Production of a Rabbit Antiserum against Human Uri­
nary Kallikrein
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2.10.3. (i) Antiserum Production
The antiserum was produced using a modification of the 
the procedure of Catty and Raykundalia (1988).
Each vial of the commercially obtained kallikrein con­
tained 0.2 Units (i.e. 40/i,g) of the enzyme dissolved in 0.5 
ml of 50% glycerol buffered with 50mM Tris-HCl, pH 7.75. 
Half of this was mixed with 0.5ml of 0.15M sdoium chloride 
solution and 0.5ml of Freund's Complete Adjuvant (FCA), and 
an emulsion formed. This was injected subcutaneously into a 
rabbit at 4 different sites.
After 4 weeks, a booster injection containing an equal 
amount of kallikrein was administered in a similar manner, 
with the single difference that Freund's Incomplete Adjuvant 
(FIA) was used instead of FCA. One week after the booster 
dose, 10ml of serum was harvested by bleeding the rabbit 
from a marginal ear vein. A week later, a further 10ml was 
collected.
Following collection, the blood was allowed to clot for 
1 hour at 37°C, and left overnight at 4°C to allow the clot 
to retract. The red cells were removed by centrifuging the 
serum at 1,500 r.p.m. at 4°C for 20 minutes. The supernatant 
was removed and stored at -20°C.
In a c c o r d a n c e  w i t h  the A n i m a l s  ( S c i e n t i f i c  
Procedures)Act, 1986, the procedures on the rabbits were 
carried out by personnel holding the necessary licenses.
The activity of the antiserum was tested by double im-
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munodiffusion using human urinary kallikrein as the test 
antigen. Human serum albumin, human IgG and human colostral 
slgA were used as control antigens.
2.10.3.(ii) Purification of Rabbit IgG
The isolation of IgG from the rabbit antiserum to uri­
nary kallikrein was carried out as recommended by Johnstone 
and Thorpe (1987; pp.51-52).
The standard working temperature for all incubations 
and centrifugations was 25°C. Ten ml of serum was warmed to 
this temperature. Sodium sulphate was then added and dis­
solved by stirring to make an 18% (w/v) solution. This was 
then incubated for 30 minutes, and centrifuged at 3,000g for 
30 minutes. The supernatant was discarded, and the protein 
precipitate was redissolved in distilled water to a final 
volume of 25ml. After warming the solution to the working 
temperature, sodium sulphate was added and dissolved to make 
a 14% (w/v) solution. This was then incubated for 30
minutes, and centrifuged at 3,000g for 30 minutes. Again, 
the supernatant was discarded and the precipitate was redis­
solved in water to a final volume of 3ml. This solution was 
then dialysed overnight against lOmM sodium phosphate buf­
fer, pH 8.0. At this stage, a partially purified IgG solu­
tion was obtained.
The Whatman DE32 anion exchanger was equilibrated over­
night against 0.07M sodium phosphate buffer, pH 8.0, and 
15ml wet settled volume of the exchanger was added to the
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p a r t i a l l y  p u r i f i e d  IgG solution. This mixture w.as 
centrifuged at 3,000g for 30 minutes. The IgG molecules were 
contained in the supernatant which was collected and its an­
tibody activity against human urinary kallikrein was tested 
by double immunodiffusion. It was then stored as 5 0 /LL ali­
quots at -20°C.
2.11. High Performance Liquid Chromatography
High Performance Liquid Chromatography (HPLC) is an ef­
ficient method of fractionating mixtures of macromolecules. 
Proteins vary widely in their properties, and it is there­
fore possible to fractionate them according to their dif­
ferences in charge, size, hydrophobicity and affinity for 
lectins. A charge fractionation method (ion-exchange 
c h r om at og ra ph y )  was used for fractionating salivary 
proteins.
In ion-exchange chromatography, a protein which has a 
region of charge on its surface, opposite in sign to the 
fixed charge of the stationary phase, will remain bound to 
the fixed charge of the ion-exchanger until it is displaced 
by buffer ions of sufficiently high ionic strength.
A Pharmacia Fast Protein Liquid Chromatography (FPLC) 
unit fitted with a Pharmacia Mono-Q anion exchange column 
(Model Mono-Q HR 5/5, dimensions 5 X 50mm) was used. Human 
parotid saliva samples were concentrated by dialysis in a 
microdialysis unit against 30% (w/v) polyethylene glycol
10,000 followed by an overnight dialysis against 20mM bis-
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tris propane-hydrochloric acid buffer solution, pH 7.0. All 
solutions were prepared using HPLC-grade water.
As this study was mainly concerned with anionic 
proteins (proteins with pi's < 6), a column which had been 
packed with a strong anion-exchanger (Mono-Q) was used. The 
pH of the eluant, pH 7.0, was chosen so that the anionic 
proteins are negatively charged when they were being frac­
tionated (Henry, 1989).
The flow-rate of the eluant through the column was 1 
ml/min, and the chart speed of the recorder was 2 cm/min. A 
214nm detector and a 500(XL sample loop were fitted. The ini­
tial, low ionic strength buffer was 20mM bis-tris propane- 
hydrochloric acid buffer solution, pH 7.0 (buffer A); and 
the final, high ionic strength buffer was 20mM bis-tris 
propane-hydrochloric acid buffer solution, pH 7.0, contain­
ing 1M sodium chloride (buffer B). Just before use, the 
solutions were filtered through a 20/tm Millipore filter.
The FPLC apparatus was operated in the programmed mode. 
The program was set as follows: the gradient, introduced at 
3 minutes, was 0-30% B from 3 to 14 minutes, and 30-100% B 
from 14 to 16 minutes. The process was stopped at 20 
minutes. 0.5ml-sized fractions were collected.
2.12. Enzymic Deglycosylation of Glycoproteins
Many proteins are conjugated proteins which contain 
non-amino acid substituents or prosthetic groups attached to 
the polypeptide chain. These proteins may be classified ac­
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cording to the nature of their prosthetic groups; for ex­
ample, glycoproteins, phosphoproteins and metalloproteins 
(Lehninger, 1975) . Enzymes capable of catalysing the removal 
of the prosthetic groups may be useful in the elucidation of 
protein structure. For example, glycosidases facilitate the 
removal of monosaccharide or oligosaccharide groups from 
glycoproteins.
2.12.1. Incubation with Neuraminidase
2.12.1.(i) Introduction
The sialic acid CkJ-N-acetylneuraminic acid often occurs 
as the peripheral residue of oligosaccharide side groups of 
glycoproteins which are N-linked to the polypeptide via 
asparagine. The presence of the carboxyl group located on C-^  
of the QJ-N-acetylneuraminic acid molecule causes the sialic 
acid to have a significant effect on the pi of the 
glycoprotein. The pi's of the sialated forms of a 
glycoprotein are, therefore, lower than that of its asialo 
forms. In addition, differing amounts of sialic acid in the 
oligosaccharide side groups of a glycoprotein will result in 
microheterogeneity (Beeley, 1985).
Neuraminidase (E .C .3.2.1.18) is an exoglycosidase 
which hydrolyses the terminal ketosidic bonds which join 
sialic acid to oligosaccharide. Neuraminidase isolated from 
Vibrio cholerae will cleave the bond between
Oi-N—ace ty lneuraminic acid and galactose at the following 
rates: NeuAc 0L-2-3 Gal > NeuAc 0L-2-4 Gal > NeuAc Ot-2-6 Gal
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(Kobata, 1979).
2.12.1.(ii) Procedure
The incubation of parotid saliva with neuraminidase was 
carried out using a modification of the procedure of Ada et 
al. (1961):
Neuraminidase was supplied as a solution of lU/lml, and 
was stored at -20°C as aliquots of 50mU/50/U. A volume of 
parotid saliva, approximately 75-125/11, containing 100/xg of 
protein was pipetted into an Eppendorf tube, followed by 
50mU of neuraminidase, lOjLtl of 0.01M calcium chloride solu­
tion and 20 fil of 0. 1M pH 5.6 sodium acetate buffer, and 
overlaid with 4 0 /cl of toluene. The mixture was then in­
cubated for 18 hours at 37*^C. Control samples were incubated 
under identical conditions, but in the absence of the en­
zyme .
2.12.2. Incubation with Endo-ff -N-Acetylglucosaminidase F 
(Endo F)
2.12.2.(i) Introduction
Endo F (E.C. 3.2.1.96) cleaves high mannose and com­
plex- type N-linked oligosaccharides from glycoproteins, 
leaving a single N—acetylglucosamine residue attached to the 
polypeptide (Elder and Alexander, 1982).
2.12.2.(ii) Procedure
The incubation with the enzyme was performed according
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to the m e thod of Elder and Alexander (1982):
Endo F was supplied as a lyophilisate (3U per vial). It 
was reconstituted to 0.3ml with 0.1M pH 6.1 sodium phosphate 
buffer (the buffer solution was prepared as described by 
Dawson et a l . (1986)). It was stored at -20^C as aliquots of
100mU/l0 1. A volume of parotid saliva, approximately 75-125 
[Al, containing lOOfig of protein was pipetted into an Eppen- 
dorf tube, followed by lOOmU of Endo F, 10 [Al of 0. 1M EDTA 
and lOfil of 5% (v/v) 2-mercaptoethanol; and overlaid with 40 
fll of toluene. The mixture was then incubated for 18 hours 
at 37^C. Control samples were incubated under identical con­
ditions, but in the absence of the enzyme.
2.12.3. Incubation with Peptide: N-Glycosidase F (PNGase F)
2.12.3.(i) Introduction
PNGase F (E.G. 3.2.2.18) hydrolyses asparagine-linked
glycans from glycoproteins. The cleavage occurs between the 
innermost residue of N , N '-diacetylchitobiose and the 
asparagine residue to which the oligosaccharide is linked. 
PNGase F has a broader substrate specificity than Endo F; 
wheareas it hydrolyses all classes of asparagine-1 inked 
glycans (i.e. high mannose, hybrid, and bi-, tri- and 
tetraantennary oligosaccharides), Endo F is unable to remove 
tri- and tetraantennary complex oligosaccharides from 
glycoproteins. In addition, PNGase F cleaves biantennary 
complex oligosaccharides 30-fold faster than Endo F does.
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While the glycosylation sites of native glycoproteins are 
inaccessible to most oligosacchride chain—cleaving enzymes, 
PNGase F could achieve this in many cases (Tarentino et al., 
1985) .
2.12.3.(ii) Procedure
A modification of the procedure of (Tarentino et al., 
1985) was used to deglycosylate parotid salivary proteins in 
their native state:
PNGase F was supplied as a lyophilisate (20U per vial). 
It was reconstituted to 2ml with 0.25M sodium phosphate buf­
fer, pH 8.0, and stored at -20^C as aliquots of 100mU/ 10/LL. 
A volume of parotid saliva, approximately 75-125/LL, contain­
ing 100[xg of protein, was pipetted into an Eppendorf tube, 
followed by 50 /xl of 50mM EDTA and 20mM 2-mercaptoethanol 
dissolved in 0.25M sodium phosphate buffer, pH 8.0. lOOmU of 
PNGase F was then added. The mixture was overlaid with 40/LL 
of toluene. Incubation was carried out for 18 hours at 37^C. 
Control samples were incubated under identical conditions, 
but in the absence of the enzyme.
2.13. Assay for Tissue Kallikrein Activity in Parotid Saliva 
The kallikrein activity in human parotid saliva was 
determined using a modification of the procedure of Amundsen 
et a l ♦ (1979). Kallikrein hydrolyses the chromogenic tripep­
tide substrate H — D — Val—Leu—Arg—NH—pNA (S—2266), releasing 
p-nitroaniline which is water-soluble and produces a yellow
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colour:
H-D-Val-Leu-Arg-NH-pNA + H 20 JtallilcreifyH-D-val-Leu-Arg-OH
+
p-nitroaniline 
The following stock solutions were prepared:
(a) 0.05M Tris-HCl buffer, pH 9.0.
(b) A 2mM solution of S-2266 was prepared by reconstituting 
25mg of the substrate with 28.8ml of distilled water.
(c) 10 KlU/ml (Kallikrein Inhibitor Unit) trasylol 
(lyophilised aprotinin) in buffer (a). Aprotinin is a potent 
inhibitor of kallikrein. 1 KIU aprotinin = 0.17^,g of the 
protein (Biochemica Information, 1st edition, Boehringer 
Mannheim Biochemicals, Indiana, U.S.A., 1987).
All solutions to be used were equilibrated to 37°C 
before use. 850jw,l of 0.05M Tris-HCl buffer, pH 9.0, and 50 
jjX of parotid saliva were pipetted into a disposable cuvette 
and mixed. For the blank, 850pel of 10 KlU/ml trasylol solu­
tion (stock solution (c)) was used instead of the buffer 
solution. S-2266 solution (200 fjiX) was added and mixed. The 
mixture was incubated for exactly 30 minutes, and stopped by 
the addition of 100 [ll of 50% (v/v) acetic acid to the con­
tents of each cuvette. The absorbance was then read at 405nm 
using a Pye Unicam SP8-100 uv/visible Spectrophotometer.
2.14. Densitometric Scans of pH 3.5-5.0 IPG's
Silver stained pH 3.5—5.0 IPG's were scanned using an 
LKB Ultroscan laser densitometer in order to compare the
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band patterns of RA patients, SS patients and normal heal­
thy individuals.
2.15. Photography
After development or destaining, the blots or gels were 
promptly photographed using a Nikon F3HP camera fitted with 
a Nikkor 55mm, f 2.8, macro lens. Kodak "Ektachrome 50" 
tungsten-balanced slide film was used. Two tungsten bulbs 
were used as the sources of illumination. When necessary, 
the slides were copied, using a slide-copier, onto Kodak 
"Tmax 100" black-and-white or Kodak "Kodacolor Gold 100" 
colour negative films.
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RESULTS
3.1. Assay Methods for the Determination of the Protein Con­
tent of Human Parotid Saliva
The standard curves obtained by the Lowry-Folin and 
Bio-Rad assays (Section 2.3), using bovine serum albumin 
(BSA) and bovine a-chymotrypsinogen as the standards, are 
shown in Fig. 3.1 (a) and (b). The standard curves obtained
by the BCA standard and microprotocols, using bovine serum 
albumin and bovine O'-chymotrypsinogen as the standards are 
shown in Fig. 3.1 (c) and (d). In the BCA standard protocol, 
the samples are incubated at 37^C, while in the 
microprotocol they are incubated at 60^C. These graphs show 
that for all 3 assay methods, the estimation of protein con­
centration is dependent on the protein standard used within 
the range of protein concentrations used. However, the sen­
sitivity (i.e. colour produced) is greater in the case of 
(X-chymotrypsinogen with the Lowry-Folin and BCA assays, 
while in the case of the Bio-Rad assay and BSA, it is less.
The principal on which the BCA assay is based is the 
reduction of copper (II) cations to copper (I) by reaction 
with the protein, followed by the chelation of the copper 
(I) cation by bicinchoninic acid (BCA), producing a purple 
colour with an absorbance maximum at 562nm.
Fig. 3.2, which is a plot of absorbance values versus 
volume of parotid saliva used for the Lowry-Folin and Bio
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Fig. 3.1. Standard curves of the Lowry-Folin, Bio-Rad and
BCA protein assays using (y-chymotrypsinogen and bovine serum 
albumin as the standards
Panel (a) shows the standard curve of the Lowry-Folin 
protein assay method while panel (b) shows the standard 
curve of the Bio-Rad protein assay method.
Panel (c) shows the standard curve for BCA standard 
protocol, in which the samples were incubated at 37^C for 30 
minutes, while panel (d) shows the standard curve for BCA 
microprotocol, in which the samples were incubated at 60^C 
for 30 minutes.
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Fig. 3.2. Comparison of the standard curves of the Lowry-
Folin, Bio-Rad and BCA protein assays
Plots of absorbance values versus volumes of parotid saliva 
used were obtained. The BCA standard protocol was used.
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Rad assays and the BCA standard protocol, shows that the BCA 
standard protocol gives the highest absorbance per unit 
volume of saliva used; therefore it is the most sensitive 
assay method of the three for the determining the protein 
content of saliva.
Of the 3 assay methods, the BCA assay requires the 
smallest volumes of parotid saliva, 20 jjil for the standard 
protocol and 5 fil for the microprotocol. In comparison, the 
Lowry assay requires 100 fil, and the Bio-Rad assay, 50 fil. 
While economy in the volume of saliva samples is usually not 
crucial when assaying samples from normal subjects with high 
salivary f low-rates , often in the case of RA and SS 
patients, many of whom have low flow-rates, only small 
volumes (frequently between 0.2 and 1ml) may be available. 
Thus the BCA microprotocol was chosen for the routine deter­
mination of the protein content of human parotid saliva for 
the reasons of its high sensitivity and low volumes of 
saliva it requires. The BCA assay may also be automated by 
using microtitre plates to determine the protein content of 
large numbers of samples.
The least time-consuming of the 3 assays is the Bio- 
Rad, the principle of which is the binding of the dye CBB 
G250 to the protein, thereby shifting the value of the ab­
sorbance maximum from 465nm to 595nm (Bradford, 1976). This 
process is rapid and takes approximately 2 minutes. The 
Lowry assay (Lowry et al . , 1951) is the most time-consuming
as it involves a number of steps in which the timing is
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critical.
The major group of proteins in saliva are P R P ' s 
(Bennick, 1982; 1987), the properties of which may give rise
to inaccuracies when certain protein assay methods are used. 
For example, they contain high levels of proline, glycine 
and glutamic acid but no tryptophan or tyrosine (Bennick, 
1982). The Lowry-Folin assay (Lowry et al ♦, 1951) depends
on the reaction of the peptide bonds in the protein with 
copper in alkaline solution (i.e. the Biuret reaction) and 
a l s o  on the r e d u c t i o n  of p h o s p h o m o 1 y b d i c  a c i d -  
phosphotungstic acid (Folin-Ciocalteau reagent) by tyrosine 
and tryptophan residues in the protein (Chou and Goldstein, 
i960). Therefore the estimation of the protein concentration 
of saliva using this method is probably inaccurate. The lack 
of amino acids containing aromatic side-groups, such as 
tryptophan and tyrosine, in P R P 's also makes the determina­
tion of the protein content of saliva using ultra-violet 
spectrophotometry (i.e. taking absorbance readings at 280nm) 
grossly inaccurate. PRP's have unusual staining properties 
towards CBB R250 (Shatzman and Henkin, 1983), and in the 
course of this study (Section 3.2.2) they have been shown to 
bind poorly to CBB G250; thus the Bio-Rad assay, which 
depends on the binding of CBB G250 to proteins, may also be 
inaccurate for determining the protein content of saliva.
The behaviour of PRP1s towards the reagents used in the 
BCA assay has not been studied. However, in this study, it 
was the protein assay method of choice due to its sen-
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sitivity and the need 
samples. Athough the 
the Bio-Rad assay, it
to use only small volumes of saliva 
BCA assay is more time-consuming than 
is no more difficult to carry out.
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3.2. Analysis of Human Parotid Salivary Proteins by SDS-PAGE
3.2.1. The Band Pattern Revealed by SDS-PAGE
SDS-PAGE of 40 fig of parotid salivary protein followed 
by staining of the gel with 0.1% (w/v) CBB R250 in 40% (v/v) 
ethanol and 10% (v/v) acetic acid, and destaining in several 
changes of 10% (v/v) acetic acid over 2-3 days (Lindsay and
Beeley, 1986) resulted in approximately 6 blue-staining and 
10-12 pink-staining bands in most normal healthy subjects. 
The metachromatic reaction, which resulted in some of the 
bands staining with a pink colour is characteristic of the 
proline-, glycine- and glutamic acid-rich phosphoproteins in 
human saliva (Shatzman and Henkin, 1983). Although the in­
clusion of ethanol or methanol in the destaining solution 
shortens the destaining time required, it resulted in poor 
staining, or even loss, of the pink-staining components, and 
as such no alcohol was included in the destaining solution. 
Metachromasia has also been noted in collagen, which is also 
proline-rich. It is thought to be due to the unique stacking 
of dye molecules and dye-dye interactions in regions of 
closely-spaced proline residues, causing a difference of ap­
p r o x i m a t e l y  3 0 n m  b e t w e e n  the a b s o r b a n c e  max i m a  for 
collagen-CBB R250 complexes and that of other protein-CBB 
R250 complexes (McCormick et al . , 1979).
The pink-staining components have been designated the 
following nonmenclature: A (Mr 72,000), B (Mr 50,000), C-^
(Mr 45,000), C2 (Mr 38,000), D ± (Mr 31,000), D2 (Mr 28,000), 
D3 (Mr 26,000), E 1 (Mr 22,000), E2 (Mr 19,000), E3 (Mr ap­
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proximately 17,000), E4 (Mr approximately 14,000), E5 (M 
approximately 1 2 ,0 0 0 ) and E6 (Mr approximately 1 0 ,0 0 0 ). 
These are indicated in Fig. 3.3. C 1 appears to contain both 
blue- and pink-staining components. Blue-staining bands were 
also obtained; 3 of which have been identified in Section 
3.2.4(ii) as the glycosylated and non-glycosylated isozymes 
of a —amylase (Mr 's 63,000 and 59,000, respectively) and lac- 
toferrin (M 90,000). In addition, there are blue-staining 
bands of low Mr , designated as F-| and F2 (Mr 's < 10,000).
3.2.2. Comparison of Coomassie and Silver Staining
The metachromatic reaction did not, however, occur when 
the gels were stained with the dye CBB G250 and only blue- 
staining bands were visualised (Fig. 3.4 (a)). CBB G250 dif­
fers from CBB R250 in having 2 additional methyl groups 
which may prevent the dye-protein stacking which results in 
metachromasia.
In order to compare the sensitivities and staining 
properties of CBB R250, CBB G250 and silver stain towards 
salivary proteins, a range of loads of parotid salivary 
proteins was fractionated by SDS-PAGE, and the gels were 
stained accordingly (Figs. 3.4 (a), 3.4 (b) and 3.5). For
CBB R250, a protein load of 40/x,g was optimal (Fig. 3.4 (b)). 
Even with a protein load of 90 fig, most of the bands which 
were stained pink by CBB R250 were either weakly stained or 
not stained at all by CBB G250 (Fig. 3.4 (a)).
Although silver stain is one of the most sensitive
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Fig. 3.3. SDS-PAGE of parotid salivary proteins from one in­
dividual, followed by CBB R250 stain
The track in the gel was loaded with 40fig of protein from a 
normal healthy individual.
The blue- and pink-staining bands were assigned the non- 
menclature as indicated. The concentration of the gel was
12.5 %T.
Figure 3 . 3
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Fig. 3.4. SDS-PAGE of a range of parotid salivary protein
loadings from one individual, followed by Coomassie stain 
The gel in panel (a) was stained with CBB G250, while the 
gel in panel (b) was stained with CBB R250.
The protein loads are as indicated. The arrowheads in panel
(b) indicate blue-staining bands. The first track in each 
gel was loaded with Mr marker proteins. The concentration of 
both gels was 12.5 %T .
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Fig. 3.5. SDS-PAGE of a range of parotid salivary protein 
loadings from one individual, followed by silver stain 
The protein loads are as indicated. The first track was 
loaded with Mr marker proteins. The concentration of the gel 
was 12.5 %T.
Figure 3 . 5
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staining methods, salivary PRP's have been reported to stain 
poorly (Friedman, 1982). A number of different silver stain­
ing methods, including that of Sammons et al . (1981) and
Morrisey (1981) were used to stain parotid salivary proteins 
after SDS-PAGE, but these methods produced a yellowish back­
ground which made it difficult to visualise the PRP' s as 
they were stained with a yellowish-brown colour. However, a 
modification of the method of Damerval et a 1 . ( 1987 )
produced a sufficiently clear background, thus allowing the 
PRP's to be visualised. It was found that the bands which 
were stained pink by CBB R250 were stained with a yellowish 
brown colour by silver stain, while the bands which were 
stained blue by CBB R250 were stained black or dark brown. 
A protein load of 5 fig was optimal (Fig. 3.5).
3.2.3. Band Patterns of Normal Healthy Individuals
The band pattern revealed by SDS-PAGE followed by 
staining with CBB R250 of 6 normal healthy subjects is shown 
in Fig. 3.6. There is considerable individual-to-individual 
variation in the pink—staining components, and certain bands 
which are strongly stained in some individuals are either 
less prominent, or not detectable in others. For example, 
the individual whose sample was loaded to track 1 displayed 
a pink-staining component of Mr approximately 100,000 which 
was not present in other samples, but did not exhibit band A 
(M 72,000). Bands A and B in Fig. 3.3, of M r 1s 72,000 and 
50,000, respectively, have been correlated, in Section
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Fig. 3.6. SDS-PAGE of parotid salivary proteins from 7 dif­
ferent normal healthy individuals followed by CBB R250 stain 
Tracks 1-7 were each loaded with 40 fig of protein from dif­
ferent normal healthy subjects, while track "M" was loaded 
with Mr marker proteins. The concentration of the gel was
12.5 % T .
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3.2.4. to the glycosylated PRP of Levine et a l . (1969). Thus
it is possible that the component of M r approximately
100,000 is a more glycosylated form of the component in band 
A. Another example is band (Mr 45,000) which is weakly
stained in the samples in tracks 1 and 2 , but more strongly 
stained in the others.
3.2.4. Identification of the Bands Revealed by SDS-PAGE
3.2.4. (i) Identification of the Pink-Staining Components
P R P 1 s which have been isolated and partially charac­
terised by other research groups were fractionated in SDS- 
PAGE gels which were subsequently stained by CBB R250. The 
acidic PRP's , designated as proteins "A" and "C" by Bennick 
and Connell (1971), most of the 9 non-glycosylated basic 
PRP ' s ( " I B 1 " IB9 " ) which have been described by Kauffman et. 
a l . (1986) and the glycosylated PRP of Levine et a l . (1969)
were loaded onto SDS-PAGE gels which were subsequently 
stained with CBB R250 (Fig. 3.7 (a) and (b)). Following
SDS-PAGE, their apparent M r 's were determined and correlated 
with the bands which had been assigned alphabetical codes in 
Fig. 3.3. Their M r values from the literature, where avail­
able, and the methods by which they were determined were 
also compared with the values obtained by SDS-PAGE. These 
results are summarised in Table 3.1.
Some of the purified PRP's appear to consist of two 
components. This could be due to fragmentation during the 
course of storage, or failure to purify the samples to
155
Fig. 3.7. 3DS-PAGE of purified acidic PRP1s and purified 
basic PRP1s
Tracks 1 and 2 in panel (a) were each loaded with 2fig of the 
acidic PRP's "C" and "A" described by Bennick and Connell 
(1971), while tracks 3-10 in panel (b) were each loaded with 
2 fig of the non-glycosylated basic PRP ' s ( " IB1 "-" IB9" and 
"DEAE II") described by Kauffman et al♦ (1986) and track 11
panel (b) was loaded with 2jLtg of the glycosylated basic PRP 
described by Levine et al. (1969). The tracks labelled "ps"
in panels (a) and (b) were each loaded with 40^tg of parotid 
salivary proteins from normal healthy subjects, and track 
"M" was loaded with M marker proteins. Track 3 was loaded
with "IB9", track 4 with "IB8", track 5 with "IB7" , track 6
with "IB6", track 7 with "IB5", track 8 with "IB4", track 9
with " IB1 " , track 10 with "DEAE II" and track 11 with
glycosylated basic PRP. The concentration of both gels was
12.5 %T, and they were stained with CBB R250.
"DEAE II" was a purified PRP sample, supplied together with 
"IBl"-"IB9" by Dr. P. Keller.
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Table 3.1. Determination by SDS-PAGE of the apparent M r 's of 
acidic and basic PRP^ s isolated by other research grroups
Purified PRP1s SDS-PAGE M r Band Mr by other methods
"A" 26,000 D 3 9,900 (ultracentri­
fugation, Bennick, 
1982)
"C" 28,000 D2 16,300 (ultracentri­
fugation, Bennick, 
1982)
"IB9" 10,000 E6
"IB8 " 10,000 and Efi+ E i
17.000
"IB7" 12,000 and E5+E 2
19.000
"IB6 " 19,000 and E^+E2 11,530 (amino acid
22.000 sequencing, Kauffman
et a l ., 1986)
"IB5" 14,000 and E 4+ E ±
22.000
"IB4" 19,000 and e i+e2
22,000
"IBl" 17,000 E3 9,571 (amino acid
*
seqencing, Kauffman 
et a l .,1986
"Glycosylated 50,000 and A+B 36,400 (gel filtra-
PRP" 72,000 tion, Levine et a l .,
1969).
N.B. * Band B is probably a contaminant of band A.
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homogeneity.
The Mr ' s determined by SDS-PAGE differ significantly 
from the values determined by other methods such as gel 
filtration, ultracentrifugation and amino acid sequencing.
Bands A and B in Fig. 3.3, of Mr 1 s 72,000 and 50,000, 
respectively, have been correlated to the glycosylated PRP 
of Levine et a 1 . (1969). They were stained by the PAS
glycoprotein stain (Fig. 3.8). This staining method locates 
glycoproteins in polyacrylamide gels and distinguishes them 
from non-glycosylated proteins. The individual whose saliva 
sample was loaded to track 6 in Fig. 3.8 exhibited a PAS- 
positive band of Mr approximately 100,000. This was the same 
individual whose sample was loaded to track 1 in Figure 3.6, 
who exhibited a pink-staining band of M r approximately 
100,000.
In addition, bands A and B in Fig. 3.3, of Mr 's 72,000 
and 50,000, have been shown to bind to the lectin ConA (Fig. 
3.9). ConA binds preferentially to Qf-D-mannopyrannosyl and 
OJ-D-glucopyrannosy 1 residues (Hawkes, 1982). The individual 
whose saliva sample was loaded onto track 1 in Fig. 3.9 ex­
hibited a ConA-binding band of Mr approximately 100,000. 
Again, this was the same individual whose sample was loaded 
onto track 1 in Figure 3.6, and who exhibited a pink- 
staining band of the same M . In the control experiment, in 
which 0. 1M Qf-D-methyl mannoside, a ConA-inhibiting sugar, 
was included in the ConA-incubating solution, no bands were 
visualised when the blot was developed in the HRP substrate
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Fig. 3.8. SDS-PAGE of parotid salivary proteins followed by 
PAS stain
Tracks 1-3 were each loaded with 40 jug of protein from RA 
patients, while tracks 4-6 were each loaded with 40 fig of 
protein from normal subjects. The concentration of the gel 
was 12.5 %T.
Figure  3 . 8
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Fig. 3.9. SDS-PAGE of parotid salivary proteins followed by 
ConA blotting
Tracks 1-3 were each loaded with 40/xg of protein from dif­
ferent normal healthy subjects. After electroblotting, the 
nitrocellulose membrane was incubated in a ConA-containing 
solution, followed by an HRP-containing solution. It was 
then developed in the HRP substrate solution. The bands 
visualised are indicated by arrowheads.
The concentration of the gel was 12.5 %T
Figure  3 . 9
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s o l u t i o n .
3.2.4. (ii) Identification of the Blue-Staining Components
The bands of Mr 's 63,000 and 59,000 have been shown, by
immunoblotting, to cross-react with sheep antiserum to human 
salivary Q!-amylase (Fig. 3.10 (a)) which would appear to
correspond to the glycosylated (Mr 63,000) and non­
glycosylated (Mr 59,000)isozymes of the enzyme. The band of 
Mr 90,000 cross-reacted with rabbit antiserum to human lac- 
toferrin (Fig. 3.10 (b)).
Control experiments were carried out in which after 
SDS-PAGE and electroblotting of the salivary proteins, the 
blots were incubated with the anti-rabbit and anti-sheep 
i m m u n o g 1o b u 1 i n - a 1k a 1 ine phosphatase conjugates, and 
developed in alkaline phosphatase substrate solution, omit­
ting the stage where the blots were incubated with the 
primary antisera. In each case, no staining reaction was ob­
tained .
3.2.5. Analysis of the Parotid Salivary Proteins of 
Rheumatoid Arthritis and Sjogren's Syndrome Patients
Parotid salivary proteins from normal subjects, RA 
patients and SS patients were fractionated by SDS-PAGE in 
gels of concentrations 12.5 %T and 20 %T. While 12.5 %T gels 
produced optimal resolution of most of the bands, 20 %T gels 
resulted in better resolution of the bands of lower M , par­
ticularly those with Mr < 40,000. These gels were stained
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Fig. 3.10. SDS-PAGE of parotid salivary proteins followed by
immunoblotting for tt-amylase and lactoferrin
Panel (a) shows an immunoblot for Ck!-amylase. 40^ig of parotid 
salivary protein was applied to each track. The primary an­
tibody was sheep antiserum to human amylase, and the detect­
ing antibody was anti-sheep immunoglobulin-alkaline phos­
phatase conjugate.
Panel (b) shows an immunoblot for lactoferrin. 40 fig of 
parotid salivary protein was applied to the track labelled 
"PS" while 2 of human lactoferrin was applied to each of 
the tracks labelled "Lf". The primary antibody was rabbit 
antiserum to human lactoferrin, and the detecting antibody 
was anti-rabbit immunoglobulin-alkaline phosphatase con­
jugate. The bands visualised are indicated by arrowheads.
The concentration of both gels was 12.5 %T.
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with CBB R250 (Figs. 11 (a) and (b)).
Parotid salivary proteins from normal subjects, RA 
patients and SS patients were also fractionated by SDS-PAGE 
in a 5-20 %T linear gradient polyacrylamide gel which was 
silver stained (Fig. 3.12).
Except for one SS patient, a female approximately 50 
years of age, who displayed a broad blue-staining band of 
Mr approximately 90,000 and a fainter blue-staining band of 
Mr approximately 35,000 (shown in Fig. 3.11(a)), no sig­
nificant differences could be noted between the SDS-PAGE 
band patterns of the patients with those of normal healthy 
controls. The other band, of Mr 35,000, was not detected 
in other patients or normal subjects. No obvious differences 
in the PRP band patterns could be associated with these dis­
orders .
3.2.6. Discussion
In most previous studies of human salivary proteins by 
SDS-PAGE followed by staining with CBB R250, the pink- 
staining bands in the gels which correspond to PRP' s have 
not been well characterised. The main reason for this is the 
inclusion of alcohol in the destaining solution, which 
causes the PRP' s to stain poorly or not at all. Thus Mar­
shall and Williams (1987) and Marshall et a 1. (1989) who in­
cluded methanol in the destaining solution, reported that 
the pink-staining components (approximately 11 in all) 
visualised by SDS-PAGE of whole human saliva were diffuse
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Fig. 3.11. SDS-PAGE of parotid salivary proteins from normal
healthy individuals, RA patients and SS patients followed by 
CBB R250 stain
The tracks labelled "N" were each loaded with 40 fig of 
parotid salivary protein from normal healthy subjects, while 
the tracks labelled "R A " and "SS" were each loaded with 
similar loads of parotid salivary proteins from different RA 
and SS patients, respectively. The tracks labelled "M" were 
loaded with Mr marker proteins. The concentration of the gel
in panel (a) was 12.5 %T, while the concentration of the gel
in panel (b) was 20 %T. The arrowheads in (a) indicate the
bands in an SS sample which were either weakly stained or
not detectable in the normal samples.
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Fig. 3.12. SDS-PAGE of parotid salivary proteins from normal
healthy individuals/ RA patients and SS patients followed by 
silver stain
The tracks labelled "N" were each loaded with 5ptg of parotid 
salivary proteins from different normal healthy subjects, 
while the tracks labelled "RA" and "SS" were each loaded 
with equal amounts of parotid salivary protein from dif­
ferent RA and SS patients, respectively. The track labelled 
"M" was loaded with M r marker proteins.
The gel was a 5-20 %T linear concentration gradient gel.
RA RA SS SS M N N N
zones. Shiba et al . (1986) performed SDS-PAGE on human
whole, parotid, submandibular and palatine saliva followed 
by staining with CBB R250, and found approximately 16 bands 
in parotid saliva but did not give any experimental details 
on the destaining procedure they used. Nor did they make any 
mention of the pink-staining components. Lindsay and Beeley 
(1986) found that the pink-staining components were most 
strongly stained when alcohol was omitted from the destain­
ing solution and recommended the use of 10% (v/v) acetic 
acid for the destaining of gels.
Most studies carried out on human salivary proteins 
have utilised whole human saliva, presumably because it is 
easier to collect than glandular secretions. Whole saliva 
contains many extra-salivary components; for example, bac­
teria, food debris and sloughed-off cells from the oral 
cavity. Thus for diagnostic purposes, glandular saliva, such 
as the secretion of the parotid gland, is preferable as it 
is relatively free of such components.
Based on the results obtained by SDS-PAGE of parotid 
salivary proteins that have been isolated and characterised 
by other research groups, such as the acidic PRP1s described 
by Bennick and Connell (1971), the glycosylated PRP 
described by Levine e t a 1 . ( 1969) and the basic non­
glycosylated PRP' s described by Kauffman et a l . (1986) and
by SDS-PAGE of parotid salivary proteins followed by immuno- 
or lectin- blotting, or staining of the gels with CBB R250 
or PAS stains, a generalised one-dimensional map of human
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parotid salivary proteins in which some of the components 
have been identified, has been obtained (Fig. 3.13). In this 
map, 3 of the 6 bands which are stained blue by CBB R250, 
and 9 of the 11 pink-staining bands have been identified. 
Thus with the exception of bands C-^ , C 2 and (Mr 's ap­
proximately 45,000, 38,000 and 31,000, respectively) the
other pink-staining bands have been correlated with those 
which have been previously isolated and partially charac­
terised .
The Mr 1 s of the purified P R P 1 s which were supplied by 
other workers were determined by SDS-PAGE and found to be 
significantly higher than the values determined by other 
methods such as gel filtration, ultracentrifugation and 
amino acid sequencing.
Many proteins are known to exhibit anomalous Mr ' s in 
SDS-PAGE gels. For example, glycoproteins with > 10% car­
bohydrates will bind less SDS per unit weight than other 
proteins, thus giving different apparent Mr 1 s than those 
determined by using other methods (Hames, 1981). The unusual 
amino acid sequence of proteins with a high proline content 
may alter the charge and conformation of the SDS-polypeptide 
complex, thus producing abnormally high Mr 's in SDS-PAGE 
gels (See and Jackowski, 1989). SDS-PAGE of collagen, which 
has a high content of proline and hydroxyproline, has been 
shown by Freytag et a l . (1979) to yield anomalously high Mr
values for the polypeptides when typical globular proteins 
were used as the standards.
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Fig. 3.13. Generalised band pattern of parotid salivary 
proteins revealed by SDS-PAGE
The darkened zones represent the bands which were stained 
blue by CBB R250, while the shaded zones represent the bands 
which were stained pink. The pink-staining bands were as­
signed the nonmenclature used in Fig. 3.3. The bands which 
have been identified, either by iitimuno- and lectin 
affinity-blotting or co-electrophoresis with P R P 1s which 
have been purified and partially characterised by other 
researchers, are indicated.
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The band patterns of the P R P 's exhibited considerable 
individual-to-individual variation, which has been at­
t r i b u t e d  to d i f f e r e n t i a l  m R N A - s p l i c i n g  and post- 
translational modification (Maeda et a l ., 1985).
Of the RA and SS patients whose parotid salivary 
proteins were fractionated on SDS-PAGE gels, only one ex­
hibited additional bands. These blue-staining bands of Mr 's 
approximately 90,000 and 35,000 could correspond to the ad­
ditional proteins, of high and low R^ values respectively, 
found in the parotid saliva of SS patients by Benedak-Spat 
et a l . (1980). The blue-staining band of Mr 90,000, which
has been shown by immunoblotting to be lactoferrin (Fig. 
3.10 (b)), was present in all the other salivary samples
analysed by SDS-PAGE, but is more intensely stained in the 
SS patient previously mentioned. The level of salivary lac­
toferrin has been reported to be elevated in SS patients 
(Jezequel et a l ., 1989).
Two possible reasons why SDS-PAGE did not reveal sub­
stantial differences between the patients and normal sub­
jects, despite differences being apparent on isoelectric 
focusing, are:
(a) The considerable degree of individual- to-individual 
variation, especially in the PRP's , tended to complicate the 
comparison of the band patterns between different in­
dividuals .
(b) The anionic salivary proteins associated with RA and SS 
could have Mr ' s which are equal or very close to that of
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another protein and therefore were not adequately resolved 
by a one-dimensional SDS-PAGE system.
Accordingly isoelectric focusing and 2-D PAGE must be 
carried out to in order to establish their pi's and Mr 1s .
Rhodus et al . (1989) subjected salivary proteins from
primary and secondary SS patients to SDS-PAGE followed by 
silver stain. They found that P R P ' s of lower Mr were defi­
cient in all SS patients compared to those of normal healthy 
controls, and also that the primary SS patients demonstrated 
more missing bands than the secondary SS patients. Although 
PRP's, in particular the acidic ones, are known to be poorly 
stained by the silver stain technique (Friedman, 1982), this 
was the staining procedure used. Their findings, however, 
could not be confirmed in this study. Indeed, no PRP band 
pattern which was charactersitic of either RA or SS could be 
detected. It is therefore highly probable that the dif­
ferences that were reported by Rhodus et al ♦ (1989) were
due to individual-to-individual variation in the band pat­
tern of the PRP's, and to the lack of sensitivity of the 
silver stain technique with respect to PRP's.
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3.3. Isoelectric Focusing of Human Parotid Salivary Proteins
From Normal Healthy Individuals in Hybrid Carrier 
Ampholyte-Immobilised pH Gradient Polyacrylamide gels
3.3.1. Determination of the pH Gradient
IPG's of a broad pH range, i.e. pH 4-9, were used to 
analyse human parotid salivary proteins. The pH profiles of 
pH 4-9 IPG's were determined using coloured pi marker 
proteins. The pH profile of the IPG's was determined under 
non-denaturing conditions (i.e. in the absence of urea) as 
the pi's of the marker proteins in urea was not supplied 
by the manufacturer. In the presence of urea, changes in the 
pi's of many proteins are known to occur (Andrews, 1986). 
The pH profile of a pH 4-9 IPG, shown Fig. 3.14, appears to 
be approximately linear.
3.3.2.Effect of Sample Application Position on the Focused 
Pattern
Samples of parotid saliva were applied at various posi­
tions on a pH 4-9 IPG in order to determine the application 
point which resulted in the best resolution of the band pat­
tern .
Optimum results were obtained when the samples were ap­
plied at a distance of 2-3 cm from the cathode, where the 
local pH is 6.5-7.0 (Fig. 3.15). When the samples were ap­
plied at other points along the gel, some degree of
precipitation and streaking is observed. Application of the
LH
sample close to the cathode resulted the most severe
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Fig. 3.14. pH profile of a pH 4-9 IPG
The IPG was rehydrated with 20% (w/v) glycerol containing
0.5% (w/v) pH 3.5-10 Ampholine. BDH broad range (pH 4.7-
10.6) coloured pi markers were used.
All the protein markers were coloured and could be 
visualised without prior staining.
Figure 3.14.
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Fig. 3.15. IEF of parotid salivary proteins from a single 
individual in a pH 4-9 IPG, with sample application made at 
various points along the gel
Twenty five fiq of protein was applied to each track and the 
gel was silver stained. The sample application points are 
indicated by arrowheads . The IPG was rehydrated with 20% 
(w/v) glycerol containing 0.5% (w/v) pH 3.5-10 Ampholine.
The gel was silver stained.
Figure 3.15
streaking.
3.3.3. Comparison of Coomassie and Silver Staining
A range of protein loads, from 10-250jn,g, was applied to 
a pH 4-9 IPG which was subsequently stained by CBB G250 
(Fig.3.16 (a)) followed by silver stain (Fig. 3.16 (b)).
By silver staining, 20fjcg of protein allowed visualiza­
tion of approximately 25 bands, while staining with CBB G250 
required 250/>tg in order to give similar results. The band 
patterns, however, were similar using both procedures, and 
the differences were only at the level of sensitivity rather 
than additional components being stained by the silver pro­
cedure .
3.3.4. Effect of Salt Levels on the Band Patterns
Upon adding known levels of sodium chloride to a sample 
of parotid saliva, it was observed that denaturation oc­
curred at sodium chloride concentrations of 200mM and above, 
the effect being more pronounced on the cathodal side of the 
sample application points (Fig. 3.17).
No differences were observed between lyophilisates of 
parotid saliva, either dialysed or undialysed, which have 
been concentrated up to sevenfold (Fig. 3.18). The sodium, 
potassium and calcium concentrations of the unconcentrated 
parotid saliva prior to dialysis were determined by flame 
photometry and found to be 18mM, 16mM and 0.2mM respec­
tively.
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Figure 3.16. Comparison of Coomassie Brilliant Blue and sil­
ver staining of parotid salivary proteins fractionated in a 
pH 4-9 IPG
Panel (a) shows the IEF of human parotid salivary proteins 
from a single individual on a pH 4-9 IPG followed by CBB 
G250 staining. The protein loads are as indicated.
Panel (b) shows the same gel after silver staining.
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Figure 3.17. IEF, in a pH 4-9 IPG, of human parotid salivary 
protein samples containing increasing concentrations of 
sodium chloride
The samples, containing 25fig of protein in 50^1 of solution, 
were from the same individual. A r r o w h e a d s  i n d i c a t e  
precipitation. The concentrations of sodium chloride are as 
indicated. The IPG was rehydrated with 20% (w/v) glycerol
containing 0.5% (w/v) pH 3.5-10 Ampholine. The gel was sil­
ver stained.
Figure  3 .1 7
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Figure 3.18. IEF, in a pH 4-9 IPG, of dialysed and un- 
dialysed lyophilised concentrates of human parotid saliva 
1 to 7-fold concentrates were applied to tracks 1 to 7, 
respectively. The tracks with subscript "U" were loaded with 
undialysed samples while tracks with subscript "D" were 
loaded with dialysed samples. 25 fxg of protein were applied 
to each track. The IPG was rehydrated with 20% (w/v)
glycerol containing 0.5% (w/v) pH 3.5-10 Ampholine. The gel
was silver stained.
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3.3.5. Effect of Urea on the Band Patterns
In a pH 4-9 IPG, a urea gradient (0-8 M urea) perpen­
dicular to the pH gradient was found to increase the resolu­
tion of the protein bands, especially above a urea con­
centration of 5M (Fig. 3.19). Most of the proteins focused 
as continuous bands throughout the length of the IPG. Some 
components exhibited a slight pi shift towards the anode, 
which is probably due to the exposure of charged groups in 
the proteins when they were enfolded by urea (Creighton, 
1979).
3.3.6. Comparison of Band Patterns of Different Individuals
Parotid saliva samples from 6 different individuals
were fractionated in a pH 4-9 IPG (Fig. 3.20). There were 
few major but several minor variations from individual to 
individual. The technique appears to give better resolution 
than that of Eckersall et al ♦ (1981) who performed IEF in
carrier ampholyte gels and also reported that the band pat­
terns of different individuals were essentially similar with 
only minor differences.
3.3.7. Discussion
In order to further the understanding of the functions 
of salivary proteins and to develop the potential for the 
analysis of this fluid in clinical diagnosis, improved 
analytical electrophoretic procedures are needed. Whilst
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Figure 3.19. IEF, in a pH 4-9 IPG, of a continuous zone of 
normal human parotid salivary proteins applied 2cm from the 
cathode throughout the length of a gel superimposed with a 
transverse 0-8 M urea gradient
One mg of protein was applied to a gel containing a urea 
gradient perpendicular to its pH gradient. The gel was sil­
ver stained.
Figure  3 .1 9
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F i g u r e  3.20. I E F , in a pH 4-9 IPG, of p a r o t i d  s a l i v a r y
proteins from 6 diferent normal healthy individuals in a pH
4-9 IPG
The protein load was 25ju,g per sample. The IPG was rehydrated 
with 20% (w/v) glycerol containing 0.5% (w/v) pH 3.5-10 Am-
pholine. The gel was silver stained.
Figure 3 . 2 0
isoelectric focusing of human parotid saliva using carrier 
ampholytes has given improved resolution, as compared to 
other electrophoretic procedures, and revealed further in­
formation about the nature of proteins present in both nor­
mal healthy individuals (Eckersall et a l ♦, 1981) and in dis­
orders such as rheumatoid arthritis (Mairs and Beeley, 
1985), use of the technique has been impaired by the need 
for prior desalting of samples because of the high 
electrolyte to protein levels. This procedure is time- 
consuming and leads to protein loss; furthermore the sample 
sizes necessary for manipulation (> 2ml) are frequently not 
available from diseased glands. The technique is also sub­
ject to problems such as cathodic drift together with the 
fact that the formation of "tailor-made" gradients necessary 
for the proteins under investigation can be difficult or im­
possible .
IPG's overcame most of these problems (Righetti, 1984) 
but did occasionally give rise to streaking and precipita­
tion at the sample application site. Addition of carrier am­
pholytes to the IPG's to form hybrid carrier ampholyte-IPG:s 
(Fawcett and Chrambach, 1986a) resolved this problem and the 
procedure described is based on this methodology.
Incorporation of urea into the gel gave improved 
resolution in pH 4-9 IPG's. Urea is often used as a 
solubilising agent in electrophoresis (Andrews, 1986) and 
IEF in gels containing urea gradients perpendicular to the 
pH axis (Hobart, 1975; Altland et a l ♦, 1984) may yield im­
1 8 2
portant clues about protein structure. Alterations in the 
pi 1s of proteins will occur if unfolding by urea results in 
the exposure of charged groups (Creighton, 1979). In IPG's 
of both pH ranges, urea was found to cause shifts in the 
pi's of most protein bands but results in better resolution.
Rehydrating the gels with 20% (w/v) glycerol was found
to be advantageous as it prevented liquid exudation (Altland 
et a l . , 1986). When liquid exudation or "sweating" occurs,
the resulting droplets on the gel surface may after 
prolonged focusing adversely affect the focused pattern.
A limitation of IPG's is their inherently low conduc­
tivity which causes difficulties such as slow sample entry, 
lateral zone spreading and the formation of salt fronts 
which halt protein migration. A hybrid carrier ampholyte- 
immobilised pH gradient IEF system was employed to circum­
vent this problem (Fawcett and Chrambach, 1986a; Altland et. 
a l . , 1987). This was achieved by reswelling dried IPGs in
carrier ampholyte-containing rehydration solutions.
The presence of salts in the samples is capable of 
causing protein denaturation because acidic and alkaline 
boundaries are produced at application points upon the ap­
plication of an electric field across the gel. Thus even low 
levels of salts (5mM) have been reported to induce modifica­
tion of haemoglobin patterns and higher levels to cause 
denaturation (Righetti et a 1 . , 1988). In order to inves­
tigate whether the levels of electrolytes present in saliva 
would have any adverse effects, a study was performed to
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determine the salt level which would lead to protein 
precipitation and denaturation. We have found salivary 
proteins to be less affected by salts, and satisfactory pat­
terns were obtained from samples containing up to 200mM 
sodium chloride. This is well above the electrolyte levels 
in parotid saliva. No precipitation was observed when 
lyophilisates concentrated up to sevenfold without desalt­
ing were fractionated on IPG's.
pH 4-9 IPG's of parotid salivary proteins produced 
highly resolved focused patterns. With samples containing as 
little as 20fig of proteins, 25-30 components were evident on 
silver staining. Interestingly, IPG's, like carrier 
ampholyte-based IEF, do not reveal the individual-to- 
individual differences in protein pattern in parotid saliva 
as is the case with SDS-PAGE (Lindsay and Beeley, 1986).
The IPG technique gives superior resolution to carrier 
ampholyte IEF of human salivary proteins (Eckersall et a l ., 
1981). Analysis of salivary proteins by focusing on IPG's 
also removes the need to desalt samples prior to analysis 
and can be used with sample volumes as small as 50fil .
Accordingly, it is now possible to analyse rapidly 
large numbers of parotid saliva samples as a function of pi. 
This development should lead to considerable progress in the 
analysis of human salivary proteins.
The commercially-available Immobilines allow gels of pH 
range between 4 and 10 to be prepared. While such a range is 
sufficient for many applications, it may not produce optimal
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resolution of highly basic or acidic proteins. Thus at 
present, a major disadvantage of the IPG system is that it 
is not possible, using commercial Immobilines, to prepare 
IPG's covering pH extremes (i.e. < 4 and > 10) (Altland, 
1990). Although acidic (pK 0.8 and 3.1) and basic (pK 10.3) 
Immobiline-type acrylamide derivatives have been synthesized 
by various laboratories in order to produce IPG's spanning 
the pH range between 2.5 and 11 (Gianazza et a 1 ♦, 1989;
Altland and Altland, 1990), they are not yet commercially 
available. When these are finally available, IPG's of pH 
range such as 2.5-10.5 could be prepared. An IPG of such a 
pH range would allow the fractionation of almost all the 
salivary proteins in a single run. IPG's covering the acidic 
(e.g. pH 2.5-5.0) or basic (e.g. pH 8-11) pH ranges could be 
prepared, which could be very useful in studying, for ex­
ample, the acidic and basic P R P 's .
The problem of cathode drift, which often makes it dif­
ficult or even impossible to fractionate basic proteins 
(pi's > 8) in carrier-ampholyte IEF gels, does not occur in
IPG's. Thus the advantages that IPG's offer over conven­
tional carrier ampholyte-based IEF make them especially 
well-suited for the fractionation of salivary proteins. 
IPG's may also be used for the separation of salivary 
proteins in the first dimension of 2-D PAGE.
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3.4. 2-D PAGE of H u m a n  Parotid S a l i v a r y  Proteins from N o r m a 1
Healthy Individuals
3.4.1. 2-D PAGE w i t h  C a r r i e r  A m p h o 1y t e - C o n t a i n i n q  
Polyacrylamide Gels in the First Dimension
Parotid salivary protein (100//,g) from a normal healthy 
subject was fractionated using a modification of the 2-D 
PAGE method of O'Farrell (1975). A carrier ampholyte- 
containing rod gel was used in the first dimension and a
5-20 %T linear gradient polyacrylamide gel of 1.5mm thick­
ness in the second. Staining of the 2-D PAGE gel with CBB 
R250 revealed 7 pink-staining and one blue-staining com­
ponents (Fig. 3.21 (a)). With the exception of a blue-
staining component of low Mr (approximately 14,000) and a 
pink-staining component of M r approximately 28,000, which 
were located near the anodic end of the gel, most of the 
other components were located near the cathodic end. 
Silver-staining revealed an additional 5 spots of M r 
aproximately 45,000 which were not visualised by Coomassie 
staining (Fig. 3.21 (b)). Considerable horizontal streaking
was evident in the silver-stained 2-D PAGE gel. The resolu­
tion was poor and it appears that many constituents may have 
been lost as a result of cathode drift.
3.4.2. 2-D PAGE with Immobilised pH Gradients in the First
Dimens ion
Parotid salivary protein (100ju,g) from a normal healthy 
subject was fractionated by 2-D PAGE, using a pH 4-9 IPG in
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Fig. 3.21. O 1 Farrel1-type 2-D PAGE of parotid salivary 
proteins
One hundred^tg of protein was applied to the first dimension 
gel. The gel in panel (a) was stained by CBB R250. Panel (b) 
shows the same gel after silver staining. The anodic and 
cathodic ends of the first dimension gel are denoted by "+" 
and signs, respectively.
Figure 3.21
the first dimension and a 3-15 %T linear gradient 
polyacrylamide gel in the second. The gel was subsequently 
stained with CBB R250, which revealed approximately 10 
pink-staining and 12 blue-staining spots (Fig. 3.22 (a)).
Most of the pink-staining components were located close to 
the cathodic end of the gel.
Silver staining of a gel which contained a similar 
protein load revealed many additional components not 
visualised by CBB R250 (Fig. 3.22(b)). Excellent resolution 
was obtained and about 50 spots could be detected. The
protein spots which were stained pink by CBB R250 were 
stained a yellowish-brown colour by the silver procedure and 
appear to be P R P 1s . Silver staining also revealed two groups 
of multiple spots; one group of M r approximately 45,000 and
pi's between 4.9 and 5.6, and another group of M r ap­
proximately 28,000 and pi's between 4.8 and 5.3.
In order to identify some of the spots in the 2-D PAGE 
gels of human parotid salivary proteins and thus construct a 
normalised 2-D map of these proteins, the 2-D gels were 
electroblotted and probed with a variety of specific an­
tisera to various proteins. After incubation in solutions
containing the appropriate anti-species immunoglobulin- 
alkaline phosphatase conjugates, the blots were developed in 
alkaline phosphatase substrate solution.
Two different sets of control experiments were carried 
out. In the first, following 2-D PAGE of parotid salivary 
proteins and electroblotting, the blots were probed with the
188
Fig. 3.22. 2-D PAGE, wit h  pH 4-9 IPG in the first dimension,
of parotid salivary proteins
One hundred^tg of protein from different normal healthy sub­
jects was applied to each gel. The gel in panel (a) was
stained with CBB R250, while the gel in panel (b) was silver
stained.
Figure 3 . 22
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anti-species immunoglobulin-alkaline phosphatase conjugate, 
i.e. omitting the primary antibody and developed in the sub­
strate solution for alkaline phosphatase. Another control 
experiment involved 2-D PAGE of parotid salivary proteins 
followed by electroblotting, after which the blots were in­
cubated in PBS containing non-immune rabbit serum (1:200 
dilution), followed by incubation in a solution containing 
anti-rabbit immunoglobulin-alkaline phosphatase conjugate, 
and finally by development of the blot in the substrate 
solution for alkaline phosphatase. None of the control ex­
periments, however, resulted in any alkaline phophatase sig­
nal in the blots after they were developed.
By immunoblotting, the locations of (2-amylase (Fig. 
3.23(a)), lactoferrin (Fig. 3.23(b)), secretory component 
(Fig. 3.23(c)), (2-heavy chain of IgA (Fig. 3.23(d)),
K-light immunoglobulin chain (Fig. 3.23(e)), X-light im­
munoglobulin chain (Fig. 3.23(f)), lysozyme (Fig. 3.23(g)) 
and albumin (Fig. 3.23(h)) were determined. The antisera to 
lactoferrin, secretory component, lysozyme and albumin ex­
hibited non-specific binding to (2-amylase. In addition, the 
antiserum to secretory component showed non-specific binding 
to 5 protein spots of Mr approximately 45,000.
Colostral slgA was fractionated in a 2-D PAGE gel, with 
a pH 4-9 IPG in the first dimension, which was eventually 
silver stained (Fig. 3.23(i)). This revealed components cor­
responding to secretory component, (2-heavy chain and K- and 
A-i ight chains; which correspond well with the immunoblots
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Fig. 3.23. 2-D PAGE, wit h  pH 4-9 IPG in the first dimension,
of parotid salivary proteins followed by immunoblots for 
(2-amylase, lactoferrin, secretory component, (2-heavy chain, 
K-light chain, X-light chain, lysozyme and albumin; and 2-D 
PAGE of human colostral slgA followed by silver stain 
Fifty fig of parotid salivary protein was applied to each 
gel. Panel (a) shows an immunoblot for (2-amylase. The 
primary antibody was sheep antiserum to human (2-amylase, and 
the detecting antibody was anti-sheep immunoglobulin- 
alkaline phosphatase conjugate.
Panel (b) shows an immunoblot for lactoferrin. The primary 
antibody was rabbit antiserum to human lactoferrin, and the 
detecting antibody was anti-rabbit immunoglobulin-alkaline 
phosphatase conjugate. The arrowheads indicates the spot 
arising from non-specific binding of the primary antibody to 
(2-amylase .
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Panel (c) shows an immunoblot for secretory component. The 
primary antibody was rabbit antiserum to human secretory 
component, and the detecting antibody was anti-rabbit 
immunoglobulin-alkaline phosphatase conjugate.
The arrowheads indicate spots arising from non-specific
and com ponen t5 o-P M r approx>/*4-b&)y H -^ooo
binding of the primary antibody to ce-amylase^.
Panel (d) shows an immunoblot for a-heavy chain. The primary 
antibody was goat antiserum to human a-heavy chain, and the 
detecting antibody was anti-goat immunoglobulin-alkaline 
phosphatase conjugate.
Panel (e) shows an immunoblot for K-light chain. The primary 
antibody was rabbit antiserum to human K-light chain, and 
the detecting antibody was anti-rabb it immunoglobulin- 
alkaline phosphatase conjugate.
Panel (f) shows an immunoblot for X-light chain. The primary 
antibody was rabbit antiserum to human X-light chain, and 
the detecting antibody was anti-rabbit immunoglobulin- 
alkaline phosphatase conjugate.
Panel (g) shows an immunoblot for lysozyme. The primary an­
tibody was rabbit antiserum to human lysozyme, and the 
detecting antibody was anti-rabbit immunoglobulin-alkaline 
phosphatase conjugate. The arrowheads indicates the spot 
arising from non-specific binding of the primary antibody to 
Q!-amylase. (Continued on following page/)
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Panel (h) shows an immunoblot for albumin. The primary an­
tibody was goat antiserum to human serum albumin, and the 
detecting antibody was anti-goat immunoglobulin-alkaline 
phosphatase conjugate. The arrowhead indicates the spot 
arising from non-specific binding of the primary antibody to 
O'-amylase .
Panel (i) shows a 2-D PAGE gel, using pH 4-9 IPG in the 
first dimension, of human colostral slgA. 4 fig of human 
colostral slgA was applied, and the gel was silver stained. 
The components in the gel corresponding to secretory com­
ponent (SC), a-heavy chain (o:) and K- or X-light chains 
(k/X) are indicated.
(/continued from previous page)
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for similar components in parotid saliva in Figs. 3.23 (c)-
(f ).
3.4.2. Discussion
All previous attempts to study human salivary proteins 
by 2-D PAGE have used modifications of the method of 
O'Farrell (1975) which involved IEF in carrier ampholyte- 
containing rod gels in the first dimension of fractionation 
and vertical SDS-PAGE gels in the second (Giometti and An­
derson, 1980; Bustos and Fung, 1981; Marshall, 1984). Mogi 
et a l ♦ (1986) performed 2-D PAGE of human salivary proteins
under non-denaturing conditions in which the second dimen­
sion gels were polyacrylamide gradient gels which did not 
contain SDS. The prolonged focusing time, usually overnight, 
necessary when performing IEF in rod gels makes cathode 
drift unavoidable, resulting in the loss of most basic 
proteins. A number of salivary proteins have high pi values, 
among them the 9 basic P R P 's isolated from parotid saliva by 
Kauffman and Keller (1979) and Kauffman et a l . (1986) and
the glycosylated basic PRP of Levine et a l . (1969).
As a result of cathode drift, many of the protein bands 
which were revealed by SDS-PAGE, such as the basic 
proline-rich proteins, could not be located on the 
0' Far rell-type 2-D PAGE gels. Some of the protein spots in 
these gels exhibited considerable horizontal streaking, im­
pairing the resolution of the spots and possibly masking 
other spots. The streaking effect is probably due to the
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fact that when IEF is performed using carrier ampholyte- 
containing rod gels, the salivary samples were applied at 
the cathodic end; thus, upon application of an electric 
field, the carrier ampholytes, being smaller molecules than 
most of the salivary proteins, would migrate more quickly 
towards their respective pi's than the salivary proteins. 
This means that the pH gradient is already partially formed 
when most of the salivary proteins are still in the process
of migrating towards their respective pi's. In the process
of doing so, the salivary proteins are exposed to the high
pH values at the cathodic end of the IEF gel, resulting in
the precipitation and denaturation of some proteins.
The use of IPG's for the first dimension of 2-D PAGE 
avoids the occurrence of cathode drift and thus allows basic 
proteins to be focused. Other advantages of using IPG's in­
clude the option of fractionating saliva samples without 
prior desalting. By contrast, when using 0'Farrell-type 2-D 
PAGE, the saliva samples had to be extensively dialysed 
prior to IEF. As IPG's are horizontal, flat-bed gels, the 
samples may be applied at the point on the gel that results 
in the best resolution of the protein bands. This is not 
possible when performing 0 1 Farrell-type 2-D PAGE as the 
first dimension involves IEF in carrier ampholyte-containing 
rod gels, and therefore the samples must be applied at the 
anodic or cathodic ends of the gels. IPG's also offer the 
possibility of designing the pH profile to provide optimum 
resolution of the proteins of interest. Thus IPG's are
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well-suited for use in 2-D PAGE. The superiority of IPG's 
over carrier ampholytes is illustrated by the fact that 
wheareas none of the basic P R P 's could be visualised on 
0'Farrell-type 2-D gels (Figs. 3.21(a) and (b)), about 10 
spots of pi ' s > 8 are evident in a 2-D PAGE gel in which a 
pH 4-9 IPG was used in the first dimension (Figs. 3.22(a) 
and (b)). Also, the severe horizontal streaking seen on 
O ' Farrell-type 2-D gels did not occur in the 2-D PAGE gels 
with IPG's in the first dimension.
As the IPG's and the linear polyacrylamide gradient 
gels were cast on GelBond plastic backing, reproducible 2-D 
patterns could be obtained as the gels do not change in size 
during the staining and destaining procedures. More accurate 
comparisons of the protein spots between different gels is 
thus made possible. The second dimension separation was
performed using horizontal SDS-PAGE gels, which facilitates 
easier handling and optimum surface-to surface contact be­
tween the first- and second-dimension gels. In addition, the 
practice of casting the second dimension gels on plastic 
backing allows fairly robust thin-layer (0.5mm thickness) 
polyacrylamide gradient gels to be prepared (Gorg et a 1 . , 
1986). The improved cooling of such gels allows the applica­
tion of higher field strengths. This improves the resolution 
of the protein zones and makes short separation times pos­
sible, thus the time required for the second dimensional run 
is approximately 3 hours.
Prior to this study, the only previous attempts to
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identify some of the components on the 2-D PAGE gels of 
human salivary proteins were made by Giometti and Anderson 
(1980) and Mogi et al . (1984). Giometti and Anderson (1980)
performed 0'Farrell-type SDS-PAGE of human whole and parotid 
saliva, and identified components such as a-amylase, albumin 
and immunoglobulin light chains by co-electrophoresis of the 
purified proteins with human salivary proteins. Mogi et al. 
(1984) performed microscale 2-D PAGE of human sublingual and 
submandibular saliva, and by immunoblotting located the 
positions of secretory IgA, a-amylase, albumin and acid 
phosphatase in the 2-D gels. The positions of the P R P 1s 
could not be located on either 2-D map, however, as most of 
these proteins were almost certainly lost as a result of 
cathode drift.
2-D PAGE was performed using IPG's in the first dimen­
sion and SDS-PAGE in the second, and by immunoblotting of 
the gels, a 2-D map of human parotid salivary proteins in 
which most of the major spots have been identified has been 
constructed (Fig. 3.24). In this map, the P R P ' s are iden­
tified by their characteristic pink-staining with CBB R250 
and by comparison of their Mr ' s with those of purified PRP 
standards analysed by one-dimensional SDS-PAGE (Fig. 3.7).
The idea of a "human protein index" was first put for­
ward by Anderson and Anderson (1982). In such an index, all 
the different proteins from human cells, tissues and body 
fluids are catalogued by establishing their standard 2-D 
PAGE patterns, assigning a specific designation to each
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Fig. 3.24. G e n e ralised 2-D map of h u m a n  parotid salivary
proteins
PRP' s were identified by their pink-staining characteristic 
with CBB R250, and by correlation with results from Section 
3.2. The locations in the 2-D map of Ql-amylase, lactoferrin, 
secretory component, CH-heavy chain, K- and X- light chains, 
lysozyme and albumin were determined by immunoblotting; and 
that of the ConA-binding and PAS-positive components by cor­
relation with results from Section 3.2.
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protein and characterising the individual protein. The 
proteins, together with their properties, could be recorded 
in a database which will allow easy access to a large amount 
of data from which the information accumulated may be 
retrieved (Klose, 1989). Manual or computerised databases 
may be constructed, although databases of the latter type 
will certainly prove to be more useful for the long-term, 
world-wide classification of human proteins. Catalogues of 
human proteins from body fluids such as cerebrospinal fluid, 
amniotic fluid, urine and milk have been partially estab­
lished (Celis et al ♦ , 1989). The 2-D map described in this 
study is the first catalogue of proteins in human parotid 
saliva in which most of the proteins, including the PRP's , 
have been listed.
Even after silver staining, the 2-D PAGE gel of human 
parotid salivary proteins contained considerably less com­
ponents than the 2-D gels of Marshall (1984), in which 
human whole saliva was fractionated and over 600 components 
were detected in a single gel after silver staining. As 
whole saliva consists of the secretions from several glands 
contains many substances such as food debris, bacteria and 
sloughed-off cells from the oral cavity, it is likely that 
most of these components in the 2-D gelS of Marshall (1984) 
were not of glandular origin.
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3.5. Purification and Properties of the Anionic Parotid
Salivary Proteins Associated with Rheumatoid Arthritis 
and Sjogren's Syndrome
In order to investigate the nature of anionic salivary 
proteins associated with RA and SS by electrophoretic 
analysis, acidic range IPG's of pH ranges 3.5-5.0 and 2.8- 
4.5, were prepared and used in both one- and two-dimensional 
analytical systems. Fast Protein Liquid Chromatography 
(FPLC) was also used.
3.5.1. Isoelectric Focusing in pH 3.5-5.0 IPG's
3.5.1.(i) pH Profile
The pH profile of a pH 3.5-5.0 IPG, determined by means 
of coloured pi markers, is shown in Fig. 3.25. The gradient 
appears to be approximately linear.
3.5.1.(ii) Isoelectric Focusing under Non-Denaturing Condi­
tions
Parotid salivary proteins from RA patients, SS patients 
and normal healthy individuals were fractionated in pH 3.5-
5.0 IPG's containing 0.5% (w/v) pH 3.5-5 Ampholine in 20%
(w/v) glycerol, i.e. under non-denaturing conditions. Silver 
staining of the gels revealed multiple additional bands of 
pi's between 4.2 and 4.8 in the RA and SS patients, which 
were not detectable, or present at only very low levels, in 
the normal controls. These bands, however, were not well- 
resolved (Fig. 3.26).
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F i g . 3.25. pH profile of a pH 3.5-5.0 IPG
The IPG was rehydrated with 20% (w/v) glycerol containing
0.5% (w/v) pH 3.5-5 Ampholine. BDH narrow range (pH 2.4-
5.65) coloured pi markers were used.
All the protein markers indicated were coloured and could be 
visualised without prior staining.
Figure 3.25
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Fig. 3.26. IEF, under non-denaturing conditions, of parotid 
salivary proteins in a pH 3.5-5.0 IPG
The gel was rehydrated with 0.5% (w/v) pH 3.5-5 Ampholine in 
20% (w/v) glycerol. One hundred fig of parotid salivary
protein, which had previously been concentrated by 
lyophilisation, was applied to each track. Samples from nor­
mal individuals were applied to the odd-numbered tracks, 
while samples from RA patients were applied to the even- 
numbered tracks. The gel was silver stained.
Figure  3 . 2 6
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3.5.1.(iii) Effect of Urea on the Band Patterns
In order to investigate whether the addition of urea to 
IPG's of pH range 3.5-5.0 would improve the resolution of 
the parotid salivary proteins, an IPG of this pH range was 
prepared which contained a 0-8 M urea gradient perpendicular 
to the pH gradient. A continuous zone of parotid salivary 
protein from a normal healthy subject, which had previously 
been concentration by lyophilisation followed by reconstitu­
tion with distilled water, was applied along the length of 
the gel at a distance of 2cm from the cathodic strip. After 
IEF and silver staining, it was found that the resolution of 
the protein bands improved with increasing urea concentra­
tion, and all the bands displayed a slight pi shift towards 
the anode with increasing urea concentration (Fig. 3.27). 
Below 3M urea, most of the bands were poorly resolved, but 
above that concentration, the resolution steadily improved 
and was optimum between 6-8 M urea. Based on this observa­
tion, 8M urea was included in the rehydration solution for 
all subsequent IPG's of pH range 3.5-5.0.
3.5.1.(iv) Isoelectric Focusing Under Denaturing Conditions
When 100/xg (Fig. 3.28(a)) and 50fig (Fig. 3.28(b)) loads
of protein from RA patients, SS patients and normal controls 
were fractionated in pH 3.5-5.0 IPG's containing 8M urea, 
silver staining revealed that the anionic salivary proteins 
associated with RA and SS were resolved in 20 or more well-
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Fig. 3.27. IEF of a continuous zone of parotid salivary
proteins applied 2cm from the cathode throughout the length 
of a gel in a pH 3.5-5.0 IPG superimposed with a transverse 
0-8 M urea gradient
Protein (10.5mg) from a normal healthy individual was ap­
plied to a gel containing a urea gradient perpendicular to 
its pH gradient. The gel was silver stained.
Arrowheads indicate bands the resolution of which improve 
with increasing urea concentration.
Figure  3 .2 7
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Fig. 3.28. IEF in a pH 3.5-5.0 IPG of parotid salivary 
proteins
Both gels were rehydrated with 8M urea in 20% (w/v) glycerol 
and 0.5% (w/v) pH 3.5-5 Ampholine.
In panel (a) the protein load on each track was 100^,g. 
Before application to the gel, the saliva samples were con­
centrated by lyophilisation followed by reconstitution with 
distilled water. The tracks in panels (a) and (b) marked 
"N" , "RA", "1SS" and "2SS" were loaded with samples from
normal healthy individuals, RA patients, primary SS patients 
and secondary SS patients, respectively.
In panel (b), the protein load on each track was 50ptg. The 
gels were silver stained.
Figure 3.28
(a)
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focused components of pi's between 3.65 and 4.75. In con­
trast, the normal subjects had few or no detectable proteins 
focusing in this pH range. In order to apply lOO^ig loads of 
protein, it was necessary to concentrate the parotid saliva 
samples by lyophilisation followed by reconstitution in a 
smaller volume of distilled water. For the application of 50 
fiq loads, no prior treatment was necessary, and the samples 
could be applied directly onto the gels after centrifugation 
to remove any insoluble material.
Laser densitometry was carried out on silver-stained pH 
3.5-5.0 IPG's. Scans of samples from a normal healthy in­
dividual and a secondary SS patient are shown in Fig. 3.29. 
The SS patient displayed multiple peaks which were not 
detectable in the normal individual. However, as silver 
stain is non-monochromatic and non-stoichiometric (Poehling 
and Neuhoff, 1981), the densitometric scans are at best a 
semi-quantitative evaluation of the amount of the proteins 
present in the gel.
In total, parotid saliva samples from 32 normal healthy 
individuals (16 male and 16 female), 34 RA patients (11 
male and 23 female), 20 primary SS patients (3 male and 17 
female), 18 secondary SS patients (all female), 26 patients 
with xerostomia (2 male and 24 female), 6 patients with 
sialadenitis (all female) and 4 patients with infection of 
the parotid salivary gland were analysed using pH 3.5-5.0 
IPG's followed by silver staining. The results are sum­
marised in Fig. 3.30.
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Fig. 3.29. Laser densitometry of silver-stained pH 3.5-5.0
IPG 1 s
The gels were rehydrated with 8M urea in 20% (w/v) glycerol
and 0.5% (w/v) pH 3.5-5 Ampholine.
Panel (a) shows the densitometric scan of an IPG loaded with 
lOOjLtg of parotid salivary protein from an normal healthy in­
dividual .
Panel (b) shows the densitometric scan of an IPG loaded with 
100 fig of parotid salivary protein from a secondary SS 
patient.
The profiles shown were obtained with backgound subtraction 
but without filtering, enhancement or boosting.
Figure 3.29
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Fig. 3.30. Histogram showing results of isoelectric focusing 
in pH 3.5-5.0 IPG's
Fifty^g loads of parotid salivary protein from normal heal­
thy individuals, and patients with RA, primary SS, secondary 
SS, xerostomia, sialadenitis and parotid gland infection 
were fractionated in pH 3.5-5.0 IPG's which were silver 
stained. In the histogram, "N", "RA", "1SS", "2SS", "xero.",
"sial." and "PGI" refers to normal subjects, and patients 
with RA, primary SS, secondary SS, xerostomia, sialadenitis 
and parotid gland infection, respectively.
The gels had previously been rehydrated with 8M urea in 20% 
(w/v) glycerol and 0.5% (w/v) pH 3.5-5 Ampholine. After
staining, the samples were classified into two groups; those 
who had visually detectable elevated levels of anionic bands 
and those in which such bands were only present at normal 
low levels and difficult to detect.
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Whilst a few of the normal controls and patients with 
disorders other than RA or SS were observed to contain 
elevated levels of the anionic salivary proteins, they were 
of a lesser intensity than in most of the RA or SS patients. 
An example of a normal individual with elevated levels of 
the anionic bands is shown in Fig. 3.37. Most of the RA and 
primary SS patients, and all of the secondary SS patients 
but one exhibited substantially increased levels of these 
proteins.
3.5.2. Isoelectric Focusing in pH 2.8-4.5 IPG's
The pH profile of a pH 2.8-4.5 IPG, determined using 
coloured pi markers, is shown in Fig. 3.31. The gradient ap­
pears to be approximately linear.
Urea was not added to IPG's of this pH range; the addi­
tion of urea was not possible because after the gels had 
been polymerised, they were used without the further wash­
ing, drying and rehydration procedures to which pH 3.5-5.0 
and pH 4-9 IPG's were subjected. These steps were omitted 
for pH 2.8-4.5 IPG's so that the gels would retain their 
glycerol density gradient which helps to prevent gel-burning 
in strongly acidic IPG's (Righetti et a l ., 1988).
Parotid salivary proteins from SS patients and normal 
healthy individuals were fractionated in pH 2.8-4.5 IPG's. 
The saliva samples from the SS patients had previously been 
analysed using pH 3.5-5.0 IPG's, and were found to contain 
strongly-staining anionic bands. Silver staining of the pH
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Fig. 3.31.pH profile of a pH 2.8-4.5 IPG
The IPG was run without the washing, drying and rehydration 
steps to which pH 4-9 and pH 3.5-5.0 IPG's were subjected. 
BDH narrow range (pH 2.4-5.65) coloured pi markers were 
used.
The protein markers of pi's 3.95 and 4.75 were coloured and 
could be visualised without prior staining, while the 
markers of pi's 3.65 and 4.25 were visualised after staining 
with CBB G250.
Figure 3.31
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2.8-4.5 IPG revealed no difference between the band patterns 
of the two groups, and no protein bands focused at a pH <
4.1 (Fig. 3.32). It is unlikely that the paucity of protein 
bands in this pH region is due to precipitation of the 
salivary proteins, as the pi marker proteins were well- 
focused.
3.5.3. Analysis by 2-D PAGE
As pH 3.5-5.0 IPG's have been found to give optimum 
resolution of the the anionic salivary proteins associated 
with RA and SS, IPG's of this pH range were used for the 
first dimension of 2-D PAGE.
3.5.3.(i ) 2-D PAGE of Parotid Salivary Proteins from Normal
Healthy Individuals
2-D PAGE of parotid salivary proteins from normal heal­
thy individuals, with pH 3.5-5.0 IPG's in the first dimen­
sion, followed by staining of the gels with CBB R250 
revealed only pink-staining spots (Fig. 3.33(a) and (b)). 
Their Mr ' s were approximately 26,000 to 30,000. The pink- 
staining components of M r 's approximately 26,000 and 28,000 
have been shown by SDS-PAGE to correspond to the acidic 
P R P 1s "A" and "C", respectively, of Bennick and Connell 
(1971) (Fig. 3.7(a)). These proteins were stained with a 
yellowish-brown colour by the silver staining procedure 
(Fig. 3.34(a) and (b)). 2-D PAGE revealed that there is con­
siderable individua1- to-individua1 variation in these
213
Fig. 3.32. IEF in a pH 2 .8-4 . 5 IPG of parotid salivary
proteins
The IPG was run without the washing, drying and rehydration 
steps to which pH 4-9 and pH 3.5-5.0 IPG's were subjected. 
The tracks marked "N", "1SS" and " 2SS" were loaded with SOfxq
loads of parotid salivary proteins from normal healthy in­
dividuals, primary SS patients and secondary SS patients, 
respectively. The track marked "pi" was loaded with pi 
marker proteins. The gel was silver stained.
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Fig. 3.33. 2-D PAGE, with pH 3.5-5.0 IPG in the first d i m e n ­
sion, of parotid salivary proteins followed by staining with 
CBB R25Q
One hundred [iq of protein from two different normal healthy 
individuals was applied to each gel (panel (a) and (b)).
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Fig. 3.34. 2-D P A G E , w i t h  pH 3.5-5.0 IPG in the first d i m e n ­
sion, of parotid salivary proteins followed by silver stain 
One hundredjLtg of protein from two different normal healthy 
individuals was applied to each gel (panel (a) and (b)). The 
arrowheads in panel (a) indicate faintly-stained components 
of Mr approximately 32,000 and pi's approximately 3.65-4.25.
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proteins, a phenomenon which Azen (1978) has attributed to 
genetic variation. Other than the acidic P R P 's , silver 
staining of the 2-D PAGE gels revealed faintly-stained com­
ponents of pi's 3.65-4.25 and Mr approximately 32,000 (Fig. 
3.34(a)). These components, however, could not be detected 
in other samples (Fig. 3.34(b)); possibly because they were 
below the detection limits in these samples.
3.5.3.(ii) 2-D PAGE of Parotid Salivary Proteins from RA 
and SS patients
Parotid salivary proteins from an RA and a secondary SS 
patient were analysed by 2-D PAGE, with pH 3.5-5.0 IPG's in 
the first dimension. Silver staining of the 2-D PAGE gels 
revealed that in addition to the acidic PRP's , there were 
strongly-staining components which were microheterogeneous 
with pi's of approximately 3.65-4.75 and an Mr of ap­
proximately 32,000 (Fig. 3.35(a) and (b)). These anionic 
salivary proteins were also visualised in a silver-stained 
2-D PAGE gel, with a pH 4-9 IPG in the first dimension (Fig. 
3 . 36) .
3.5.4. Identification by Immunoblotting
In order to identify the anionic salivary proteins as­
sociated with RA and SS, parotid salivary proteins from RA 
patients, SS patients and normal healthy individuals were 
fractionated in pH 3.5-5.0 IPG's which were subsequently 
electroblotted onto nitrocellulose membranes. Immunoblotting
217
Fig. 3.35. 2-D PAGE, with pH 3.5-5.0 IPG in the first d i m e n ­
sion, of parotid salivary proteins from RA and SS patients 
100/xg of protein from a secondary SS patient was applied to 
the gel in panel (a) while a similar load of protein from an 
RA patient was applied to the gel in panel (b) . The gels 
were silver stained.
Figure 3 .3 5
(a)
- 20.1
- 14.4
(b)
M r X  10
-3
20.1
.14.4
218
Fig. 3.36. 2-D PAGE, with pH 4-9 IPG in the first dimension,
of parotid salivary proteins from a secondary SS patient 
One hundredptg of protein was applied, and the gel was silver 
stained. The anionic proteins associated with RA and SS are 
indicated by arrowheads.
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was performed using the alkaline phosphatase-conjugated 
second antibody method of Blake et a 1 . (1984). These
electroblotted membranes were first probed using the follow­
ing antisera and antibodies: Rabbit antiserum to C-Reactive
Protein, rabbit antiserum to K-light chain, rabbit an­
tiserum to X-light chain, rabbit antiserum to secretory 
component, rabbit antiserum to human plasma kallikrein, 
sheep antiserum to C¥^-acid glycoprotein (orosomucoid), sheep 
antiserum to IgG ('y-chain specific), goat antiserum to IgA 
(Qf-chain specific), goat antiserum to human urinary (tissue) 
kallikrein and mouse monoclonal antibody to 
^ 2 - m i c r o 9l°fru l i n •
Following incubation of the membranes in the ap ­
propriate species-specific alkaline phosphatase-conjugated 
antibody solutions, the blots were developed in the sub­
strate solution for alkaline phosphatase.
None of the immunoblots gave a positive response, ex­
cept for the blot which had been incubated with commercial 
goat antiserum to human urinary kallikrein (HUK) which 
resulted in a weak staining reaction in a few of the tracks 
which had been loaded with RA and SS samples. These, 
however, were difficult to photograph. The use of 
laboratory-produced rabbit antiserum to HUK, however, did 
result in a strong staining reaction in RA and SS samples 
and a weaker staining reaction in the normal individuals 
(Fig. 3.37).
Two sets of control experiments were carried out. In
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Fig. 3.37. IEF in a pH 3.5-5.0 IPG of parotid salivary 
proteins and human urinary kallikrein followed by an im- 
munoblot for tissue kallikrein
The IPG was 1mm thick and cast on glass rather than on Gel- 
Bond film so as to facilitate easy removal prior to the 
e lectroblott ing step. The gel was incorporated with 0.5% 
(w/v) pH 3.5-5 Ampholine and 4.46M urea.
100jug of parotid salivary protein was applied to each track. 
The tracks marked "N" and "RA" were loaded with parotid 
saliva from normal healthy individuals and RA patients, 
respectively. The track marked "HUK" was loaded with 2fiq of 
human urinary kallikrein (HUK).
Rabbit antiserum to HUK was used as the primary antibody and 
anti-rabbit immunoglobulin-alkaline phosphatase-conjugate as 
the detecting antibody.

the first, after electroblotting, the membranes were in­
cubated with the anti-rabbit immunoglobulin-alkaline phos­
phatase conjugate and developed in alkaline phosphatase sub­
strate solution, omitting the stage where they were in­
cubated with the primary antisera. This did not result in 
any staining reaction. Another control experiment involved 
incubation of the blots in PBS containing non-immune rabbit 
serum (1:200 dilution), followed by incubation in a solution 
containing anti-rabbit immunoglobulin-alkaline phosphatase 
conjugate, and finally development of the blot in the sub­
strate solution for alkaline phosphatase. This procedure 
also did not result in any alkaline phosphatase signal in 
the blots after development.
Immunoblotting was also performed on RA, SS and normal 
parotid saliva which had been fractionated in 2-D PAGE gels, 
with pH 3.5-5.0 IPG's in the first dimension. Using the 
alkaline phosphatase-conjugated second antibody method of 
Blake et a l . (1984), both the commercial goat antiserum to
HUK and laboratory-produced rabbit antiserum to HUK produced 
either very weak or no staining reactions. This lack of sen­
sitivity could be due to the loss of some proteins from the 
IPG strips during the equilibration period of 30 minutes 
before they were applied to the second dimension gels.
In order to increase the sensitivity of the staining 
reaction, an amplification procedure, involving an alkaline 
phosphatase / anti-alkaline phosphatase (APAAP) complex was 
used. The 2-D PAGE gels were first electroblotted, and the
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blots then incubated in goat antiserum to HUK, followed by 
mouse monoclonal antibody to goat IgG, rabbit antiserum to 
mouse IgG and the APAAP complex. The second and third an­
tibodies served as the link between the primary antibody 
(i.e. goat antiserum to HUK) and the APAAP complex. 
Amplification of the alkaline phosphatase signal using 3 
stages of the APAAP amplification procedure (Cordell et al.,
1984) resulted in more strongly-stained bands of pi's be­
tween 3.65-4.75 and M r approximately 32,000 in the blots of 
the 2-D PAGE gels which had been loaded with salivary 
samples from a normal healthy individual and an RA patient 
(Figs. 3.38(a) and (b)). These parameters corresponded to 
those of the anionic salivary proteins associated with RA 
and SS, revealed after silver staining of 2-D PAGE gels 
(Figs. 3.35(a) and (b)). The control experiment, which con­
sisted of first probing the membrane using goat antiserum to 
human serum albumin followed by mouse monoclonal antibody to 
goat IgG, rabbit antiserum to mouse IgG and amplification 
of the alkaline phosphatase signal using 3 stages of the 
APAAP amplification procedure, did not result in any stain­
ing .
3.5.5. Enzymic Degradation of Parotid Salivary Proteins with
Exo- and Endo-Glycosidases
3.5.5. ( i) Neuraminidase Treatment
In order to investigate whether differing amounts of 
sialic acid in the oligosaccharide side chain is a con-
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Fig. 3.38. 2-D PAGE, with pH 3.5-5.0 IPG in the first dimen­
sion, of parotid salivary proteins followed by an immunoblot 
for tissue kallikrein
Fifty fig of proteins from a normal healthy individual was 
applied to the gel in panel (a), and a similar load from an 
RA patient to the gel in panel (b).
Goat antiserum to human urinary kallikrein was used as 
the primary antibody, followed by 3 stages of APAAP complex 
for detection.
The components visualised are indicated by arrowheads.
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tributory factor to the charge heterogeneity of the anionic 
proteins being studied, neuraminidase-treated and control 
parotid saliva samples from RA patients, SS patients and 
normal healthy individuals were fractionated in pH 3.5-5.0 
IPG's and 2-D PAGE gels with pH 3.5-5.0 IPG's in the first 
dimension. The neuraminidase incubations had previously been 
carried out for 18 hours . It was found that incubation with 
neuraminidase resulted in the loss of the anionic bands and 
also the bands which cross-reacted with antiserum to HUK 
(Fig. 3.39, Fig. 3.40). This finding was also confirmed by 
2-D PAGE of parotid salivary proteins from an SS patient, 
with pH a 4-9 IPG in the first dimension (Fig. 3.41). Im- 
munoblotting of the pH 3.5-5.0 IPG's using goat antiserum 
against urinary kallikrein revealed that the immunoreactive 
protein bands, both in an RA patient and in a normal healthy 
individual were removed by neuraminidase treatment (Fig. 
3.42). Attempts to determine the pi's of the digested com­
ponents by immunoblotting a pH 4-9 IPG were unsuccessful be­
cause of non-specific binding of the antiserum to the 
isozymes of a -amylase.
3.5.5. (ii) Endo F and PNGase F Treatment
The results from neuramindase treatment suggests that 
the anionic bands and the bands which cross-reacted with an­
tiserum to HUK are sialated. If the sialic acid residues 
are located on oligosaccharide moieties which are suscep-
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Fig. 3.39. IEF in a pH 3.5-5.0 IPG of control and
neuraminidase-treated parotid salivary protein
The IPG was rehydrated with 8 M urea in 20% (w/v) glycerol
and 0.5% (w/v) pH 3.5-5 Ampholine.
One hundred fig of parotid salivary protein was applied to 
each track. The tracks labelled "1" were loaded with parotid 
saliva from a normal healthy individual, the tracks labelled 
"2", "3" and "4" were loaded with parotid saliva from RA
patients and the tracks labelled "5" and "6" were loaded 
with parotid saliva from secondary SS patients. The super­
script "n" refers to neuraminidase-treated samples, while 
and the superscript "u" refers to control samples which had 
been treated under the same buffer conditions in the absence 
of the enzyme.
The gel was silver stained.
Figure 3 . 3 9
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Fig. 3.40. 2-D PAGE, with pH 3.5-5.0 IPG in the first dimen­
sion, of native and neuraminidase-treated parotid salivary 
protein from a secondary SS patient
One hundred^g of protein was applied to each gel.
The gel in panel (a) was loaded with native parotid saliva 
while the gel in panel (b) was loaded with neuraminidase- 
treated parotid saliva.
The gels were silver stained.
Figure 3 .4 0
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Fig. 3.41. 2-D PAGE, with pH 4-9 IPG in the first dimension,
of native and neuraminidase-treated parotid salivary
protein from a secondary SS patient
One hundred^g of protein was applied to each gel.
The gel in panel (a) was loaded with native parotid saliva 
while the gel in panel (b) was loaded with neuraminidase- 
treated parotid saliva.
The gels were silver stained.
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Fig. 3.42. IEF in a pH 3.5-5.0 IPG of control and
neuraminidase-treated parotid salivary proteins followed by 
immunoblot for tissue kallikrein
The IPG was 1mm thick and cast on glass rather than on Gel- 
Bond film so as to facilitate easy removal prior to the 
electroblotting step. The gel was incorporated with 0.5% 
(w/v) pH 3.5-5 Ampholine and 4.46M urea.
FiftyjLig of parotid salivary protein was applied to each 
track. The tracks marked "1" and "2" were loaded with 
parotid saliva from a normal healthy individual and an RA 
patient, respectively. The superscript "n" refers to 
neuraminidase-treated samples and the superscript "u" refers 
to control samples which had been treated under the same 
buffer conditions in the absence of the enzyme.
Goat antiserum to human urinary kallikrein was used as the 
primary antibody, followed by 3 stages of APAAP complex for 
detect ion.
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tible to hydrolysis by endoglycosidases such as Endo F and 
PNGase F, then incubation of the salivary samples with these 
enzymes should also cause a shift in the pi's of the anionic 
bands and the bands which cross-reacted with antiserum to
H U K . Although Endo F and PNGase F are more effective in
deglycosylating N-linked oligosaccharides from SDS-denatured 
proteins (Elder and Alexander, 1982; Tarentino et al . ,
1985), there were insufficient amounts of the salivary
samples for such an experiment to be carried out.
As Endo F and PNGase F have been reported, in some
cases, to be able to effect the deglycosylation of N-linked
oligosaccharides from native glycoproteins, an attempt was
made to deglycosylate N-linked oligosaccharides from
salivary proteins in their native states. For this purpose,
control and Endo F- and PNGase F-treated parotid saliva from 
an RA patient and a normal healthy individual, together with 
HUK were fractionated in a pH 3.5-5.0 IPG which was then sil­
ver stained (Fig. 3.43). While incubation of the RA sample in 
the enzymes resulted in a substantial decrease in the intensity 
of the anionic bands, the process of deglycosylation did not 
appear to be exhaustive, even after an incubation time of 18 
hours, as faintly-stained bands could be observed in the tracks 
which had been loaded with Endo F- and PNGase F-treated samples. 
Endo F did not appear to have any effect on the band patterns 
of HUK, while PNGase F appeared to decrease the intensity of 
some bands.
IEF in a pH 3. 5-5.0 IPG of Endo F- or PNGase F-treated
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Fig. 3.43. IEF in a pH 3.5-5.0 IPG of control, Endo 
F-treated and PNGase F-treated parotid salivary proteins and 
urinary kallikrein followed by silver staining 
The gel had previously been rehydrated with 8M urea in 20% 
(w/v) glycerol and 0.5% (w/v) pH 3.5-5 Ampholine.
The tracks labelled "1" were loaded with samples from a nor­
mal healthy individual and the tracks labelled "2" were
loaded with samples from a secondary SS patient. The tracks 
labelled "3" were loaded with HUK. The superscripts "u", "e"
and "p" refer to control, Endo F-treated and PNGase 
F-treated samples, respectively. The controls had been 
treated under the same buffer conditions in the absence of 
either enzyme.
Fifty ju,g of parotid salivary protein was loaded to each of 
tracks 1" and "2", and 2 i^g of HUK to each of tracks "3".
Figure  3 . 4 3
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and control parotid salivary protein from a normal healthy 
individual and an RA patient, followed by an immunoblot for 
tissue kallikrein, showed that the pi's of the immunoreac- 
tive bands were not affected by Endo F- or PNGase F treat­
ment (Fig. 3.44) and unlike neuraminidase treatment there 
was no change in their intensity.
2-D PAGE, with a pH 4-9 IPG in the first dimension, was 
also used to compare control and Endo F-treated parotid 
salivary proteins from an RA patient. This revealed that 
pi's of most of the anionic components associated with con­
nective tissue disorders were changed by incubation in Endo 
F (Fig. 3.45). Once again, attempts to immunoblot for the 
digested components, using goat antiserum to HUK and 3 
stages of the APAAP complex, were unsuccessful because of 
the weak cross-reaction between the components of interest 
and the antiserum to HUK, and also the occurrence of non­
specific binding of the antiserum to a-amylase.
One possible interpretation of these results is that 
the deglycosylation of the proteins which were immunoreac- 
tive with antiserum to HUK was not exhaustive or complete, 
and there may still have been sufficient levels of these 
proteins, even after deglycosylation, to be detected by im- 
munoblotting. Another possible interpretation of the results 
involving Endo F and PNGase F is that since these two en­
zymes changed the pi ' s of the anionic proteins associated 
with RA and SS whilst those of the bands which were im- 
munoreactive with antiserum to HUK remained unchanged, there
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Fig. 3.44. IEF in a pH 3.5-5.0 IPG of control, Endo F- and 
PNGase F-treated parotid salivary protein followed by im­
munoblot for tissue kallikrein
The IPG was 1mm thick and cast on glass rather than on Gel- 
Bond film so as to facilitate easy removal prior to the 
electroblotting step. The gel was incorporated with 0.5% 
(w/v) pH 3.5-5 Ampholine and 4.46M urea.
Fifty fig of parotid salivary proteins was applied to each 
track. The tracks marked "1" and "2" were loaded with 
parotid saliva from an RA patient and a normal healthy in­
dividual, respectively. The superscript "e" refers to Endo 
F-treated samples, the superscript "p" refers to PNGase 
F-treated samples, and the superscript "u" refers to control 
samples. The controls had been treated under the same buffer 
conditions in the absence of either enzyme.
Rabbit antiserum to human urinary kallikrein was used as the 
primary antibody and anti-rabbit immunoglobulin-alkaline 
phosphatase-conjugate as the detecting antibody.
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Fig. 3.45. 2-D PAGE, with pH 4-9 IPG in the first dimension,
of control and Endo F-treated parotid salivary proteins from 
an RA patient
One hundred^tg of protein was applied to each gel.
The gel in panel (a) was loaded with a control sample, while 
the gel in panel (b) was loaded with an Endo F-treated 
sample. The arrowheads in panel (a) indicate the anionic 
components associated with connective tissue disorders.
The control had been treated under the same buffer condi­
tions in the absence of the enzyme.
Both gels were silver stained.
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may be in fact be two groups of proteins which focus in the 
pH range under investigation, one of which is tissue kallik­
rein and another which is not.
By contrast, neuraminidase treatment had a profound ef­
fect on the pi's of the immunoreactive bands (Fig. 3.42) and 
the silver stained components (Fig. 3.39) probably because 
N-acetylneuraminic acid, being the terminal sugar residue in 
the oligosaccharide side-chain of a sialated glycoprotein, 
is more easily removed than the intact oligosaccharide 
side-chains.
3.5.6. Studies on Human Urinary Kallikrein
HUK was fractionated in a urea-containing pH 3.5-5.0 
IPG which was then silver stained, and was found to display 
charge heterogeneity with approximately 12 pi forms which 
focused between pH 4.25-4.90 (Fig. 3.46). Parotid saliva 
samples from a normal healthy individual with relatively 
high levels of the anionic protein bands and from an SS 
patient were also fractionated in the same gel, and some of 
the bands in these samples focused at the same pi ' s as a 
number of the bands of HUK (Fig. 3.46). 2-D PAGE, with a pH
3.5-5.0 IPG in the first dimension, revealed that HUK has an 
M r value of approximately 40,000 (Fig. 3.47(a)).
HUK is sensitive to neuraminidase treatment, after 
which there was reduced heterogeneity and its pi ' s being 
shifted to approximately 4.8-5.0 (Fig. 3.47(b)). This shows 
that the charge heterogeneity in HUK is also largely due to
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Fig. 3.46. IEF in a pH 3.5-5.0 IPG of human urinary kallik­
rein and parotid salivary proteins
The gel was rehydrated with 8M urea in 20% (w/v) glycerol
and 0.5% (w/v) pH 3.5-5 Ampholine.
Two/ig of human urinary kallikrein was applied to the 
tracks labelled "1" and "2". Tracks "3" and "4" were each 
loaded with 50 fig of parotid salivary protein from a normal 
healthy individual and an RA patient, respectively. The nor­
mal subject selected had a higher level of anionic bands 
than other normal subjects.
The gel was silver stained.
Figure 3.46
Fig. 3.47. 2-D PAGE, with pH 3.5-5.0 IPG in the first dimen­
sion/ of control and neuraminidase-treated human urinary 
kallikrein followed by immunoblot for tissue kallikrein 
Twojug of human urinary kallikrein (HUK) was applied to each 
gel. The gel in panel (a) was loaded with control HUK while 
the gel in panel (b) was loaded with neuraminidase-treated 
HUK. The control had been treated under the same buffer con­
ditions in the absence of the enzyme.
Rabbit antiserum to HUK was used as the primary antibody and 
anti-rabbit immunoglobulin-alkaline phosphatase conjugate as 
the detecting antibody.
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differing contents of sialic acid in its oligosaccharide 
side-chains.
In an attempt made to deglycosy late HUK in its native 
state, with Endo F and PNGase F, IEF in a pH 3.5-5.0 IPG 
followed by immunoblott ing for HUK showed that the en- 
doglycosidases Endo F and PNGase F had no effect in alter­
ing the pi's of the immunoreactive bands (Fig. 3.48).
3.5.7. Separation of Parotid Salivary Proteins by FPLC
3.5.7.(i) Analysis of FPLC Fractions by SDS-PAGE and Im­
munoblot ting
S’Q/npleS'
Parotid saliva^from a normal healthy individual and an 
RA patient (the latter had previously been found by IEF in a 
pH 3.5-5.0 IPG to contain strongly-stained anionic bands) 
were fractionated by FPLC in a Pharmacia Mono-Q anion ex­
change column.
Fractionation by FPLC of parotid saliva from the normal 
healthy individual and the RA patient produced approximately 
15 well-resolved peaks (Figs. 3.49(a) and (b) ) . Subsequent 
fractionations by FPLC of parotid saliva from 7 normal heal­
thy subjects, 12 RA patients and 9 SS patients seemed to in­
dicate that the differences in the peak patterns of the FPLC 
traces of the normal subjects and those of the RA or SS 
patients were due to individual-to-individua1 variation in 
these patterns, and no peaks that could be clearly iden­
tified as characteristic of RA or SS could be observed.
Fractions corresponding to each peak were collected,
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Fig. 3.48. IEF in a pH 3.5-5.0 IPG of control, Endo F- and 
PNGase F-treated human urinary kallikrein followed by im- 
munoblot for tissue kallikrein
The IPG was 1mm thick and cast on glass rather than on Gel- 
Bond film so as to facilitate easy removal prior to the 
electroblotting step. The gel was incorporated with 0.5% 
(w/v) pH 3.5-5 Ampholine and 4.46M urea.
Two fig of human urinary kallikrein was applied to each track. 
The track labelled "e" was loaded with Endo F-treated 
sample, the track labelled "p" with PNGase F-treated 
sample, and track labelled "u" with control sample. The con­
trol had been treated under the same buffer conditions in 
the absence of either enzyme.
Rabbit antiserum to human urinary kallikrein was used as the 
primary antibody and anti-rabbit immunoglobulin-alkaline 
phosphatase-conjugate as the detecting antibody.
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Fig. 3.49. Separation by F P L C , using an anion-exchange 
column (Mono-Q), of parotid salivary proteins from a normal 
healthy individual and an RA patient
Panel (a) shows the separation of proteins from a normal 
healthy individual.
Panel (b) shows the separation of proteins from an RA 
patient.
Column: Pharmacia Mono-Q HR 5/5, 5mm X 50mm; sample volume: 
0.5ml; mobile phase: 20mM bis-tris propane, pH 7.0, as the
initial buffer (A) and 1M sodium chloride in 20mM bis-tris 
propane, pH 7.0, as the final buffer (B); gradient: 0-30 %B 
from 3-14 minutes, 30-100 %B from 14-16 minutes; flow-rate: 
1 ml/min; detection: UV (214nm), 2.0 AUFS.
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and 50/xl of each was analysed by SDS-PAGE followed by silver 
staining (Figs. 3.50(a) and (b)). Comparison of the gel in 
Fig. 3.50(a) with that in Fig. 3.50(b) showed that the gels 
loaded with FPLC fractions from the RA patient exhibited 
protein bands of M r ' s between 27,000 and 30,000 in the 
tracks which had been loaded with FPLC fractions correspond­
ing to peaks 4-9, while in the normal healthy control 
similar bands were not detectable. The bands in the later 
fractions had slightly higher Mr values than those in the 
earlier fractions, a finding that could be explained on the 
basis of the proteins being glycoproteins which are 
heterogeneous in their oligosaccharide moieties; those with 
larger oligosaccharide moieties being eluted in later frac­
tions .
SDS-PAGE, followed by immunoblotting for tissue kallik­
rein using the alkaline phosphatase-conjugated anti-antibody 
method of Blake et a l . (1984), of the FPLC fractions from an
RA patient produced weakly stained immunoreactive bands cor­
responding to the protein bands of M r ' s approximately 
27,000. SDS-PAGE of these FPLC fractions was repeated, and 
another immunoblot for kallikrein was performed using the 
APAAP amplification method of Cordell et a 1 . (1984). This
procedure resulted in strongly stained bands of M r ap­
proximately 27,000 in the tracks loaded with FPLC fractions 
corresponding to peaks 4-9 being visualised (Fig. 3.51). 
Goat antiserum to human serum albumin was shown, by double 
radial immunodiffusion, not to cross-react with HUK. It was
241
Fig. 3.50. Separation by FPLC, using an anion-exchange 
column (Mono-Q), of parotid salivary proteins from a normal 
healthy individual and an RA patient, followed by SDS-PAGE 
and silver stain
Panel (a) shows an SDS-PAGE gel of parotid salivary protein 
fractions, separated by FPLC, of a normal healthy in­
dividual. The track labelled "PS" was loaded with 40 fig of 
parotid salivary proteins, while the tracks labelled "1" to 
"15" were each loaded with 50 pel of each FPLC fraction cor­
responding to peaks 1-15 in Fig. 3.49(b), in the order in 
which they were eluted.
Panel (b) shows an SDS-PAGE gel of parotid salivary protein 
fractions, separated by FPLC, of an RA patient. The track 
labelled "PS" was loaded with 40 fig of parotid salivary 
proteins, while the tracks labelled "1" to "15" were each 
loaded with 50 f/1 of each FPLC fraction corresponding to 
peaks 1-15 in Fig. 3.49(b), in the order in which they were 
eluted. The concentration of both gels was 12.5 % T .
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Fig. 3.51. Separation by FPLC/ using an anion-exchage column 
(Mono-Q)# of parotid salivary proteins from an RA patient 
followed by SDS-PAGE and immunoblot for kallikrein 
The track labelled "PS" was loaded with 40fig of parotid 
salivary proteins. The tracks labelled "1" to "15" were 
each loaded with 50ju,l of each FPLC fraction corresponding to 
peaks 1-15 in Fig. 3.49(b)# in the order in which they were 
eluted.
Goat antiserum to human urinary kallikrein was used as the 
primary antibody# followed by 3 stages of APAAP complex for 
detection.
The concentration of the gel was 12.5 %T.
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the control experiment, the procedure of which is similar to 
that described in Section 3.5.4, which involved using goat 
antiserum to human serum albumin instead of goat antiserum 
to HUK, but retaining all the other steps involved in the 
APAAP amplification method. This did not result in any- 
staining reaction.
The acidic P R P 1s , which have been shown by SDS-PAGE of 
purified standards to have M r ' s of approximately 26,000 and
28,000 (Fig. 3.7(a)) and tended to co-electrophorese with 
the anionic proteins associated with connective tissue dis­
orders, were more strongly bound to the anion-exchanger and 
were eluted in the fractions corresponding to peaks 12-15. 
These proteins were stained with a yellowish-brown colour by 
silver staining (Figs. 3.50(a) and (b)). SDS-PAGE, followed 
by staining with CBB R250, of fractions correponding to each 
FPLC peak showed pink-staining bands of M r ' s of ap­
proximately 26,000 and 28,000 in the tracks which had been 
loaded with fractions corresponding to peaks 12-15 (Fig. 
3.52) .
As the acidic P R P 1s and anionic proteins associated 
with connective tissue disorders were eluted in different 
fractions, FPLC provided a means of separating these two 
groups of proteins. As they have overlapping pi's and very 
close M r ' s , they could not be separated from each other by 
preparative IEF or SDS-PAGE. However, by performing FPLC in 
an anion-exchange column, the acidic P R P 's and the anionic 
proteins of interest were successfully separated with the
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Fig. 3.52. Separation by FPLC, using an anion-exchage column 
(Mono-Q), of parotid salivary proteins from a normal heal­
thy individual, followed by SDS-PAGE and Coomassie staining 
The tracks labelled "PS" was loaded with 40 peg of parotid 
salivary protein. The tracks labelled "1" to "15" were each 
loaded with 50 pci of each FPLC fraction corresponding to 
peaks 1-15 in Fig. 3.49(b), in the order in which they were 
eluted
The concentration of the gel was 12.5 %T, and it was stained 
with CBB R250.
Figure  3 . 52
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former being eluted in the later fractions. This provides 
the basis for the further characterisation of the anionic 
proteins associated with connective tissue disorders by 
SDS-PAGE followed by electroblotting onto PVDF membrane and 
the possibility of amino acid sequencing.
3.5.7.(ii) Electroblotting onto PVDF Membranes and Amino 
Acid Sequencing
As the FPLC fractions of parotid salivary proteins 
corresponding to peaks 4-9 have been shown by SDS-PAGE and 
immunoblotting to contain the anionic proteins associated 
with connective tissue disorders, these fractions were used 
for SDS-PAGE followed by electroblotting onto PVDF for the 
purpose of amino acid sequencing. After electroblotting, the 
PVDF membrane was stained with CBB R250. Following destain- 
ing of the membrane, the protein bands of interest (Mr 
27,000) were removed for amino acid sequencing. This proce­
dure is outlined in the flow-diagram in Fig. 3.53.
Staining with CBB R250 revealed faint bands of M r
27,000 (Fig. 3.54), which were cut out and used for amino 
acid sequencing. However, the quantity of protein (6 pmol) 
on the membrane was too low for a sequence to be obtained.
3.5.7.(iii) Assay for Tissue Kallikrein Activity in Parotid 
Saliva
The kallikrein activity in parotid saliva samples from 
normal healthy individuals and RA and SS patients was
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Fig. 3.53. Flow-diagram showing sequence of events from the 
separation of parotid salivary proteins from an RA patient 
to electroblotting onto PVDF membrane and amino acid se­
quencing
Path 1, which was followed before path 2, showed the 
presence of silver stained protein bands of M r 's between
27,000 and 30,000 in the fractions corresponding to peaks 
4-9 in Fig. 3.49; and that bands of M r approximately 27,000 
in these fractions were immunoreactive with goat antiserum 
to tissue kallikrein. On the basis of this information, the 
procedures outlined in path 2 were carried out, in which 
the fractions corresponding to peaks 4-9 were pooled 
together, concentrated and subjected to SDS-PAGE. The SDS- 
PAGE gel was then electroblotted onto a PVDF membrane which 
was subsequently stained with CBB R250, after which protein 
bands of Mr approximately 27,000 were visualised. These were 
cut out and used for amino acid sequencing.
Figure
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to human urinary kallikrein.
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Fig. 3.54. SDS-PAGE of the FPLC fractions from an RA patient
which contained the anionic proteins associated with RA and 
SS/ followed by electroblotting onto PVDF
The fractions which contained the anionic proteins of inter­
est, i.e. the fractions corresponding to peaks 4-9 in Fig. 
3.49, were pooled together and concentrated by overnight 
dialysis against 30% (w/v) polyethylene glycol, after which 
50{il was applied to each track of the SDS-PAGE gel. The con­
centration of the gel was 12.5 %T.
The SDS-PAGE gel was electroblotted onto a PVDF membrane 
which was stained with CBB R250. After destaining, bands of 
Mr approximately 27,000 were obtained. They were cut out of 
the membrane for the purpose of amino acid sequencing.
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measured using the chromogenic tripeptide substrate H-D- 
Val-Leu-Arg-NH-pNA. The absorbance values, measured at 
405nm, obtained from 9 patients (4 RA and 5 S S ) and 9 normal 
subjects were as follows:
Normal subjects
Mean= 2.27 X 10“3 U/ml
Standard deviation= 1.83 X 10-3 U/ml
RA/SS patients
Mean= 8.95 X 10-3 U/ml
Standard deviation= 5.48 X 10-3 U/ml
The Unit (U) of enzyme activity stated is the Interna­
tional Unit, which is defined as the amount of enzyme that 
causes the transfomation of 1 /jmol/min of the substrate.
The kallikrein activity is higher in the RA and SS 
patients than in the normal subjects.
3.5.7.(iv) Latex Slide Test for Rheumatoid Factors
Parotid saliva samples from 13 SS patients, 10 RA 
patients and 10 normal healthy individuals were tested using 
the latex slide test for the presence of rheumatoid factors. 
Four of the SS samples (or 31%) and 3 of the RA samples (or 
30%) exhibited agglutination of the human gamma-globulin- 
coated latex particles, which indicated a positive reaction. 
None of the samples from the normal healthy individuals 
resulted in agglutination. All 7 RA and SS patients whose
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parotid saliva exhibited rheumatoid factor activity were 
subjected to IEF in pH 3.5-5.0 IPG's and found to contain 
elevated levels of the anionic bands of interest.
3.5.8. Discussion
The anionic salivary proteins associated with connec­
tive tissue disorders have been investigated by Fischer et 
a 1 ♦ (1968) using paper electrophoresis, Herzberg et a 1 .
(1973) using disc electrophoresis, Chisholm et a l . (1973)
using IEF in carrier ampholyte-containing polyacrylamide rod 
gels and Mairs and Beeley (1985) using IEF in carrier 
ampholyte-containing flat-bed polyacrylamide gels.
The IPG technique developed during the course of this 
study has allowed parotid saliva samples to be focused 
without prior treatment except for centrifugation, therefore 
making it possible to analyse salivary samples as small as 
50 fjLl. This makes the IPG technique especially ideal for the 
analysis of salivary proteins from RA and SS patients, as 
many of them, especially the latter, suffer from xerostomia, 
which makes the collection of large volumes of saliva ex­
tremely difficult or even impossible. The use of IPG's has 
also allowed the pH profile to be designed to suit the 
proteins of interest. Thus, IPG's of 2 acidic pH ranges, pH 
2.8-4.5 and pH 3.5-5.0, were prepared to produce optimum 
resolution of the anionic salivary proteins. The addition of 
8M urea to pH 3.5-5.0 IPG's optimised the resolution of the 
focused bands. In this study, IEF in IPG's was utilised in
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order to further investigations into the nature of these 
anionic proteins. IPG's were used both in one- and two- 
dimensional systems.
The resolution of the protein bands obtained by IEF in 
IPG's was far superior to that obtained by IEF in carrier- 
ampholyte-based gels. In addition, because of the sen­
sitivity of the pH gradients of carrier-ampholyte IEF gels 
towards electrolytes, the saliva samples have to be desalted 
before they were fractionated in such gels. This n e c e s ­
sitates relatively large volumes of saliva (preferably > 
2ml). Using IEF in carrier ampholyte-containing flat-bed 
polyacrylamide gels, Mairs and Beeley (1985) found that the 
anionic proteins associated with connective tissue disorders 
tended to precipitate near their pi's, thus impairing the 
resolution of the focused bands. In this study, it was found 
that IEF in non-denaturing IPG's of pH range 3. 5-5.0 
produced poor resolution of these anionic proteins, but upon 
the addition of 8M urea to the gels, the resolution was 
greatly improved.
By performing IEF in urea-containing pH 3.5-5.0 hybrid 
carrier ampholyte-IPG's , the anionic salivary proteins as­
sociated with RA and SS have been found to display charge 
heterogeneity, with pi's 3.65-4.75.
Using 2-D PAGE with IEF in pH 3.5-5.0 hybrid carrier 
a m p h o l y t e - I P G 's in the first dimension and SDS-PAGE in 
linear polyacrylamide gradient gels in the second, followed 
by s i 1ver- st a i n i n g , the M r of the anionic proteins as­
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sociated with connective tissue disorders has been estab­
lished as approximately 32,000. In the 2-D PAGE gels which 
were loaded with parotid saliva from normal healthy in­
dividuals, protein spots of a similar M r were either not 
detectable or appeared as only faintly-staining components 
of pi's 3.65-4.25. Thus, on the basis of the evidence from 
silver staining of the 2-D PAGE gels alone, these proteins 
appeared to be less heterogeneous with respect to p i ' s in 
normal healthy individuals compared to the RA and SS 
patients.
In the majority of normal healthy individuals, these 
components were not evident in silver stained one­
dimensional pH 3.5-5.0 IPG's. That they were detectable in 
2-D PAGE, but not in IEF gels is probably because of the 
greater sensitivity exhibited by SDS-denatured proteins 
towards silver staining(Heukeshoven and Dernick, 1985).
IEF of human salivary proteins in IPG's of extremely 
acidic pH range (i.e. pH 2.8-4.5) produced no protein bands 
focusing below pH 4.1, and no differences could be detected 
between the IEF band patterns of RA or SS patients and that 
of normal healthy individuals. Therefore, there is little 
information to be gained by studying this pH range. However, 
in their study, Greaves et a 1 . (1989) chose to concentrate
on the protein bands focusing below pH 4 because the acidic 
P R P 's tended to dominate the IEF pattern above this pH 
value. Although pH 2.8-4.5 IPG's did not succeed in frac­
tionating the anionic proteins of interest, pH 3.5-5.0
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IPG's, however, provided optimum resolution of these 
proteins.
Using 2-D PAGE, acidic P R P 's of M r 's 26,000 and 28,000 
have been located in the pH 3.5-5.0 range. Although the 
acidic P R P 1s did not display charge microheterogeneity, they 
exhibited considerable individual-to-individual variation, 
which has been attributed to genetic polymorphism by Azen 
and Oppenheim (1973) and Azen (1978). The overlap in the 
pi's of the PRP's and that of the anionic salivary proteins 
associated with RA and SS, together with their close M r 
values have played a large part in hindering investigations 
into the nature of the latter group of proteins. However, 
2-D PAGE has successfully resolved these two groups of 
proteins, thus providing a valuable method for the further 
study of the anionic salivary proteins associated with con­
nective tissue disorders.
Although the anionic salivary proteins associated with 
RA and SS have been investigated by Fischer et a l . (1968),
Herzberg et a l . (1973), Chisholm et a l . (1973) and Mairs and
Beeley (1985), their identity remained uncertain until 
Greaves et a1 . (1989) reported that a number of the protein
bands focusing over the pH range 3-4 cross-reacted with rab­
bit antiserum to HUK. That the pi's of these bands were 
shifted by neuraminidase treatment led them to postulate 
that the salivary kallikrein in connective tissue disorder 
patients could be unusually glycosylated, i.e. in having 
higher contents of sialic acid, than the salivary kallikrein
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in normal individuals. Although immunoblotting was performed 
on isoelectrically focused parotid salivary proteins from 
connective tissue disorder patients and normal subjects with 
a high concentration of anionic proteins, no such experi­
ments were performed using samples from normal subjects with 
low concentrations of the anionic proteins. In addition, the 
resolution of the IEF gels appeared to be poor. Thus, the 
occurrence of novel or unusual glycosylation of salivary 
kallikrein in connective tissue disorder patients remained 
questionable. Another inadequacy of the study^Greaves et a l ♦ 
(1989) was the omission of the desalting procedure although 
carrier ampholyte-based IEF, the pH profile of which is sen­
sitive to electrolytes, was used. The salivary samples were 
freeze-dried and reconstituted to a protein content of 
6mg/ml, which entailed a four- to five-fold concentration, 
and applied to the IEF gels without prior dialysis. The high 
levels of electrolytes in parotid saliva will thus cause 
distortion of the pH gradient and impair the resolution of 
the protein bands. Finally, no attempts were made to improve 
the resolution of the pH range used, or to further charac­
terise the anionic proteins, for example, by establishing 
their Mr 's .
Immunob lot ting of the pH 3.5-5.0 IPG's and 2-D PAGE 
gels with pH 3.5-5.0 IPG's in the first dimension has 
demonstrated that the anionic salivary proteins associated 
with RA and SS focused within the same pH range as com­
ponents which were immunoreactive with both commercial goat
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antiserum to HUK and laboratory-produced rabbit antiserum to 
HUK. In the immunoblots of the IEF gels, the rabbit an­
tiserum produced a strong staining reaction, and the goat 
antiserum a weak reaction. However, in the immunoblots of 
2-D PAGE gels with pH 3.5-5.0 IPG's in the first dimension, 
both antisera produced weak staining reactions when the 
alkaline phophatase-conjugated anti-antibody method of Blake 
et a l . (1984) was used. The alkaline phosphatase signal was,
however, successfully amplified using APAAP complexes 
(Cordell et a l ., 1984), and the use of 3 stages of APAAP
complexes resulted in an intensification of the signal, both 
in the immunoblots of pH 3.5-5.0 IPG's and 2-D PAGE gels 
with pH 3.5-5.0 IPG's in the first dimension. The pi's and 
M r of the immunoreactive bands correlated closely with those 
of the RA- and SS-associated anionic salivary proteins which 
were visualised in 2-D PAGE gels after silver staining.
When parotid saliva from RA patients and normal healthy 
individuals was fractionated in pH 3.5-5.0 IPG's which were 
immunoblotted for tissue kallikrein using the alkaline 
phophatase-conjugated anti-antibody method of Blake et a l . 
(1984), the pi's of the immunoreactive bands were found to 
be 3.65-4.25. In RA patients, they were more intensely 
stained than in normal individuals. However, amplification 
of the alkaline phosphatase signal using APAAP complexes 
(Cordell et a 1 . , 1984) revealed immunoreactive bands of a
broader pi range, i.e. 3.65-4.75, both in the RA patients 
and in the normal individuals. In both the RA patients and
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normal individuals, the bands of pi's 4.25-4.75 are most 
probably the minor isozymes of salivary kallikrein, and 
therefore the alkaline phophatase-conjugated anti-antibody 
method was not senstive enough to detect them. They were, 
however, successfully visualised using APAAP complexes.
Silver staining of 2-D PAGE gels with pH 3.5-5.0 IPG's
in the first dimension revealed protein spots of pi's 3.65-
4.75 and Mr approximately 32,000 in the RA and SS
patients.The silver stained components of similar M r ,
however, were less heterogeneous in the normal individuals
(i.e. pi's 3.65-4.25). Silver staining failed to reveal the
bands of pi's 4.25-4.75 in the normal healthy individuals
although components in this pH range were detected by im-
munoblotting for kallikrein followed by amplification of the
alkaline signal using APAAP complexes. This may be explained
on the basis of the silver stain being less sensitive than
APAAP complexes for protein detection. However, in the RA
and SS patients, the level of salivary kallikrein is
■that
elevated and therefore the isozymes of pi's 4.25-4.75^could 
be detected by silver staining might correspond to this en­
zyme. The evidence obtained from the silver stained 2-D PAGE 
gels, with pH 3.5-5.0 IPG's in the first dimension, could 
also suggest that the parotid saliva of RA and SS patients 
contains a larger proportion of less sialated kallikrein 
than that of normal subjects if that is in fact its iden­
tity .
Preparative IEF is unsuitable for the purification of
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the anionic proteins of interest because of the presence of 
the acidic PRP's which focus over the same pH range. In ad­
dition, due to the closeness of the M r values (approximately 
26,000 and 28,000 for the acidic P R P ' s and 32,000 for the 
anionic proteins of interest), preparative SDS-PAGE would 
also be unsuitable for separating these two groups of 
proteins. However, FPLC using an anion-exchange (Mono-Q) 
column successfully separated these two groups of proteins 
as the acidic PRP's were more strongly bound to the anion- 
exchanger, and eluted in later fractions, than the anionic 
proteins associated with connective tissue disorders. This 
could provide a valuable step for the further purification 
of the anionic proteins associated with RA and S S . During 
the course of this study, attempts were made to subject the 
FPLC fractions containing these anionic proteins to further 
purification procedures, including size-exclus ion HPLC 
(Welling and W e i 1 i n g-Wester, 1989) and lectin-affinity
chromatography, including the use of Wheat Germ agglutinin 
and Ricinus Communis agglutinin (Gallagher, 1989). These at­
tempts were unsuccessful, mainly because of insufficient 
amounts of saliva samples.
When the FPLC fractions of an RA patient which con­
tained the anionic proteins of interest were analysed by 
SDS-PAGE in a 12.5 %T gel followed by immunobloting for kal­
likrein, the immunoreactive bands exhibited an M r of 27,000. 
This value agrees very well with the M r of purified 
salivary kallikrein, also determined by SDS-PAGE, estab-
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lished by Hare and Verpoorte (1982). However, in the linear 
polyacrylamide gradient gels which were used in the second 
dimension of 2-D PAGE, the components which were immunoreac­
tive with antiserum to HUK displayed an M r of 32,000. This 
discrepancy in Mr values is possibly due to the anomalous 
behaviour of kallikrein under the conditions for SDS-PAGE. 
Being a glycoprotein, it binds SDS only at the protein part 
of the molecule (Hames, 1981). Although there is some 
evidence that a number of glycoproteins do not behave 
anomalously in gradient SDS-PAGE gels, because in such gels 
molecular sieving would predominate over the anomalous 
charge effect caused by the reduction in SDS-binding, sialic 
acid-containing glycoproteins may still behave quite dif­
ferently under such conditions (Hames, 1981). Some of the 
carbohydrate moieties of HUK are sialated (Iketika et a l . , 
1983b) and the sensitivity of the pi's of salivary kallik­
rein towards neuraminidase treatment strongly suggests that 
it is a highly sialated glycoprotein. Thus the determination 
of the M r ' s of many glycoproteins by SDS-PAGE is very much 
an approximation. Fujimoto et a 1 . (1973) have reported that
the M r of salivary kallikrein, determined by gel filtration, 
was 28,000. However, when ultrafiltration was used, a value 
of 23,500 was established. These values are probably closer 
to the actual Mr of salivary kallikrein than the value ob­
tained by SDS-PAGE.
On the basis of the information obtained by immunoblot- 
ting, there is no evidence to suggest the occurrence of un-
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usual glycosylation of kallikrein in the parotid saliva of 
RA and SS patients. Instead, in the RA and SS patients, 
there appears to be an elevation in the levels of all the 
different pi forms of salivary kallikrein. The chromogenic 
assay for tissue kallikrein, used in this study, has shown 
that the enzyme activity was higher in RA and SS patients 
than in the normal subject. A similar finding in SS patients 
has also been reported by Friberg et a l . (1988).
Urinary kallikrein and the anionic proteins associated 
with connective tissue disorders were found to be sensitive 
to neuraminidase treatment, as was salivary kallikrein as 
demonstrated by immunob1otting, thus showing that the charge 
microheterogeneity in both is largely due to the differing 
contents of sialic acid in their carbohydrate moieties. In­
cubation of parotid saliva samples from an RA patient with 
Endo F or PNGase F followed by IEF in a pH 3.5-5.0 and sil­
ver staining revealed that the intensity of the anionic 
bands of interest was very substantially reduced by Endo F 
and PNGase F treatment. The process of d e g l y c o s y l a t i o n , 
however, did not appear to be complete as some anionic 
bands, although less intensely stained, could still be 
visualised in the IPG tracks which had been loaded with the 
Endo F- and PNGase F-treated samples. However, components 
detectable using an immunoblot for tissue kallikrein were 
still present in this pH region, and their intensity did not 
appear to be changed.
Immunoblott ing, using antiserum to HUK, of IPG's of pH
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range pH 3.5-5.0 which had been loaded with HUK also showed 
no change in the band pattern after Endo F or PNGase F 
treatment. It is possible that Endo F and PNGase F treatment 
may have resulted in a shift of some of the immunoreactive 
bands to pi values above that of the pH range of the IPG
used. However, immunob lotting of an IPG of broader pH range 
(i.e. pH 4-9) for kallikrein was unsuccessful; only non­
specific binding of the antiserum to HUK (to some of the 
isozymes of Ctf-amylase was observed.
Endoglycosidases such as Endo F and PNGase F may not 
be effective in the removal of large quantities of car­
bohydrates from glycoproteins as the intact molecules may 
not be accessible to the enzyme (Dunbar, 1987). Endo F will 
slowly hydrolyse high mannose oligosaccharides and complex 
biantennary oligosaccharides, but large amounts of the en­
zyme are required for complete deglycosylation (Tarentino et 
a l . , 1985). PNGase F effects the deglycosylation of some
glycoproteins with complex or mu 1tiantennary oligosac­
charides even in their native state. Glycoproteins with high 
mannose or hybrid carbohydrates require prior denaturation 
(e.g. by treatment in S D S ) to make them susceptible to 
deglycosylation, possibly due to the limited accessibility 
of these types of o l i g o s a c c h a r i d e s  in the n a t i v e  
glycoproteins (Mussar et a l . , 1989). In contrast, the pi's
of the silver stained anionic bands and the bands which were
immunoreactive to antiserum to kallikrein were readily al-
because
tered by neuraminidase treatment, almost certainly^the ter­
2 6 0
minal sialic acid residues are more accessible to the enzyme 
than whole oligosaccharide moieties. The amounts of parotid 
saliva from RA and SS patients and commercial HUK available, 
however, were insufficient for denaturation in SDS to be 
carried out prior to the enzymic digestions.
Evidence that the anionic salivary proteins associated 
with connective tissue disorders may be tissue kallikrein 
includes the close correlation between the pi's and Mr ' s of 
the silver stained and immunoblotted components in 2-D PAGE 
gels with pH 3.5-5.0 IPG's in the first dimension, and the 
results from neuraminidase degradation which showed that 
both HUK and the components in saliva which cross-reacted 
with antiserum to HUK are sialated.
Enzymic degradations in Endo F or PNGase F have shown 
that the anionic proteins associated with RA and SS are sus­
ceptible to degradation by these enzymes but HUK and 
salivary kallikrein do not appear to be as susceptible to 
such treatment. This result could be interpreted in two 
w a y s ; the first is that the deglycosylation effected by 
these enzymes was not complete, as is often the case when 
attempting to deglycosylate N-linked oligosaccharides from 
native glycoproteins (Dunbar, 1987; Tarentino et al . , 1985;
Mussar et a l ., 1989). In addition, neither Endo F nor PNGase
F will have any effect in the removal of 0-linked oligosac­
charides from glycoproteins. The structures of carbohydrate 
side-chains of salivary kallikrein remain to be elucidated, 
but Kellermann et a 1 . (1988) have identified 6 carbohydrate
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side chains on the HUK molecule; 3 are N-glycosidically 
linked and the remaining 3 are O-glycosidically linked. The 
second possible interpretation is that salivary kallikrein 
and the anionic proteins associated with connective tissue 
disorders are two separate groups of proteins which focus 
close to one another in IPG's and are co-electrophoresed in 
SDS-PAGE gels. This may explain the slight discrepancy be­
tween the M r 's of the silver stained (Mr 's between 27,000 
and 30,000) and immunoblotted components (Mr approximately 
27,000) in the SDS-PAGE gels which had been loaded with the 
FPLC fractions of parotid saliva from an RA patient.
Although the IPG's of pH range 3.5-5.0 provided optimum 
resolution of the anionic proteins associated with connec­
tive tissue disorders, it was not suitable for comparing the 
IEF band patterns of native and glycosidase-treated HUK, 
salivary kallikrein or the anionic proteins associated with 
connective tissue disorders because after deglycosylation 
the pi ' s of most of the products appeared to have been 
shifted to values close to, or even beyond, the upper limit 
of the pH range. The formulae provided for IPG's of broader 
pH ranges, e.g. pH 4-7 or pH 4-9, do not, however cover the 
pH region of interest. When they finally become available, 
Immobilines of p K ' s 0.8, 3.1 and 10.3 will allow the
preparation of IPG's with ranges spanning the pH extremes 
(Altland, 1990), thus allowing the preparation of IPG's of, 
for example, pH 2.5-10.5. An IPG of such a range would make 
it possible to compare the IEF band patterns of native and
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enzymically-digested H U K , salivary kallikrein and the 
anionic proteins associated with connective tissue disorders 
on the same g e l .
The effect of drugs on the levels of the anionic 
proteins is difficult to assess as a wide variety of drugs 
is used in the treatment of RA and SS. Of the 13 primary SS 
patients who had high levels of the anionic bands, 9 were 
receiving topical treatment for dry eyes and mouth (such as 
tear and saliva substitutes) and drugs used in the treatment 
of xerostomia such as diuretics, antihistamines and an- 
tidepressives (Petersen, 1986). The majority of patients 
with xerostomia were also receiving these drugs, but they 
did not exhibit elevated levels of the anionic proteins. It 
is therefore unlikely that the presence of these proteins 
could have been induced by drugs. The remaining 4 of the 
primary SS patients who had high levels of the anionic bands 
were treated with the seed oil Efamol, which was obtained 
from a cultivated strain of evening primrose (Manthorpe and 
Prause, 1986). The mode of action of Efamol is unknown, al­
though it may have a weak immunomodulatory effect on pros­
taglandin biosynthesis. Its effect on the composition of 
saliva has not been investigated.
Drugs which are used in the treatment of SS and which 
are known to have an effect on the composition of saliva in­
clude bromhexine, which reduces the levels of sodium ions, 
slgA and IgG (Nahir et a 1 . , 1979) and corticosteroids
(prescribed in only very severe cases) which reduce the
2 6 3
level of kallikrein (Friberg et a l ., 1988). However, none of
the SS patients involved in this study were receiving either 
of these drugs.
The 17 secondary SS patients and 25 RA patients who had 
high levels of the anionic bands were receiving treatment 
with d i s e a s e  m o d i f y i n g  a n t i - r h e u m a t i c  drugs (e.g. 
salazopyrine, oral gold and penicillamine), immunosuppres­
sive drugs (e.g. flurbiprofen, ibuprofen, sodium salicylate, 
cyclophosamide and methotrexate and steroids (e.g. pred­
nisone and prenisolone) (Olsen et a l ., 1988; Arnold et a l .,
1988; Abramson and Weissman, 1989; Cush et a l . , 1990). Of
these, only steroids have been shown to have an effect on 
the composition of saliva. An example is corticosteroids 
which reduces the level of salivary kallikrein (Friberg et 
a 1 . , 1988). Both testosterone and the sodium-retaining
steroid fluodrocortisone, which are not used in the treat­
ment of RA or SS, increase the level of salivary kallikrein 
(Van Leeuwen et a l ., 1984; Horwitz et a l . , 1982).
Two of the 5 patients with sialadenitis, but without 
SS, whose parotid saliva samples were investigated in this 
study were receiving the immunosupressive drug flurbiprofen, 
another 2 were receiving steroid treatment and the remaining 
one not receiving any drugs. None of these patients, 
however, was found to exhibit high levels of the anionic 
proteins in their parotid saliva.
Thus, it is extremely unlikely that the levels of the 
anionic proteins associated with RA and SS could have been
2 6 4
elevated as a result of drug treatment. Some of the evidence 
in this study indicates that these proteins may be kallik­
rein. The levels of salivary kallikrein has been shown to be 
reduced by corticosteroid treatment (Friberg et al . , 1988).
Anti-inflammatory drugs such as corticosteroids act by in­
hibiting the production of prostaglandins (Friberg et a l . , 
1988), and prostaglandin-dependent mechanisms are involved 
in controlling the release of kallikrein (Vio et a l ., 1983). 
As the mode of action of disease-modifying anti-rheumatic 
drugs also involves the inhibition of prostaglandin biosyn­
thesis (Cush et a l ., 1990) it is highly possible that these
drugs may have a similar effect in lowering the levels of 
salivary kallikrein. No studies, however, have been made on 
the effect of disease-modifying anti-rheumatic drugs on 
salivary composition. The levels of salivary kallikrein in 
the SS patients, even after receiving corticosteroids, were 
higher than in the normal subjects (Friberg et a l ., 1988).
All the RA and SS patients whose parotid saliva was 
rheumatoid factor-positive were found, by IEF in pH 3.5-5.0 
IPG's, to have intensely-stained anionic bands. As the role 
of rheumatoid factors in the immunopathogenesis of RA and SS 
still remains obscure (Muller et a 1 ., 1989), the sig­
nificance of this is unknown. Rheumatoid factor has been 
demonstrated to be present in the saliva of SS patients, but 
has not been connected to any measurement of the severity of 
the disease (Atkinson et a 1 ♦ , 1989a). However, the levels of
r h e u m a t o i d  factor may r e f l e c t  the a c t i v a t i o n  of
265
B lymphocytes in the diseased exocrine glands (Muller et 
a l ., 1989 ) .
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4. General Discussion and Conclusions
Human saliva contains a number of proteins, some of 
which are of value for diagnostic purposes. At present the 
application of sialochemistry, in particular, the fractiona­
tion of human salivary proteins by electrophoretic methods, 
remains limited. One reason for this is the lack of 
familiarity of clinicians towards such techniques. Another 
is that many of the electrophoretic techniques currently 
used for fractionating human salivary proteins require con­
siderable preparation of the samples prior to fractionation. 
Preparation of saliva samples include the use of techniques 
such as centrifugation, lyophilisation, dialysis and 
denaturation (e.g. by treatment in SDS or urea). Such proce­
dures require relatively large volumes of saliva, which may 
be difficult to obtain from patients. In addition, they may 
result in the loss of some proteins, e.g. proteins of low M r 
may be lost by passage through dialysis membranes.
In this study, some of the latest electrophoretic tech­
niques which have resulted in high resolution of the 
separated components, including SDS-PAGE, IEF in IPG's and 
2-D PAGE using IPG's in the first dimension, have been 
utilised in the study of human salivary proteins. They were 
used in conjuction with protein detection methods of high 
sensitivity such as protein blotting and silver staining. 
These methods produced high resolution of the protein com­
ponents of human saliva. The IPG technique has allowed 
salivary samples to be fractionated with little prior
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preparation except for centrifugation, thus allowing rela­
tively large numbers of samples to be fractionated. 2-D PAGE 
may benefit from this if IPG's are used in the first dimen­
sion. All these developments have advanced the techniques 
for the analysis of human salivary proteins.
Although one-dimensional separation techniques such as 
SDS-PAGE or IEF may not successfully separate proteins of 
very close Mr or pi values. 2-D PAGE overcomes this problem. 
These techniques, together with immuno- and lectin-affinity 
blotting, were used to characterise the proteins in human 
parotid saliva. Most of the major components in SDS-PAGE 
and 2-D PAGE gels have been identified in this study.
IEF in hybrid carrier ampholyte-IPG polyacrylamide gels 
has made it possible to analyse the proteins in human saliva 
without prior desalting of the samples, thus allowing the 
proteins in small volumes of saliva to be analysed. IPG's 
were also used for the first-dimensional fractionation of 
salivary proteins in 2-D PAGE. In order to visualise or 
characterise the components in IEF and 2-D gels, sensitive 
protein detection techniques such as silver staining and im- 
munoblotting were used. Such detection procedures often did 
not require concentration of the salivary samples prior to 
electrophoretic separation, and as such are useful for the 
analysis of salivary proteins from patients with disorders 
which affect the functions of the salivary glands. After 
these techniques had been used in a general study of human 
salivary proteins, they were applied specifically to the
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investigation of the nature of the anionic salivary proteins 
associated with connective tissue disorders such as RA and 
SS.
Although the literature on sialochemistry in SS, and to 
a lesser extent in RA, is vast and still growing, 
sialochemistry has yet to achieve a significant role in the 
diagnosis and monitoring of patient progress in these disor­
ders (Thorn et a l . , 1989). Reasons for this include the un­
familiarity on the part of clinicians towards the techniques 
used in the chemical analysis of saliva, the lack of 
specificity or sensitivity of certain tests, and the lack of 
studies which have correlated the sialochemical data with 
the severity of the disorder. One of the few studies which 
have correlated sialochemical with clinical data is that of 
Michalski et a l . (1975) who found a direct relationship be­
tween the concentration of salivary Q 2 -m i-c roqlobulin an<3 the 
degree of local lymphocytic infiltration of the labial 
salivary glands in SS patients.
In view of its non-invasiveness, the possibility of 
using sialochemical data in the diagnosis and monitoring of 
the disease process in RA and SS remains an attractive one, 
especially when used in conjunction with one or more of the 
other clinical tests. Unlike biopsy and scintigraphy which 
are very painful to the patient, saliva samples are in most 
cases easily collected. However, a recurrent problem encoun­
tered when collecting saliva from SS patients is that be­
cause a large proportion of them suffer from xerostomia, it
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is difficult to collect large volumes of saliva (such as 
> 2ml). However, the electrophoretic and protein detection 
methods developed in the course of this study allowed the 
proteins in very small volumes (often < 50 (il) of saliva to
be analysed.
The results obtained by using IEF in IPG's and 2-D PAGE 
with IPG's in the first dimension followed by immunoblot- 
ting, indicate that there is some evidence that the identity 
of the anionic salivary proteins associated with RA and SS 
is tissue kallikrein. Future research could be carried out 
in order to elucidate the amino acid sequence of these 
anionic proteins and compare them with the sequence of uri­
nary kallikrein and other sequences on databases. If suffi­
cient volumes of saliva samples are available, salivary 
kallikrein might also be isolated, for example, following 
the method of Fujimoto et a l . (1973), its amino acid se­
quence obtained, and a more detailed comparison made. Alter­
natively, adsorption of parotid saliva with antiserum to 
H UK, followed by IEF in an IPG of pH range 3.5-5.0 fol­
lowed by immunoblotting to confirm that kallikrein removal 
is complete, and silver staining of the gel to ascertain 
whether or not this results in a decrease in the levels of 
the anionic salivary proteins associated with RA and SS 
could resolve this problem.
The diagnostic significance of kallikrein in SS is 
still uncertain. The function of tissue kallikrein, espe­
cially in saliva and the salivary glands, has not yet been
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elucidated. However, as tissue kallikrein has been localised 
mainly in the striated duct cells of the salivary glands, 
the levels of this enzyme in saliva may serve as a marker of 
striated cell function in SS, and may indicate the extent of 
damage to these cells (Thorn et a l ., 1989). However, using a
chromogenic substrate to measure the kallikrein activity in 
the whole saliva of SS patients, Friberg et al. (1988) 
failed to find any relationship between the extent of in­
flammation in the labial glands and kallikrein activity.
As immunoblotting of 2-D PAGE gels with pH 3. 5-5.0 
IPG's in the first dimension followed by amplification of 
the alkaline phosphatase signal using APAAP complexes has 
shown that the p i 1s of the components which were immunoreac- 
tive towards antisera to tissue kallikrein were the same 
both in the RA and SS patients and in normal subjects, it 
is unlikely that kallikrein in the saliva of these patients 
is more extensively sialated as postulated by Greaves et a l . 
(1989). However, in view of the number of reports of unusual 
glycosylation in some plasma proteins in the course of the 
inflammatory process, the carbohydrate moieties of salivary 
kallikrein in RA and SS deserve further investigation. The 
plasma proteins, the levels of which are increased, usually 
two- to a h u n d r e d - f o l d , during inflammation are often 
referred to as "acute-phase proteins" (Putnam, 1982). They 
are unrelated in their amino acid sequences, have different 
biological functions, and play an important role in the in­
nate immunity to infection. Many acute-phase proteins have
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high carbohydrate contents.
An example is Q^-acid glycoprotein, which is syn­
thesized by liver parenchyma cells (Nicollet et al , 1982).
Like many other acute-phase proteins, cy^-acid glycoprotein 
has a carbohydrate content of 45% of the total weight of the 
protein (Arnaud and Gianazza, 1982). A large degree of its 
charge microheterogeneity is due to uneven sialation. Some 
degree of heterogeneity is present after desialation, and 
the asialo-variants could represent different gene products.
Alterations in the microheterogeneity of a ^ -acid 
glycoprotein have been noted in the course of disease 
processes. For example, Mackiewicz et a l . (1986) found an
increase in Concavanalin A non-reactive variants in RA 
patients.
Another example of an acute-phase protein is 
Q^-antichymotrypsinogen, which is a serum protein (Mr ap­
proximately 68,000) with a carbohydrate content of 26%. In 
advanced cancer and RA its level remains high for many 
months (Bowen et al., 1982). Its carbohydrate portion is 
microheterogeneous, and in the event of acute diseases and 
there is an increase in Concavanalin A-binding variants.
Thus in view of these examples, the carbohydrate 
moieties of the anionic salivary proteins associated with RA 
and SS merit further studies. Methods that could be used for 
this purpose include lectin-affinity electrophoresis (Faye 
and Salier, 1989) and HPLC (Hounsell, 1986). Therefore fu­
ture work could consist of ascertaining whether or not the
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identity of the anionic salivary proteins associated with 
connective tissue disorders is kallikrein, and whether 
salivary kallikrein in RA and SS patients is abnormally 
glycosylated as compared with normal healthy individuals.
IEF of parotid saliva from RA and SS patients in IPG's 
of pH range 3.5-5.0 followed by silver stain to detect the 
presence of the anionic proteins of interest has shown good 
correlation between elevated levels of these bands and the 
diagnosis of the disorders; therefore, although further in­
vestigations are needed in order to establish the identity 
of the anionic proteins, the use of IEF to analyse saliva 
samples from connective tissue disorder patients is still 
potentially useful for diagnostic purposes.
In this study, using SDS-PAGE in gradient gels (the 
second dimension of 2-D PAGE), it was established that the 
M r of urinary kallikrein is approximately 40,000 while that 
of the component in saliva which cross- reacted with an­
tiserum to tissue kallkrein is approximately 32,000. Kallik- 
reins from different tissues are closely related or even 
identical in their polypeptides (Kellermann et a l . , 1988).
Hare and V e r p o o r t e  (1982) h a v e  e s t a b l i s h e d ,  using 
homogeneous SDS-PAGE gels, that the M r of human salivary 
kallikrein is 27,000. Thus on the basis of M r values it is 
almost certain that salivary kallikrein is less glycosylated 
than its urinary counterpart.
The m a m  difficulty encountered when attempting to 
purify salivary kallikrein is its low levels in human
273
saliva. For example, Fujimoto et a l . (1973) succeeded in 
isolating only 1.5mg of the enzyme from 4 litres of mixed 
human saliva. Although the level of kallikrein is elevated 
in the saliva of RA and SS patients, their low salivary 
flow-rates, especially in the SS patients, make the collec­
tion of reasonably large volumes very difficult or even im­
possible .
Urinary kallikrein occurs in both inactive and active 
forms. The inactive form has an additional 7 amino acid 
residues at the amino terminus of active kallikrein 
(Takahashi et a l ., 1986). Using a radioimmunoassay (RIA)
technique, Oza et a l . (1981) discovered that between half to
two-thirds of the kallikrein in urine occurs as the inactive 
form. The proportion of active to inactive forms of salivary 
kallikrein has not yet been ascertained. As the salivary 
kallikrein activity, measured by chromogenic assays, in SS 
patients is known to be elevated (Friberg et a 1 ., 1988)
there is obviously an increase in the active form of kallik­
rein in SS patients. However, if there is also an increase 
in the level of the inactive form of salivary kallikrein, 
chromogenic assay methods cannot give any indication of 
this. Therefore it is possible that IEF in pH 3.5-5.0 IPG's 
followed by immunoblotting for kallikrein could provide a 
more sensitive indication of the of the levels of salivary 
kallikrein, both active and inactive. An alternative method 
is the use of RIA to measure the kallikrein levels in human 
saliva.
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During the course of this study, attempts were made to 
visualise the active form of both urinary and salivary kal­
likrein following IEF in non-denaturing pH 3.5-5.0 IPG's by 
overlaying the focused gels with cellulose acetate membranes 
which had been impregnated with the fluorogenic substrate 
for kallikrein, D-Val-Leu-Arg-AFC (AFC = 7-amino-4- 
trifluoromethylcoumarin) (Smith, 1984). These attempts were 
unsuccessful, probably due to the low amounts of kallikrein 
present in parotid saliva, to the lack of sensitivity of the 
method used, or to the presence of a substantial amount of 
the enzyme in its inactive form.
Much of the protein analyses which have been carried 
out on human body fluids, including cerebrospinal fluid, 
urine, serum and saliva are still purely descriptive, and 
the functions and origins of many proteins have yet to es­
tablished (Bueler et a l ., 1989). Monitoring the levels of,
or the analysis of changes in glycosylation, of some of 
these proteins, such as the acute phase proteins in serum, 
is at present of significance in the diagnosis of a number 
of diseases. This study has concentrated in developing and 
refining electrophoretic techniques for the analysis of 
human salivary proteins, and has investigated and partially 
characterised the anionic salivary proteins associated with 
c o n n e c t i v e  tissue d i s o r d e r s  as an e x a m p l e  of how 
electrophoretic techniques may be of value in the diagnosis
of these disorders.
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